%PDF-1.6 % 58 0 obj <> endobj 71 0 obj <>/Filter/FlateDecode/ID[]/Index[58 23]/Info 57 0 R/Length 72/Prev 270772/Root 59 0 R/Size 81/Type/XRef/W[1 2 1]>>stream hbbd``b` $CA=`OAl3A,!"\Ab@ #I qO endstream endobj startxref 0 %%EOF 80 0 obj <>stream hb```a``2d`f`hc`@F f݆YFW~pC0˴ < F~2ym UT[86`Ska`~ [3,ˇ0 endstream endobj 59 0 obj <> endobj 60 0 obj <>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Type/Page>> endobj 61 0 obj <>stream hެ 0Ee~$ͣB)XPt%hu T.k^2 E(4J1XPUѓ޸d0X%7~}Ҧ?IޯuihF$-FYܰ!jgռJ/O endstream endobj 62 0 obj <>stream HWnF}W`~ik4m#cTI.]MÀ(Y;gf̜Y+n!B`I5447N/5`kNH~Pzd]'ʚDHdH@WNub&܁ Ev׬9@NU}IbAA*vɊP GZjӃq䝗CY욳cY6cTg/y6JiA3{,m>eM[5:+6{UnbH#a>"; ]ӑ.bɐbgTdM^t31 )/ TyjyPGxF?5|yi V>ryYPO ^p(t1 %gK>>/ަ 1FBPm1ߢgnG$61Ǵӥ&rT?A^F!uUus:ז +;=aK*\%}N`I0Etbު" X0Dp=i߳z)f0~irw?2;>#4.[xXP4 +LibEw*ėkư`%zq^"moYD7k*r@WW0~9R@N g!36(~;a އVDz![sߥ\4ʂqB3o=/g]bZ8{J<WrJ\p s"Aaq@n..K3Ő),2.a =jh!('E|,BsS4DQ_lo2Cbv͘id9P6mޞZk$Ȩ(H\you~ tӂ(WE{E;=omvțt].uw|zڟ7xlbDSf*eWV7yI`4C[ endstream endobj 63 0 obj <>stream HWnF+xqOK2`1s Rb"n.0|UU{jN>r>o$ݮ0X$]' Io+T$X!M%?Btub~>$S 1I" Ħ!CV{[}`!1$)ΟW[D/ a )6uz([[Y]ԝ3CҀcY}j7:/5Y/nFr" |7a#lv_m\Z]^ԕ C^eֹ*xlv&>}-X׃P<dJf٤=&zZ }S$;1nK \pyM[5׵-nB ~ܶ”IGޢzd3/-lQH#[y#Xerm;8ũALow~c(I3L A0l^P) SuA?t^m^M"L* Beo߂"!ւ4E>vV_ B&ka\~n1ǀ&h5oEfFE!%\&sS]̳?TuUV{E3EbvW= J %ɕ7~dcn9$ 0 r endstream endobj 64 0 obj <>stream HWMkHWLNW2 L2X[ȒW1﷤RKN`oUW{^URvJ(gX F8-VCS p"1D.B1#^n_~#$r0X6$%`FSHUjs 2$e GoQ*?0B:,L0Mݞ =3DXV^ CTuDMo"=- )\!A<݌GnW7?C>??Vut&9j ®[qo(rj&=Fd̏ A)|4[RS1|pkO}I"s,Dx_fV{N (c^B=(79cKv_p2gO*h7Al'OJB_î7c ?陹˕_Yxt$sgd&lAN]c''9&Os`oNH ;TNN'ν2[*t@eѨCJ80 >stream HWɎF+xvcN`pmGb" |}MfVZ^ի֋^w}/_y]"~zSiD4`+ Ƥ#C+j}\=[wln?VoOHd7C2Sl&WBk{om;dիt%`qg$!B^τ)I$ nm}Xə!a x'4I6O6Ai淶j{ h2g/Z/sNИ>E[7ٺ\KC^gg&Y9[",l?ECo7%ī[Ξu=OvN<Đt4 |mlrHRU;ΥE~ ln癠oAHcݟq $1ZST,lid!2G{]xb{qM&nb D-wR,'fj2DŌAY`#FMM^qgP/B!6T&gF~ ~5A1BY2 qD\6g.3##TYE/X^xpygQwsM3 G8E[iMj(? ,f@s΍L2D jv%,'fUyx>ŢIyG% umS9 H |w(M>TVje!i@EE'Q>i":-^(p$cDZ-,HVȈ;s$ OK,2+o,luyxY5뉤5lkx܅0=t]8gq"|N3͋(¢Q.!Y`N꾱Cqq8\.O%1Hp|Ӈc-()gO>|@V8Ԣ"'ReQ Re޺:◅*MLR[Az\quɮ豠qᳵm)qRII4 Cܘ ^¬_&u3Lx7?T09h`‘6pK*k79  v}Wa'p4گН<Gdq5þӈŊr\vvk\Ir1$[Hvu>!BcBX>stream HWێ6}߯cS$}+~,ӶZYruߑ!i"Ep49gPJl[exF]3q%I掹zls8 xHu12xn SKZ>x_,Xo.gYd13b6P#KS3hJPT6㩛';s19Qt){Vl|*ա+$äDsy[$vq`}x><6 (\Ǯ=͇ϟ>fO[' d0kA 2As˜8ΐForɯL֝$׊g0wc5\T]um՝lJbQR74̤ۯֆsk#1D@c7lz۔7=-jyZD3kŠB/Iwqq^^Pˤ0Kc>bOrSW>\Uy a.&X(ހO{8L-ҥ3/_#۹!A )PzŮp(.Z߄0Q1>Eӗ_^ZFbsF±Тzi f9#\lGpX H >eE5L,mQQk(xmID cF%H.)"@ěK #S<> :Fh"˺-PJt,8t qaCw =| =wxSh jn‘@~(?;nf咙v AٻՆ(xX˄skWZ~P|,X=`*r3``w ;0[g? W+hwp06OGȅ [ AXS(\{*j2vM7ЁԒ%wַdgyCDR!%wxswM0=o摰f>sc0tZxGL;e86N4V,[`h&+5L)6>bfVR0|2Dm|F|Ƣ^e}@;dKu@…~)fNWl~#@Ou78+=R$QK))rDJ{^<i}x!E{ @Hv!zlGSȄtEdWIv9j=87b4lٯM3?uXB1O Cæ0i ^ k.]*QM.h endstream endobj 67 0 obj <>stream HWo6 ~_pUEY?ulC{Qo8NmʒSpf@"E~s-,gȌg|b}kW9p !F23pt-׽ LXÜ$vSG#n{#0K{>@4SSI\8lף]>…@(.5.{L`h Y㹏dž̭qU~w"]*ph=bR]@OACC`4Li}Jbv#!]QxCH7tNIeOձMC[jI؀|Q.c@d!!{"Ŀ_.nNǃ/ÇOz>~-'&[)F4swh|PgEoECmg"2ЊY9B IJ3Qlsl:MQ z~|BB'][P3k.0ʝ јqz?>fxyj?`~ ;L *^kҪZ=Y1/}~+:gs@.RxJ1prHu %qLSgimps=~lPJQg֑h84x/} }u袺6TE)éM3P>):09AI3#$9d[qE[,^h0a>YH)V 3L(˩4xfEFo]K\su"<2]XY`[7J6 vW!\.bnf4qFXSXi+&4VpfNpEs5A-@b0e 'Kn:":::l&Ȱ/H< f/Vą^Bq-JwP:.̅J5$"0[$*41:w\m$HA;jrܳ9%$[gj h:gȃ%!#!TB8,* G i,r7 y)Qffj-¤2ZovNU'Sy\H̓bZ \gh]5ň`C W ;T:bk׫?z]vHC__[ endstream endobj 68 0 obj <>stream HWnF}W~rh74 hV#$$eW޸T( ;;;s̙]ެcA&# ßʔFk뛻`z/a6^(9Yoo9uE-ZJ>Z2D[nE7}$ΐ %gްhA*l?lڸpD/h6CǶف>f7k'wW`8GJb1#EU6m_d?7'c >]nXb(n<4`NOPV&`̖CP2ea'0*9XZ:hb= U,ή,u2DHBJ.ҾLͿ;Eb!. DŽZh$ġ8;ݜL+"l4C1m3Z+ q&D-s"3&lO~{ӛ"R.c*ʄZI ˛:ĕps8\  ^rxv7 8)2πݤ̚TL)pV>ves!us@#9eNxE4h_dlr84Q9T"`rNG>J1brI1&z]cJVNiS8ph;h(.#{Τ;'rtހ@9CʖE0LaTmcTs9E>}Qyx]{ȂU=8fLd!SI?2::1^ (eюRHxv˯N)pH\6}SFlvUQvdqQHP>dC-re[RHiʳQ&􎟖Tܵ]mIE<ޣ"9hڧ8Қ5Z'ٗ;X!OdJNsRv[fZ q*Ro A$4N!Xg''U GRàjIJ`5ribN1SvӤ5?5ҫ Ͷ!Q ؜/Ō$~[BEIȓ/w삥A24P1ʂq8߉.N˨K OI2+o\jfqi{.=%kCc23li!pi.hX#YxE( +4[OZWN'")j`=0 |A/pfwjr~cӾZ,JBRrҺ)&$2$A8SӠQF̱:I1A  $o endstream endobj 69 0 obj <>stream HVo6~_GH4{V @9'Y$HZ&x}ݺeo6(lSeQHH2.1imhHшmFvduU76\_I*?nV?ꜽ}{mvpݻ͆2ޭuR"?X^g>/օGY($Z#aF:6!ѹO~u! *\p O ǣiVjȧ 7JDv}0.!>t .x^?ugncfk > G]y N)5F\) lS٦:|WRCXFTꪫ϶pxrpGĘRQ~橠(tG:9,@ZXPkpuoeo  * V B9\ONI!OOQJ C-·+J'&r*9d0L'.x3vkz;NȊN3" Kj(=nD<54^xX|w/=p OB,$$81&%Tp\>F؇o$]Gv&# .%plV+3l*P(tW!S k8Q[ dK(-Nm׏d_Wr#&a R [Ӓ3T>=@-:jew$aJ7 :L~0bedn!NO*i i IX 2,$MmngvU cjsbs:6LRP q\=c ְyI97_ }fvH`:C=S^ }T`a>0o5n=))A M jAN5u5d^J|L&G=ɔ1Wb+vlT;re 0gV endstream endobj 70 0 obj <>/Filter/JBIG2Decode/Height 3505/ImageMask true/Length 22124/Name/X/Subtype/Image/Type/XObject/Width 2480>>stream 6H}Vn"h @!i- 5HnjX:"t[Vܙ0l,r՜CLD7 F4 Rd1}jBA7ϋ.imW9j^,mD!dz#o#ʬ"f_A_FǻuV7ObBnXBM3F 6fsm/xygDzm>v+fOgVLҌ\i3\_ :#颩;d<?HCe,dn3 gљYi%8eq&Z%5r0~0yR|]| ODE%9?MX:i$!QY{ yl w^/x:"dY&&Av#+Ǻ}5~ \u)kI}k#dѻ g4>~0 Iv =DiAW.lkY2]A{n5fT Ƌ l-ҊWhkT?8*OvhE`̱. > x$[8SBEk;Pκ'ZCA HEͮ4GD 8X^Lo~m-csu( ޓlat>dwͷھgtI$XMe(JMU'4 62vk]^A6-4(X2ʶo:\fx8Pj*VhzeHkMgj[/Lx'sg88To63єa\ ?Fx\(+Х<ނj q Q:*on ZBdûq{(Ȱ0NJt?ml._kb$n$F` Ūo@]]wUw1w _Ge1,l/w|#$ ]5x7ʀGe7'S66 w w~'}jtblWAz5{<9K$͸.1-zݵ% J)SL;FM`ހd D睭P:cOj8\/z>*{05#ADoD/߄:,Ϗr_/g>]7{eB/T8r5J\kV*Tl,]>w~8oX0us! b ,)w.(<Ͷ\$_kSOAцqMG)$;b/ TebW0X^WοH 1J|7ԬgPmў~xonIe ?ǠmPc&B#4xWC>mڔKM{ ?añQy %1Ny` P /;+pCkH2',_"!cHwG`\# OTo\&e1:i>7F03Mk/b\fU9Y=GTF+n< (Xx J뵶LG׉򟍒uS幜=|(vӲP`VrX])Ǩal/収&4^_Ӄ - ]y,a㧬p/[r p?`NfD *ƨ~5A<<7nCalIR'aj΋"Q{T'^?Nk\Eؐ:d8[(X殠etyH"> ?{JsP~q[$ | >?td+Ѭ,wӮx)jZ<U@:hRސsNgQ0mjdиuS G1ZU*?[ECϫmhc5%zAtn7 L5 5%{&Tx~CԳM4UjR EZ O^o+s_Qf 1/ӖЛSM=CB6O#roݝH@ؾKL:@≠ ' _{g+b6l_f~rӕLx9gv4|_@ @ϮQe>^]dޟe6d؂R=-da^hpJs|TfOxm`~҈a#EܶZ%0 nuc fT Tj9cyL/4Q0 @EIg'vS.p;]8 B"2I,/cnQ㰣퐥 aK."HDB:E 9puәC|9uXjBUtB RŻrt#"*#@LPUn{cS.gt%뙄G&-,л3NSn.;x[[_L̩}w [P&Mt5]!.[AbW0wXZpA ; É^;›,_ jV'!YVme[ xgKgVfVc4GiW o;q9k;՛"<w<c[FیV#vFi>Xtj?*lHa Yl@l/wy-<Ĺ~1aL[k䭦6fBfju15{j3HofV:M:{\sya !UD;D 7w3f&W^(QXQ,ho11pj'èaYXH6|fEӿKp(tڞwU եJ>RI{8^2dt0@|ޮKЁ_,}{뻩-1YA-j8βI>^$ʩ=?τ`5=Gzt+GHLXH>̄Wefe_mz$ FNp܎}Pms}ѰtNV j51C9`= ;s@HPP4Ax"Ixc`wsV}J8MUn_j)e W@pZݲs-2_&ɣWKT'VJWPt푶2}]i'?_Sbvœ!aSԣ'+h P$6 VQR Zu:'C%m$aΛmU 乁$Nm%|%Qa ?P &oH*A[W<"v ]%'8eOubƼmd7o0AIDԊ$lT71ݑd!e'zЉ3e,pI GX$^ bӳj,*k26LIw#ts,A,/kXcRG.4:[P*mQ-UƬj34-V}WGdj-)!f^1>0-נT-X^1=)K(.n^P".o"WMpƍ]”X Wp=rtE4Ĭ.ny ez"ڜ8A0w4qnD_%\wMCj"zqkVs @U7`(iNۅ gsFbbR֣ }y ܫګGtvL^^$r9vjuvEm* klDl_4jw~wlspQUKKMɇ޼/>7FB@n=C8q:&{Y]TZ!k[l\y<࣢k \ B`@[_kW.dNڄy '6qfg۾A)il_Q ;d$ PGQti'@eU^zIf~̜,6bCO/XzL:5eZf]-ڵ+nyIv郃;|lh/eIji~G6G݈Sotݶ8jh6c&ԇZTZkDdBB_0-+_*yfv[#5d)D MCpo&Ч:x&OUh^. dKE44kb4a΅"D:ػ 2E. +gHo_ ].((ԛ]OԾ}vԂR۵Aχu?SSVpJt؅Lݢ0/vY׫RH/Z)!(w~]ڼFy!hsq)4u0o{D" ݪHQpb'Žߣٟq5⇏Fk6^Jxb[ӒE7KNy@* B@ ) q^\+ q!5-Q̹Q@'[ͪ*}ɿ$#;Yh4=T3:%hVǵN |iLmw"EqsVQkJh{]vڅD$9Ż]:<[G>u8}!BqW4̸6;y2=Ϫv vQv}G ׽ ٜ';b Ѱȕ is%q{oPVU^s;AE3g#N'ef\_w}e}{Qur$r*FRsȏ|Ŕ \MzK.(aJI}nT._8#D"J^•ozo ibtXdƓZw֢碌ꦵi`&t=K@sqNnf[\'z}#+ֻM|:@Zo- q11 o(e35~Hx?ry;d4QWsG@} -'ntu ̛+ GUE:՞7 Y &{y@-ɜGoϬߴ}e(={r"1!- {#jZ %76H:f(3EY筠u۞\B~B9IX>U!2Id n.q6QMoq;Oƈ|ЊittD cgOv 6SI|32%5j+]'0'SP02GM?yBj|}\]YĚMq]2_ 'TQD4,b&5:j€ pL6-s4svwR[|Ld4hl<g{&Bq#l~!@Q (?=4{}PM brC!nQ/!xUP AeRa=YbRܰ8"Y TRSiQM`6q!?4"=2V$?) .r/M׸.RwKg dyFs!aZ 'iaGg tcOA/)Z饟OABia>i=d,%K3i6`qڍRNGኴ@yf2Z@ZSm9eeL7p*$N|c+G=vM '41Q!73 .j"kXDogZ2]@5'e}K2WѦF1.q8iMسT(;}*\ ϥp'3y?O/\L#?[{5,oB9(pUhȸBKsQԾ7'x1'9-w+' ""Lx#8ya$/:^Z矺d=tAE3ЄX/@AB?ϙ63rQ{jĜke.aucCsZ-+z dBL~5 rs]_h/d*geQY4Os6Lwpؐy^DƾyҭeA6;qbz3 ͬI! 0 Tv t%cn-tkY]EQ P 3VaMD?ʘdݙwJ-LEW[ΓI[V!L Ԅcފ#TKep2@eՎX&h5I h6;!Bjb_Ln@'O)Fn`Ŧ\P o@ĸp8bhB_߄;+;9ndhQsjr ]^Wp wCKf'/tUo$ߌp._8KwMjQ'S#1Cmiˁ/,֏Y_ʖ u}CE"\b781zXhLg6#kC'+mn PqoʦlC˚d0"4kѿPͷ<-j~Zedy04 u`ۗ:wEoxW{.vSlԃqVy7',U7uτgA沃Ș~4킉2O Еê; fuV[g%/Q Q'*'!j_\AA{vO;\oK~h;FKkvreݤ?okH!fM* x!IrPE?>O67ҠC_)oFI[Yx=TR6F~d3(sKؔ[jDDemw^qN+%>~jX56\eI{UWq Ui&kH PmӴ <1ӸsH@(dZ(=#XEG-nFȐK@W6;:uY y-@u Sq~Z$j˽\Cس綪%w=[y=LZ/c^_7g8(^V.lhe|Hp<5XlKmxY,?-+ffd6!xÄ@RIֆOZ$5^r -UיLKn=ŝ{7>Z0o f",d~9aj3NAE60 h0|li&k>?0%d|^3\CYڲۚ&u:X~k Qj t?>VĹ%k=vOXWy&lW\; Wh. !q>P7RY ɿ7{oðC!?KkQ4֩ϕ~`A*NN4yvRn.+,)?7$Th&G YSHVH77Y306Pe?\= )u1J1iZnfxCrtEF^47NJcpڰ h7pZ1ۥ+}oan`ID/Rxv-W>UXה_|1i7@Qzk̲ፘxLj)ɤo"FQ>+.vr: x(2I]eqW[/z- Ӝ]GC5o t{䉿X#tlAHVq奫WԠpHEUdBȷ9ߣ_k~0--Y!`#.@ UZܮאA ~ WxIk`?@!yBEAD6zS&au+!t`-Ev?CH/=Da,O_BoDvбơ1At_,s贀NM Ogc7!b˅i@]xآe&EOӑV$2#؊o7zu),%hVI=[>iJ^]ml{9F}|!99x¦&,puK3;km}z7[9+Pnt,F @wAƇEnC] }{Fz.փzM_̚qHACF u=J=P"DlxjOI?C 7(`6)Ԁf0nZߗ-,pI?KfxM|etˢߑSSJliS~;Ϭ NF%8Ԥ9Dp=YKwZR$bky M/:1xC#&~j[!$3JsvٙKv.;Mf6rO\c{ qڝJV6P᫝};eEQג>Ye #t:@&9$N!<0J }REuBM0|T3guĿ{пªVx2EA^z\̨w&1S8዇@wA#t5tI F$qHPN9jpd&b4pa|wM v: dv4 r2E ~fZ;)H4| _UŶt/a_<}6*'o tߏJ @ax@@gct1 R*`%VԏJ1G.G\9}^ =􋥉ҕ uƹC!DZ5.dĒ\M$\M (z%QV m|VFI Yߒ"̛NW:LQ͌`PĦXps绪q+])Lx |HTz±u}U>MRub˶5r{E 7~]Ss]4,Dc]pԅw.{ Z9HyBT|Y+D?T@RSǻ~_P[#˶(B:A\$6:Ğk 2ǘw -=ٕ"8CgҶ\wY n|Ʀ7%/] OZ8@nVٽ!* %9¦xCU"yϟCxǷ C*ˉd] Mm*hk%-F'`ȢpĵAfM;{́-O\lI1BSl ,y3/A#)2@a8;q,9ڥ=E&H{&O3*tA9vPWF0trXCwԷH}(1A,ؐiq XrzoM5~$]\:P)aj 7cXvC J)I:y s,c.}qP̪1"Urh{ML {z ~V&Ɋ=xey/Sc8ePEGBgMYwE|Gj3=YhaxmV+6ůAV=)$ULm1Lr%1'B9ISY^rUOHQ}bgz {g]w%(Bn?BAgfISJS1w-^̿.[;L 5ޟ4&u+_&`r:#qa#H9q2pvB.gh!#˫6KNDA% "R˩вL%/9vnڦjozKZ|&3 q ?Tz[xNGe.3E{ Yg^q7j }=K_S QYEM<IW;€üybNYA?\٫>1GC ި*vh%lzE$Ǧ4" _Da]ߨCڿ|H.%w:("cPz9~x[`Ōq0ZY"0Ei(|9'$4Uұ-vq6H?5utB1gt?0 @  +1x zGL'&7N[JԼm~s2],*)`W-@>h-`?\[p ƘےF:>9$fHNs(x7~#ѭK_,Z5cȕ9i/Uװi!ZQ3 02[.QKeB=@^C9Y5_=^iTO ;EpUvɌ'#ٚ4@}k?W8PΑb'R:uA r߶2hl^}ڨ'KqJi513 8Fpjˋ? {_)>}z4e /^V]b(پH_ux5 /+Sg9rYo5*s9] Γ$"kgŘOߚ{رíyrcfԑƦ->\VU7a&Cn!vlN;iRkIĽ 5@/rO o;Pfg:)Oaݰ93>mT,<&}qVelJuaz~_k.ՀP7 T)+4M`gtqp^J,nN@l{C`:/0yq7)2(aCt#]L6Y/;O=#"E1a#s!I--&2P b>sϻ8 ; w43?nmn U"1'I{aZ?B7(")\ vܢ&2SX#%~hS-ɚ!|?ϩRpbtx~&p3 vKi:K73NmH`Uu:γy  h($0E->L`fC3zLހ^Q_sh丠NM95m+ٹ~R]+ wq$!IE-(o1ͮ`,7ؖ!%, 8WAn[|Ěng 02":.M޴r"R!]~^Bx0?AKsy#~ia4$m`>0/xDJH_SfQ+WwV|رG/z fٗ hD~zD%,A/m?tl&m1} !S-B&4PN!?u$߯k%SQg.w;3IB,HRFFS#i4{/V>eUI?MP95y͙2Y 'ʻbρ$/ 5Y>DC4pHH;q,E.sdEaL.bXVH0ݿ-cNAR=(xBP:Bwu}cQI_7a>+ʏ24wm/! LMn Oud Uga q;[]_< Og"zLq/y711lSoV|k_,,rjR6I#A.@'i(_I_n3}p̆r AZo1;!szj}[vpmR'9 Q }}dQgRX'՞N> )8Yܐ?z*,pC !N7>L6nSe."bፎ(ȯ4?OZb@ 0q2#aʯ󯉲ۭAu{ 8-A'0 m nX=YxcLKBN¶2e젋1nٹsqkCde{sK_MA !` $-4-Ek/#(*yx'bK *Dڳ2kUU/3:Q=0a"Ae |*6a[5ۺhV(?~Y* uG{kvCU|Ѧ~ Ҭo쇪+9?dj|s d4kb["^4)ps#]՞ $(2^Π Aޣ <6V֫% {d!R.bty}ʩhet>[޳[<"ɚty <4>$a+~ sGPӠ[kBy7~v@?JMQ΁ FQ?m'2$VIx5yjtܘCăE3diqݎ?tirͧhpwnGedw6S<9e4 <xPbOnR!4;=6xW/| NEIMk{ʆ Qk>ݿbO8rt en]SQ$ װs*ɸk):<i(d{"Ԙ(}GbR##=_QR(TSj*7Tpok b>ʗhq]F~i[t,5׬+ :pae&gi#:}>W}Y~,Rb>3f|n4v]-8U0QC_ W#|#{؈Kی'a/Oգ :R{C"=>Qy\H^E$8nT}P]eB>|Z7 ncI̍ŧLv ypBOƬ5{y>(U >MM0bA&pn3Iz{3 T cjz$4$?R]%^qwtOTiQY1T&:#kPuHdKҤ*P(ÿ0J՜{ҴݩCg[r2R:?`F+A {hj8-m L."=fWkh/ԁ o9]62zc|GWTa/+]{N|t}B AIΊuxj)1pz%kP!E>rW]汔rlʘ<(=2ʻ?)T^\2OcŨ+Dm Ћ÷fW2ae\N|%p PN#vg!Y0MXУÁgd2F~?{瀦ǯJ #i@j7!Z_N>`ƭ`'B7z7#đHVr7: iPu;$8L3DFYD)5B8Q9n|}sR q#N1 $T y]!zÛt3HbIX:nM"h7Q]of9 p5.SaVJANZ`QʗۼZ"Xn< dF(;?}-K|*$v|鿃lzfqRcJ2x䎇JY7cvwC:o|`U$[T@05&6u}W{Tr]4wƷ,m{ϸٿ!t'BNh hw$*v}mp:ߝ{f<:o:g>RH0]QtO8 '<;T3;Ǣ8s n=zqYlNHcMJ?`FA}Q#N>kW}{_(}^xll Sf"UncG| xq6ה}acqd78#ar{1J(we,[ܱ᫕ı Z߱h܃Jl^m,pfPԧ%T6=ԭ+ yhZRFG;RưĚD%*H}#uvѠ+]N NV#7`}t1ͪdi? ؞=|zX8/j e-lŇ:%LEJ,kDYe3kݍ2@˳opi|9܂7^#9[#rmb㱯:ah}O^rÔ!}V㮑?R|Mx Q&nj=~}w8n=v`q+ܡ XxGd7 d0RI,7_.? 0dvtJ)ZMu^M?얠v U2pm^t7N,-6_s22h\ VÆݡ _]DEƑ:N~;9Է\KlקS1o6'LgBj" o"[03_v*9 A+/ %ſ&QhAE'J:-oۜUΦ l_?.6=~v>``#g =S~_=;@,#Hp.M ׿%YNCrePE= ŀ4<{7͔]۔>wBW*gHWA +pm ?YC[{^b!*=?,٧sxmH>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Type/Page>> endobj 2 0 obj <>stream q 0.153 0.153 0.153 rg 595.1999969 0 0 841.1999969 0 0 cm /Im0 Do Q BT /Suspect <>BDC 0.114 g /T1_0 1 Tf 0.0273 Tc 3 Tr 7.7 0 0 7.7 165.56 749.88 Tm (LYMPHOID )Tj EMC /Suspect <>BDC 0.0229 Tc 6.079 0 Td (PHENOTYPES )Tj EMC ET BT /T1_0 1 Tf -0.0117 Tc 7.7 0 0 7.7 267.7852 749.88 Tm (IN )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0294 Tc 7.7 0 0 7.7 280.5441 749.88 Tm (ASBESTOS-RELATED )Tj EMC /Suspect <>BDC 0.0237 Tc 10.905 0 Td (LESIONS )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 9.2236 0 0 10.1 508.22 748.92 Tm (939 )Tj 0.0181 Tc 9.7 0 0 9.7 50.3 723.97 Tm (Consecutive )Tj 0.0115 Tc 5.653 0 Td (patients, )Tj 0.0142 Tc 3.997 0 Td (all )Tj 0.0041 Tc 1.616 0 Td (male, )Tj 0.0225 Tc 2.772 0 Td (were )Tj 0.0085 Tc 2.54 0 Td (collected. )Tj 0.0235 Tc 4.504 0 Td (The )Tj 0.176 g 0.0086 Tc -21.939 -1.089 Td (number )Tj 0.114 g 0.05 Tc 10.0163 0 0 9.7 76.94 713.41 Tm (of )Tj 0.0065 Tc 9.7 0 0 9.7 90.25 713.41 Tm (patients )Tj -0.0132 Tc 3.685 0 Td (with )Tj 0.05 Tc 9.8374 0 0 9.7 148.04 713.41 Tm (PP )Tj 0.0046 Tc 9.7 0 0 9.7 164.39 713.41 Tm (was )Tj 0.0054 Tc 2.096 0 Td (limited )Tj -0.0324 Tc 3.445 0 Td (to )Tj ET BT /Suspect <>BDC 0.176 g /T1_0 1 Tf 0.003 Tc 9.7 0 0 9.7 230.0978 713.41 Tm (20. )Tj EMC ET BT 0.114 g /T1_0 1 Tf 0.0157 Tc 9.7 0 0 9.7 247.3541 713.41 Tm (There )Tj 0.176 g -0.0022 Tc -21.197 -1.114 Td (were )Tj -0.035 Tc 9.4002 0 0 9.7 66.15 702.6 Tm (15 )Tj 0.114 g 0.01 Tc 9.7 0 0 9.7 80.17 702.6 Tm (patients )Tj 0.176 g -0.0132 Tc 3.709 0 Td (with )Tj 0.114 g 0.0315 Tc 2.298 0 Td (DPF )Tj 0.176 g 0.0263 Tc 2.344 0 Td (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 9.6688 0 0 9.7 181.11 702.6 Tm (10 )Tj EMC ET BT /T1_0 1 Tf -0.0132 Tc 9.7 0 0 9.7 195.35 702.6 Tm (with )Tj 0.114 g 0.0034 Tc 2.298 0 Td (BAPE. )Tj 0.176 g 0.0222 Tc 3.287 0 Td (They )Tj -0.0022 Tc -21.42 -1.113 Td (were )Tj 0.114 g -0.0229 Tc 2.391 0 Td (all )Tj 0.0118 Tc 1.436 0 Td (occupationally )Tj 0.176 g 0.0059 Tc 6.506 0 Td (exposed )Tj -0.0324 Tc 3.819 0 Td (to )Tj 0.0116 Tc 1.179 0 Td (asbestos, )Tj 0.114 g 0.0053 Tc 4.14 0 Td (mainly )Tj 0.176 g 0.0203 Tc 3.233 0 Td (as )Tj 0.114 g 0.0133 Tc -22.776 -1.112 Td (building )Tj 0.0139 Tc 3.957 0 Td (workers, )Tj 0.0016 Tc 4.098 0 Td (and )Tj 0.0136 Tc 1.988 0 Td (most )Tj -0.0144 Tc 2.525 0 Td [(had )-343(had )]TJ 0.0083 Tc 3.951 0 Td (only )Tj 0.176 g 0.0121 Tc 2.352 0 Td (intermittent )Tj 0.0058 Tc -18.831 -1.113 Td (exposure. )Tj 0.114 g 0.0139 Tc 4.505 0 Td (They )Tj -0.0144 Tc 2.704 0 Td (had )Tj 0.0013 Tc 2.006 0 Td (been )Tj 0.176 g 0.0142 Tc 2.488 0 Td (exposed )Tj 0.114 g -0.0235 Tc 3.982 0 Td (for )Tj 0.176 g 0 Tc 1.684 0 Td (a )Tj 0.114 g -0.0102 Tc 1.047 0 Td (mean )Tj 0.05 Tc 10.2945 0 0 9.7 246.38 670.21 Tm (of )Tj ET BT /Suspect <>BDC 0.176 g /T1_0 1 Tf 0.0086 Tc 9.7 0 0 9.7 260.34 670.21 Tm (20 )Tj EMC ET BT 0.114 g /T1_0 1 Tf 0.0041 Tc 9.7 0 0 9.7 41.2655 659.6467 Tm (years, )Tj 0.0115 Tc 2.92 0 Td (with )Tj 0.176 g 0.0109 Tc 2.366 0 Td (extremes )Tj 0.114 g 0.05 Tc 10.2945 0 0 9.7 132.86 659.65 Tm (of )Tj 0 Tc 9.7 0 0 9.7 146.53 659.65 Tm (3 )Tj -0.0324 Tc 1.024 0 Td (to )Tj 0.176 g -0.0229 Tc 1.277 0 Td (35 )Tj 0.114 g -0.0058 Tc 1.544 0 Td (years. )Tj 0.176 g 0.028 Tc 2.863 0 Td (There )Tj 0.114 g -0.0078 Tc 2.952 0 Td (was )Tj -0.0318 Tc 2.078 0 Td (no )Tj 0.176 g 0.0021 Tc -22.598 -1.113 Td (difference )Tj -0.035 Tc 9.5888 0 0 9.7 84.4 648.85 Tm (in )Tj 0.114 g 9.6197 0 0 9.7 95.98 648.85 Tm (the )Tj 0.176 g -0.0012 Tc 9.7 0 0 9.7 110.8 648.85 Tm (intensity )Tj 0.114 g 0.0286 Tc 3.809 0 Td (or )Tj -0.0065 Tc 1.213 0 Td (length )Tj 0.05 Tc 10.2945 0 0 9.7 187.34 648.85 Tm (of )Tj 0.176 g 0.0034 Tc 9.7 0 0 9.7 199.1 648.85 Tm (exposure )Tj 0.114 g -0.0046 Tc 4.02 0 Td (between )Tj -0.0026 Tc -20.292 -1.139 Td (the )Tj 0.0137 Tc 1.633 0 Td (various )Tj 0.0078 Tc 3.433 0 Td (groups )Tj 0.0021 Tc 3.189 0 Td (\(PP, )Tj 0.0218 Tc 2.11 0 Td (BAPE )Tj 0.0387 Tc 3.012 0 Td (and )Tj 0.0061 Tc 1.911 0 Td (DPF\). )Tj /T1_1 1 Tf 0.0054 Tc 9.8 0 0 9.8 41.09 607.56 Tm (Controls )Tj /T1_0 1 Tf 0.0236 Tc 9.7 0 0 9.7 49.36 583.33 Tm (Twenty-four )Tj 0.0137 Tc 5.995 0 Td (healthy )Tj 0.0146 Tc 3.812 0 Td (blood )Tj 0.0166 Tc 3.082 0 Td (donors )Tj 0.0143 Tc 3.596 0 Td (were )Tj -0.0002 Tc 2.772 0 Td (used )Tj -0.0045 Tc 2.612 0 Td (as )Tj 0.0081 Tc -22.762 -1.113 Td (controls. )Tj /T1_1 1 Tf 0.0159 Tc 9.8 0 0 9.8 40.16 542.04 Tm (Peripheral )Tj 0.0237 Tc 4.834 0 Td (blood )Tj 0.0131 Tc 2.696 0 Td (mononuclear )Tj 0.0053 Tc 5.801 0 Td (cells )Tj /T1_0 1 Tf 0.02 Tc 9.7 0 0 9.7 48.92 517.8 Tm (Mononuclear )Tj 0.0179 Tc 5.908 0 Td (cells )Tj 0.0062 Tc 2.302 0 Td (in )Tj 0.012 Tc 1.244 0 Td (heparinized )Tj 0.0087 Tc 5.22 0 Td (venous )Tj 0.0208 Tc 3.294 0 Td (blood )Tj 0.006 Tc 2.794 0 Td (were )Tj 0.0075 Tc -21.657 -1.112 Td (isolated )Tj -0.0007 Tc 3.622 0 Td (by )Tj 0.176 g 0.0078 Tc 1.444 0 Td (standard )Tj 0.114 g 0.0096 Tc 3.922 0 Td (methods )Tj 0.0062 Tc 3.878 0 Td (in )Tj 0 Tc 1.186 0 Td (a )Tj 0.0176 Tc 0.847 0 Td (Ficoll-Hypaque )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0048 Tc 9.7 0 0 9.7 251.6694 507.0136 Tm (den\255)Tj EMC ET BT 0.176 g /T1_0 1 Tf -0.0025 Tc 9.7 0 0 9.7 40.1803 495.9653 Tm (sity )Tj 0.0006 Tc 1.986 0 Td (gradient. )Tj 0.114 g -0.0013 Tc 4.107 0 Td (The )Tj 0.176 g 0.0117 Tc 2.077 0 Td (cells )Tj 0.114 g 0.006 Tc 2.408 0 Td (were )Tj -0.0035 Tc 2.498 0 Td (then )Tj 0.0151 Tc 2.228 0 Td (washed )Tj 0.0088 Tc 3.562 0 Td (three )Tj 0.0042 Tc 2.573 0 Td (times )Tj -0.035 Tc 9.5888 0 0 9.7 40.24 485.17 Tm (in )Tj 0.0121 Tc 9.7 0 0 9.7 54.49 485.17 Tm (phosphate-buffered )Tj 0.176 g 0.0143 Tc 8.694 0 Td (saline )Tj ET BT /Suspect <>BDC 0.114 g /T1_0 1 Tf 0.0061 Tc 9.7 0 0 9.7 169.0955 485.17 Tm (\(PBS\) )Tj EMC ET BT /T1_0 1 Tf 0.0148 Tc 9.7 0 0 9.7 199.8348 485.17 Tm (containing )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0139 Tc 9.7 0 0 9.7 248.5482 485.17 Tm (0.1% )Tj EMC ET BT /T1_0 1 Tf 0.0121 Tc 9.7 0 0 9.7 40.0952 474.1217 Tm (bovine )Tj 0.176 g 0.0082 Tc 3.127 0 Td (serum )Tj 0.0088 Tc 2.849 0 Td (albumin )Tj 0.0079 Tc 3.76 0 Td (\(BSA\) )Tj 0.114 g 0.05 Tc 9.8031 0 0 9.7 163.58 474.12 Tm (at )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0131 Tc 9.7 0 0 9.7 174.86 474.12 Tm (10)Tj 0 Tc 6 0 0 6 184.25 477.49 Tm (6 )Tj EMC /Suspect <>BDC 0.0064 Tc 9.7 0 0 9.7 190.47 474.12 Tm (cells\267ml\267)Tj 0 Tc 6 0 0 6 224.19 477.49 Tm (1)Tj 0.5 -0.562 Td (\225 )Tj EMC /Suspect <>BDC 0.0074 Tc 9.7 0 0 9.7 232.78 474.12 Tm (Approxi\255)Tj EMC ET BT /T1_0 1 Tf 0.0167 Tc 9.7 0 0 9.7 39.8179 463.3336 Tm (mately )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 10.206 0 0 10.5 72.13 463.33 Tm (10 )Tj EMC /Suspect <>BDC 0.0126 Tc 10.5 0 0 10.5 86.1 463.33 Tm (Jll )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 10.0163 0 0 9.7 99.26 463.33 Tm (of )Tj -0.015 Tc 9.7 0 0 9.7 112.54 463.33 Tm (the )Tj -0.0032 Tc 1.7 0 Td (cell )Tj 0.013 Tc 1.949 0 Td (suspension )Tj 0.0046 Tc 5.036 0 Td (was )Tj 0.0163 Tc 2.045 0 Td (dropped )Tj 0.007 Tc 3.861 0 Td (into )Tj 0.0237 Tc -22.097 -1.139 Td (each )Tj 0.0141 Tc 2.508 0 Td (well )Tj 0.05 Tc 10.2945 0 0 9.7 87.02 452.28 Tm (of )Tj 0 Tc 9.7 0 0 9.7 101.42 452.28 Tm (a )Tj 0.0094 Tc 1.097 0 Td (multiple )Tj 0.0058 Tc 4.059 0 Td (well )Tj 0.0167 Tc 2.374 0 Td (microscope )Tj -0.0015 Tc 5.381 0 Td (slide. )Tj 0.0358 Tc 2.777 0 Td (The )Tj 0.0103 Tc -22.052 -1.138 Td (slides )Tj 0.006 Tc 2.859 0 Td (were )Tj 0.0138 Tc 2.465 0 Td (air-dried )Tj 0.05 Tc 10.1194 0 0 9.7 130.46 441.24 Tm (at )Tj 0.0262 Tc 9.7 0 0 9.7 142.51 441.24 Tm (+37\260C )Tj 0.0136 Tc 3.235 0 Td (for )Tj 0.031 Tc 1.685 0 Td (one )Tj 0.0254 Tc 2.012 0 Td (hour )Tj 0.0139 Tc 2.366 0 Td (and )Tj 0.0048 Tc 2.012 0 Td (then )Tj 0.0065 Tc -21.909 -1.112 Td (stored )Tj 0.05 Tc 9.8031 0 0 9.7 67.1 430.45 Tm (at )Tj 0 Tc 9.7 0 0 9.7 78.13 430.45 Tm (-)Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0097 Tc 9.7 0 0 9.7 81.4959 430.45 Tm (70\260C. )Tj EMC ET BT /T1_0 1 Tf 0.0126 Tc 9.7 0 0 9.7 107.7344 430.45 Tm (After )Tj 0.01 Tc 2.536 0 Td (storage )Tj 0.0097 Tc 3.303 0 Td (the )Tj 0.005 Tc 1.626 0 Td (cell )Tj 0.004 Tc 1.841 0 Td (preparations )Tj 0.006 Tc 5.416 0 Td (were )Tj 0.0122 Tc -21.756 -1.139 Td (immediately )Tj 0.0139 Tc 5.712 0 Td (fixed )Tj 0.0062 Tc 2.725 0 Td (in )Tj 0.0174 Tc 1.408 0 Td (acetone )Tj 0.0134 Tc 3.737 0 Td (diluted )Tj -0.035 Tc 9.2991 0 0 9.7 205.6 419.4 Tm (1:1 )Tj -0.0049 Tc 9.7 0 0 9.7 223.67 419.4 Tm (with )Tj 0.0095 Tc 2.425 0 Td (water )Tj 0.0091 Tc -21.412 -1.112 Td (\(+4\260C\) )Tj 0.0136 Tc 3.39 0 Td (for )Tj 0 Tc 1.807 0 Td (1 )Tj 0.0046 Tc 0.998 0 Td (min )Tj 0.0139 Tc 2.144 0 Td (and )Tj 0.0077 Tc 2.003 0 Td [(finally )-319(fixed )]TJ 0.0062 Tc 5.892 0 Td (in )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0034 Tc 9.7 0 0 9.7 210.6235 408.6136 Tm (100% )Tj EMC ET BT /T1_0 1 Tf 0.0174 Tc 9.7 0 0 9.7 238.4625 408.6136 Tm (acetone )Tj 0.176 g 0.0042 Tc -20.512 -1.113 Td (\(+4\260C\) )Tj 0.114 g 0.026 Tc 3.241 0 Td (for )Tj /T1_1 1 Tf 0 Tc 10.7 0 0 10.7 86.29 397.81 Tm (5 )Tj /T1_0 1 Tf 0.0046 Tc 9.7 0 0 9.7 95.26 397.81 Tm (min )Tj 0.021 Tc 1.958 0 Td (before )Tj 0.0183 Tc 3.053 0 Td (staining )Tj -0.0148 Tc 3.727 0 Td ([8]. )Tj /T1_1 1 Tf 0.0174 Tc 9.8 0 0 9.8 38.55 367.09 Tm (Antisera )Tj 0.0381 Tc 3.897 0 Td (and )Tj 0.0166 Tc 1.908 0 Td (other )Tj 0.0089 Tc 2.573 0 Td (reagents )Tj /T1_0 1 Tf 0.0111 Tc 9.7 0 0 9.7 47.68 343.09 Tm (The )Tj 0.004 Tc 1.961 0 Td (murine )Tj 0.0045 Tc 3.241 0 Td (monoclonals )Tj 0.0104 Tc 5.535 0 Td (denoted )Tj 0.0025 Tc 3.611 0 Td (anti-Leu )Tj 0.0076 Tc 3.767 0 Td (4, )Tj -0.0021 Tc 1.18 0 Td (-Leu )Tj -0.0056 Tc 2.257 0 Td (2a, )Tj 0.0144 Tc -22.471 -1.089 Td (-Leu )Tj 0.0034 Tc 2.351 0 Td (3a, )Tj 0.0144 Tc 1.633 0 Td (-Leu )Tj -0.0326 Tc 2.352 0 Td (7, )Tj 0.0144 Tc 1.162 0 Td (-Leu )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 11.1764 0 0 9.7 135.27 332.53 Tm (lib, )Tj EMC ET BT /T1_0 1 Tf 0.0226 Tc 9.7 0 0 9.7 155.89 332.53 Tm (-Leu )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0202 Tc 9.7 0 0 9.7 179.4222 332.53 Tm (10, )Tj EMC ET BT /T1_0 1 Tf 0.0144 Tc 9.7 0 0 9.7 195.2526 332.53 Tm (-Leu )Tj -0.0131 Tc 2.401 0 Td (12 )Tj 0.0139 Tc 1.361 0 Td (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.003 Tc 9.7 0 0 9.7 249.98 332.53 Tm (anti\255)Tj EMC ET BT /T1_0 1 Tf 0.0156 Tc 9.7 0 0 9.7 38.5976 321.7339 Tm (HLA-DR, )Tj 0.006 Tc 4.803 0 Td (were )Tj 0.0142 Tc 2.589 0 Td (all )Tj 0.0205 Tc 1.659 0 Td (obtained )Tj -0.0108 Tc 4.229 0 Td (from )Tj 0.0175 Tc 2.605 0 Td (Becton )Tj 0.0143 Tc 3.563 0 Td (Dickinson )Tj 0.176 g 0.0116 Tc -19.455 -1.113 Td (\(Sunnyvale, )Tj 0.0127 Tc 5.494 0 Td (California, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0112 Tc 9.7 0 0 9.7 140.3894 310.9378 Tm (USA\). )Tj EMC ET BT 0.114 g /T1_0 1 Tf 0.0043 Tc 9.7 0 0 9.7 172.0599 310.9378 Tm (Anti-Leu )Tj 0.176 g 0 Tc 4.254 0 Td (4 )Tj 0.114 g 0.0155 Tc 1.084 0 Td (defines )Tj 0.176 g -0.0229 Tc 3.562 0 Td (all )Tj 0.114 g 0.0075 Tc -22.677 -1.139 Td (peripheral )Tj 0.176 g 0.0108 Tc 4.618 0 Td (T-cells )Tj -0.0148 Tc 3.349 0 Td ([9], )Tj 0.0161 Tc 1.854 0 Td (whereas )Tj 0.114 g 0.0096 Tc 3.851 0 Td (anti-Leu )Tj 0.176 g 0.0408 Tc 3.913 0 Td (2a )Tj 0.114 g 0.0114 Tc 1.407 0 Td (defines )Tj -0.015 Tc 3.496 0 Td (the )Tj ET BT /Suspect <>BDC 0.176 g /T1_0 1 Tf 0.0169 Tc 9.7 0 0 9.7 38.2387 288.8509 Tm ("suppressor/cytotoxic" )Tj EMC ET BT 0.114 g /T1_0 1 Tf 0.0017 Tc 9.7 0 0 9.7 134.8216 288.8509 Tm (T-cell )Tj 0.176 g 0.0201 Tc 2.963 0 Td (subset )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0124 Tc 9.7 0 0 9.7 193.7103 288.8509 Tm ([10]. )Tj EMC ET BT 0.114 g /T1_0 1 Tf -0.0127 Tc 9.7 0 0 9.7 217.4365 288.8509 Tm (Anti)Tj 0.286 g 0 Tc 1.846 0 Td (-)Tj 0.176 g 0.009 Tc 0.303 0 Td (Leu )Tj -0.0154 Tc 2.146 0 Td (3a )Tj 0.114 g 0.0225 Tc -22.802 -1.112 Td (react )Tj -0.0214 Tc 2.548 0 Td (with )Tj -0.0026 Tc 2.275 0 Td (the )Tj ET BT /Suspect <>BDC 0.176 g /T1_0 1 Tf 0.0205 Tc 9.7 0 0 9.7 101.3372 278.0645 Tm ("helper/inducer" )Tj EMC ET BT /T1_0 1 Tf 0.0067 Tc 9.7 0 0 9.7 173.1948 278.0645 Tm (T-cell )Tj 0.0201 Tc 2.938 0 Td (subset )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0062 Tc 9.7 0 0 9.7 231.841 278.0645 Tm ([10], )Tj EMC ET BT 0.114 g /T1_0 1 Tf 0.0343 Tc 9.7 0 0 9.7 255.3635 278.0645 Tm (but )Tj 0.176 g 0.0117 Tc -22.403 -1.114 Td (also )Tj 0.0046 Tc 2.137 0 Td (reacts )Tj -0.0132 Tc 2.87 0 Td (with )Tj 0.0147 Tc 2.312 0 Td (some )Tj 0.0179 Tc 2.628 0 Td (cells )Tj 0.114 g 0.05 Tc 10.0163 0 0 9.7 157.58 267.24 Tm (of )Tj -0.0026 Tc 9.7 0 0 9.7 170.86 267.24 Tm (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0108 Tc 9.7 0 0 9.7 187.6604 267.24 Tm (monocyte/macroph\255)Tj EMC ET BT 0.176 g /T1_0 1 Tf 0.0177 Tc 9.7 0 0 9.7 37.8245 256.4536 Tm (age )Tj 0.114 g 0.0045 Tc 1.907 0 Td (lineage )Tj 0.176 g -0.0075 Tc 3.374 0 Td ([11] )Tj 0.114 g -0.035 Tc 9.5888 0 0 9.7 110.08 256.45 Tm (in )Tj 0.0135 Tc 9.7 0 0 9.7 121.93 256.45 Tm (prefixed )Tj 0.176 g 0.0133 Tc 3.849 0 Td (cell )Tj 0.0101 Tc 1.925 0 Td (samples. )Tj 0.0079 Tc 4.07 0 Td (Anti-Leu )Tj -0.035 Tc 9.6688 0 0 9.7 258.87 256.45 Tm (12 )Tj 0.0073 Tc 9.7 0 0 9.7 37.83 245.41 Tm (defines )Tj -0.0105 Tc 3.686 0 Td (all )Tj 0.0157 Tc 1.743 0 Td (peripheral )Tj 0.0106 Tc 4.968 0 Td (B-cells )Tj -0.0239 Tc 3.692 0 Td ([12\))Tj 0.286 g 0 Tc 1.735 0 Td (. )Tj 0.114 g 0.0043 Tc 0.983 0 Td (Anti-Leu )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 9.6688 0 0 9.7 244.95 245.41 Tm (10 )Tj EMC ET BT /T1_0 1 Tf 9.3682 0 0 9.7 261.52 245.41 Tm (is )Tj 0.176 g 0.0089 Tc 9.7 0 0 9.7 37.78 234.61 Tm (specific )Tj -0.0112 Tc 3.714 0 Td (for )Tj 0.0097 Tc 1.716 0 Td (the )Tj 0.0179 Tc 1.804 0 Td (HLA-DQ )Tj 0.016 Tc 4.423 0 Td (antigen, )Tj 0 Tc 3.86 0 Td (a )Tj 0.114 g 0.0014 Tc 0.999 0 Td (human )Tj 0 Tc 3.312 0 Td (D )Tj 0.009 Tc 1.24 0 Td (region )Tj 0.176 g 0.0126 Tc -21.09 -1.139 Td (associated )Tj 0.0108 Tc 4.726 0 Td (antigen )Tj -0.0124 Tc 3.624 0 Td ([13], )Tj -0.0032 Tc 2.447 0 Td (which )Tj 0.0122 Tc 3.01 0 Td (differs )Tj -0.035 Tc 9.6921 0 0 9.7 202.93 223.56 Tm (from )Tj -0.015 Tc 9.7 0 0 9.7 227.26 223.56 Tm (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0002 Tc 9.7 0 0 9.7 244.041 223.56 Tm (HLA\255)Tj EMC ET BT 0.114 g /T1_0 1 Tf 0.0141 Tc 9.7 0 0 9.7 37.6444 212.7736 Tm (DR )Tj 0.0067 Tc 1.849 0 Td (antigen )Tj 0.0135 Tc 3.473 0 Td (recognized )Tj -0.0007 Tc 5 0 Td (by )Tj -0.0026 Tc 1.506 0 Td (the )Tj 0.176 g 0.0146 Tc 1.649 0 Td (anti-HLA-DR )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0049 Tc 9.7 0 0 9.7 229.6559 212.7736 Tm (monoclo\255)Tj EMC ET BT 0.114 g /T1_0 1 Tf -0.0145 Tc 9.7 0 0 9.7 37.6638 201.9775 Tm (nal )Tj 0.176 g 0.011 Tc 1.896 0 Td (antibody )Tj -0.0077 Tc 9.6 0 0 9.6 98.41 201.97 Tm ([14]. )Tj 0.0235 Tc 9.7 0 0 9.7 123.76 201.97 Tm (The )Tj 0.0076 Tc 2.333 0 Td (human )Tj 0.114 g 0 Tc 3.51 0 Td (D )Tj 0.176 g 0.009 Tc 1.413 0 Td (region )Tj 0.0098 Tc 3.331 0 Td (associated )Tj 0.0067 Tc -19.472 -1.113 Td (antigens )Tj 0.0146 Tc 3.909 0 Td (are )Tj 0.0172 Tc 1.781 0 Td (expressed )Tj 0.114 g -0.035 Tc 9.5888 0 0 9.7 137.92 191.17 Tm (in )Tj 0 Tc 9.7 0 0 9.7 150.68 191.17 Tm (B )Tj 0.176 g 0.0116 Tc 1.233 0 Td (lymphocytes, )Tj 0.0193 Tc 6.068 0 Td (monocytes/ )Tj 0.0078 Tc -18.953 -1.113 Td (macrophages )Tj 0.0263 Tc 5.781 0 Td (and )Tj 0.0149 Tc 1.905 0 Td (activated )Tj 0.0089 Tc 4.134 0 Td (T-cells. )Tj 0.0358 Tc 3.538 0 Td (The )Tj 0.0096 Tc 2.027 0 Td (anti-Leu )Tj 0 Tc 3.885 0 Td (7 )Tj 0.0016 Tc 0.94 0 Td (and )Tj 0.0061 Tc -22.243 -1.114 Td (anti-Leu )Tj 0.05 Tc 12.224 0 0 9.7 77.66 169.56 Tm (llb )Tj 0.114 g 0.0193 Tc 9.7 0 0 9.7 97.9 169.56 Tm (monoclonals )Tj 0.176 g 0.0146 Tc 5.93 0 Td (are )Tj 0.114 g 0.0192 Tc 1.889 0 Td (thought )Tj -0.0076 Tc 3.786 0 Td (to )Tj 0.176 g 0.0123 Tc 1.403 0 Td (define )Tj 0.114 g 0.0097 Tc 3.224 0 Td (the )Tj 0.0186 Tc -22.491 -1.137 Td (major )Tj 0.0044 Tc 2.97 0 Td (natural )Tj 0.0192 Tc 3.389 0 Td (killer )Tj 0.0113 Tc 9.6 0 0 9.6 125.89 158.53 Tm (\(NK\) )Tj 0.0139 Tc 9.7 0 0 9.7 152.54 158.53 Tm (and )Tj 0.0192 Tc 2.062 0 Td (killer )Tj /T1_2 1 Tf 0.05 Tc 9.4091 0 0 9.4 199.27 158.53 Tm (\(K\) )Tj /T1_0 1 Tf 0.0133 Tc 9.7 0 0 9.7 218.31 158.53 Tm (cell )Tj 0.0138 Tc 2.073 0 Td (subsets )Tj -0.0019 Tc -20.719 -1.089 Td ([15,16]. )Tj 0.0417 Tc 0.811 -1.139 Td (FITC-conjugated )Tj 0.05 Tc 9.9607 0 0 9.7 125.44 136.92 Tm (goat )Tj 0.0413 Tc 9.7 0 0 9.7 151.58 136.92 Tm (anti-mouse )Tj 0.0357 Tc 5.641 0 Td (antibody )Tj 0.0417 Tc 4.587 0 Td (was )Tj 0.0134 Tc -22.054 -1.113 Td (obtained )Tj -0.0025 Tc 4.006 0 Td (from )Tj 0.0221 Tc 2.508 0 Td (the )Tj 0.0177 Tc 1.738 0 Td (National )Tj 0.0148 Tc 4.074 0 Td (Bacteriological )Tj 0.0195 Tc 6.778 0 Td (Laboratory )Tj 0.0084 Tc -19.107 -1.138 Td (\(SBL\), )Tj 0.0141 Tc 3.506 0 Td (Sweden. )Tj 0.0165 Tc 4.27 0 Td (Biotinylated )Tj 0.0226 Tc 5.842 0 Td (horse )Tj 0.0221 Tc 2.91 0 Td (anti-mouse )Tj 0.0009 Tc 5.349 0 Td (JgG, )Tj 0.0076 Tc -21.902 -1.137 Td (avidin )Tj 0.0323 Tc 3.124 0 Td (DH )Tj 0.0387 Tc 1.973 0 Td (and )Tj 0.0193 Tc 2.04 0 Td (biotinylated )Tj 0.0147 Tc 5.54 0 Td (horseradish )Tj 0.0177 Tc 5.297 0 Td (peroxidase )Tj 0 Tc 5.042 0 Td (H )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0312 Tc 9.7 0 0 9.7 36.5768 93.2506 Tm (\("ABC" )Tj EMC ET BT /T1_0 1 Tf -0.0002 Tc 9.7 0 0 9.7 75.0664 93.2506 Tm (kit\) )Tj 0.0143 Tc 2.055 0 Td (were )Tj 0.024 Tc 2.59 0 Td (obtained )Tj -0.0025 Tc 4.204 0 Td (from )Tj 0.0169 Tc 2.657 0 Td (Vector )Tj 0.0159 Tc 3.384 0 Td (laboratories )Tj 0.0081 Tc -18.832 -1.138 Td (\(Burlingame, )Tj 0.0176 Tc 5.914 0 Td (California, )Tj 0.0174 Tc 4.982 0 Td (USA\). )Tj 0.0173 Tc 3.231 0 Td (3-Amino-9-ethylcarba\255)Tj 0.0101 Tc -14.171 -1.113 Td (zole )Tj 0.0046 Tc 2.107 0 Td (was )Tj 0.0205 Tc 1.946 0 Td (obtained )Tj -0.0025 Tc 3.981 0 Td (from )Tj 0.0261 Tc 2.418 0 Td (Sigma )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0203 Tc 9.7 0 0 9.7 167.3813 71.4159 Tm (\(St )Tj EMC ET BT /T1_0 1 Tf 0.0119 Tc 9.7 0 0 9.7 182.8043 71.4159 Tm (Louis, )Tj 0.0146 Tc 3.02 0 Td (Mo, )Tj 0.0174 Tc 2.081 0 Td (USA\). )Tj /T1_1 1 Tf 0.0147 Tc 9.8 0 0 9.8 291.49 723.01 Tm (lmmunoenzyme )Tj 0.006 Tc 6.749 0 Td (staining )Tj /T1_0 1 Tf 0.0126 Tc 9.7 0 0 9.7 300.7 698.53 Tm (After )Tj -0.0026 Tc 2.647 0 Td (the )Tj 0.0058 Tc 1.673 0 Td (fixation )Tj 0.0182 Tc 3.674 0 Td (procedure )Tj 0.0097 Tc 4.599 0 Td (the )Tj 0.0103 Tc 1.744 0 Td (slides )Tj 0.0225 Tc 2.834 0 Td (were )Tj 0.0151 Tc 2.499 0 Td (washed )Tj -0.0186 Tc -20.593 -1.113 Td (in )Tj 0.0286 Tc 1.142 0 Td (PBC )Tj 0.0113 Tc 2.343 0 Td (\(pH )Tj 0.0001 Tc 1.931 0 Td (7.4\) )Tj 0.0012 Tc 2.003 0 Td (for )Tj /T1_3 1 Tf 0 Tc 1.574 0 Td (5 )Tj /T1_0 1 Tf -0.0143 Tc 0.909 0 Td (min. )Tj 0.0235 Tc 2.171 0 Td (The )Tj 0.0152 Tc 1.998 0 Td (subsequent )Tj 0.0086 Tc 4.93 0 Td (incubations )Tj 0.006 Tc -18.995 -1.089 Td (were )Tj 0.0156 Tc 2.416 0 Td (carried )Tj 0.0397 Tc 3.291 0 Td (out )Tj 0.0134 Tc 1.776 0 Td (sequentially )Tj 0.0333 Tc 5.447 0 Td (at )Tj 0.006 Tc 1.197 0 Td (room )Tj 0.0132 Tc 2.671 0 Td (temperature )Tj 0.0139 Tc 5.386 0 Td (and )Tj 0.0097 Tc -22.186 -1.09 Td (the )Tj 0.0152 Tc 1.744 0 Td (slides )Tj 0.0143 Tc 2.884 0 Td (were )Tj 0.0101 Tc 2.524 0 Td (washed )Tj 0.0136 Tc 3.602 0 Td (for )Tj /T1_3 1 Tf 0 Tc 1.723 0 Td (5 )Tj /T1_0 1 Tf 0.017 Tc 1.033 0 Td (min )Tj 0.0062 Tc 2.146 0 Td (in )Tj 0.0097 Tc 1.367 0 Td (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0094 Tc 9.7 0 0 9.7 473.6898 666.5976 Tm (PBS )Tj EMC ET BT /T1_0 1 Tf 0.0232 Tc 9.7 0 0 9.7 497.0183 666.5976 Tm (buffer )Tj 0.0036 Tc -21.179 -1.113 Td (between )Tj 0.0155 Tc 3.725 0 Td (each )Tj 0.176 g -0.0069 Tc 2.272 0 Td (step. )Tj 0.114 g 0.0104 Tc 2.261 0 Td (Endogenous )Tj 0.0122 Tc 5.425 0 Td (peroxidase )Tj 0.017 Tc 4.823 0 Td (was )Tj 0.0146 Tc 1.981 0 Td (blocked )Tj 0.024 Tc -20.487 -1.137 Td (by )Tj 0.0088 Tc 1.352 0 Td (incubation )Tj -0.035 Tc 9.5888 0 0 9.7 350.32 644.77 Tm (in )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0057 Tc 9.7 0 0 9.7 361.34 644.77 Tm (0.3% )Tj EMC /Suspect <>BDC 0.05 Tc 9.8527 0 0 9.7 385.39 644.77 Tm (Hz0)Tj 0 Tc 6.2 0 0 6.2 402.69 641.65 Tm (2 )Tj EMC ET BT /T1_0 1 Tf 0.0012 Tc 9.7 0 0 9.7 409.09 644.77 Tm (for )Tj -0.035 Tc 9.4002 0 0 9.7 424.71 644.77 Tm (15 )Tj 0.0105 Tc 9.7 0 0 9.7 437.26 644.77 Tm (min. )Tj 0.0358 Tc 2.221 0 Td (The )Tj 0.0133 Tc 1.954 0 Td (cell )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0159 Tc 9.7 0 0 9.7 495.6152 644.77 Tm (prepa\255)Tj EMC ET BT /T1_0 1 Tf 0.0129 Tc 9.7 0 0 9.7 291.3526 633.9739 Tm (rations )Tj 0.0225 Tc 3.39 0 Td (were )Tj 0.0048 Tc 2.622 0 Td (then )Tj 0.176 g 0.0177 Tc 2.344 0 Td (incubated )Tj 0.114 g 0.0136 Tc 4.599 0 Td (for )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 9.7128 0 0 9.7 434.53 633.97 Tm (30 )Tj EMC ET BT /T1_0 1 Tf 0.017 Tc 9.7 0 0 9.7 450.22 633.97 Tm (min )Tj 0.0062 Tc 2.245 0 Td (in )Tj 0 Tc 1.359 0 Td (a )Tj 0.012 Tc 1.098 0 Td (humid )Tj 0.0091 Tc -21.065 -1.139 Td (atmosphere )Tj 0.0033 Tc 5.106 0 Td (with )Tj -0.0162 Tc 2.222 0 Td (25 )Tj ET BT /Suspect <>BDC /T1_3 1 Tf -0.035 Tc 7.3061 0 0 12.1 376.25 622.92 Tm (J.ll )Tj EMC ET BT /T1_0 1 Tf 0.014 Tc 9.7 0 0 9.7 388.33 622.92 Tm (portions )Tj 0.05 Tc 10.2945 0 0 9.7 425.18 622.92 Tm (of )Tj 0.0152 Tc 9.7 0 0 9.7 437.26 622.92 Tm (monoclonal )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0101 Tc 9.7 0 0 9.7 488.3014 622.92 Tm (antibod\255)Tj EMC ET BT /T1_0 1 Tf 0.0103 Tc 9.7 0 0 9.7 291.5175 612.3567 Tm (ies )Tj 0.0052 Tc 1.729 0 Td (\(dilution )Tj 0.05 Tc 9.9482 0 0 9.7 348.88 612.36 Tm (l/32 )Tj 0.176 g 0.0136 Tc 9.7 0 0 9.7 371.65 612.36 Tm (for )Tj 0.114 g 0.0167 Tc 1.782 0 Td (anti-Leu )Tj 0.0323 Tc 4.064 0 Td (4, )Tj 0.0226 Tc 1.403 0 Td (-Leu )Tj 0.0068 Tc 2.578 0 Td (2a, )Tj 0.0226 Tc 1.826 0 Td (-Leu )Tj 0.0034 Tc 2.548 0 Td (3a, )Tj 0.0144 Tc -22.466 -1.113 Td (-Leu )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0131 Tc 9.7 0 0 9.7 315.487 601.5639 Tm (10 )Tj EMC ET BT /T1_0 1 Tf 0.0263 Tc 9.7 0 0 9.7 329.164 601.5639 Tm (and )Tj 0.176 g 0.0144 Tc 1.978 0 Td (-Leu )Tj 0.114 g -0.0202 Tc 2.5 0 Td (12, )Tj 0.0139 Tc 1.707 0 Td (and )Tj -0.0009 Tc 2.029 0 Td (1/128 )Tj 0.0012 Tc 2.795 0 Td (for )Tj 0.022 Tc 1.634 0 Td (anti-HLA-DR )Tj -0.035 Tc 9.5888 0 0 9.7 513.52 601.56 Tm (in )Tj ET BT /Suspect <>BDC 0.176 g /T1_0 1 Tf 9.6417 0 0 9.7 291.56 590.77 Tm (PBS )Tj EMC ET BT /T1_0 1 Tf 0.0065 Tc 9.7 0 0 9.7 312.63 590.77 Tm (containing )Tj -0.0311 Tc 4.657 0 Td (4% )Tj -0.0078 Tc 1.781 0 Td (BSA\). )Tj 0.0075 Tc 2.944 0 Td (Biotinylated )Tj 0.114 g 0.0057 Tc 5.471 0 Td (horse-antimouse )Tj 0.176 g -0.0031 Tc -17.029 -1.138 Td (IgG )Tj 0.0021 Tc 2 0 Td (\(dilution )Tj ET BT /Suspect <>BDC 0.114 g /T1_0 1 Tf 0.002 Tc 9.7 0 0 9.7 349.3348 579.7314 Tm (1/400\) )Tj EMC ET BT 0.176 g /T1_0 1 Tf -0.0201 Tc 9.7 0 0 9.7 379.1817 579.7314 Tm (was )Tj 0.015 Tc 1.921 0 Td (allowed )Tj -0.0324 Tc 3.744 0 Td (to )Tj 0.0411 Tc 1.114 0 Td (react )Tj 0.114 g 0.0033 Tc 2.499 0 Td (with )Tj 0.176 g 0.0097 Tc 2.251 0 Td (the )Tj -0.0032 Tc 1.626 0 Td (cell )Tj 0.0037 Tc -22.184 -1.114 Td (preparation )Tj -0.0112 Tc 5.134 0 Td (for )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0018 Tc 9.7 0 0 9.7 357.9581 568.9256 Tm (30 )Tj EMC ET BT /T1_0 1 Tf -0.0143 Tc 9.7 0 0 9.7 372.9252 568.9256 Tm (min. )Tj 0.114 g 0 Tc 2.351 0 Td (A )Tj 0.176 g 0.0156 Tc 1.18 0 Td (complex )Tj 0.114 g 0.05 Tc 9.738 0 0 9.7 446.79 568.92 Tm (of )Tj 0.176 g 0 Tc 9.7 0 0 9.7 460.19 568.92 Tm (5 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 9.1577 0 0 9.7 469.63 568.92 Tm (Jll )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 10.2945 0 0 9.7 482.78 568.92 Tm (of )Tj -0.0023 Tc 9.7 0 0 9.7 496.22 568.92 Tm (avidin )Tj 0.114 g -0.0171 Tc -21.099 -1.138 Td (DH )Tj ET BT /Suspect <>BDC 0.176 g /T1_0 1 Tf 0.011 Tc 9.7 0 0 9.7 309.7278 557.8814 Tm (\(10 )Tj EMC /Suspect <>BDC 0.114 g -0.0178 Tc 1.815 0 Td (mg\267ml-)Tj 0 Tc 6.2 0 0 6.2 355.23 561.01 Tm (1)Tj 0.415 -0.505 Td (\) )Tj EMC ET BT 0.176 g /T1_0 1 Tf 0.0016 Tc 9.7 0 0 9.7 365.18 557.88 Tm (and )Tj 0.114 g 0.05 Tc 10.2945 0 0 9.7 383.66 557.88 Tm (of )Tj 0.176 g /T1_3 1 Tf 0 Tc 9.7 0 0 9.7 396.52 557.88 Tm (5 )Tj ET BT /Suspect <>BDC 0.114 g /T1_0 1 Tf -0.035 Tc 8.8802 0 0 9.7 405.55 557.88 Tm (Jll )Tj EMC ET BT 0.176 g /T1_0 1 Tf 0.05 Tc 10.2945 0 0 9.7 418.22 557.88 Tm (of )Tj 0.114 g 0.0103 Tc 9.7 0 0 9.7 431.05 557.88 Tm (biotinylated )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.005 Tc 9.7 0 0 9.7 483.3524 557.88 Tm (horserad\255)Tj EMC ET BT /T1_0 1 Tf -0.0059 Tc 9.7 0 0 9.7 291.5252 547.3264 Tm (ish )Tj 0.176 g 0.015 Tc 1.494 0 Td (peroxidase )Tj /T1_2 1 Tf 0 Tc 9.8 0 0 9.8 352.33 547.33 Tm (H )Tj /T1_0 1 Tf -0.035 Tc 9.5495 0 0 9.7 363.01 547.33 Tm (\(5 )Tj ET BT /Suspect <>BDC 0.114 g /T1_0 1 Tf -0.0008 Tc 9.7 0 0 9.7 374.62 547.33 Tm (mg\267ml)Tj 0.286 g 0 Tc 2.654 0 Td (\267)Tj 0.176 g 6.2 0 0 6.2 402.75 550.45 Tm (1)Tj 0.376 -0.503 Td (\) )Tj EMC ET BT 0.114 g /T1_0 1 Tf -0.0186 Tc 9.7 0 0 9.7 412 547.33 Tm (in )Tj ET BT /Suspect <>BDC 0.176 g /T1_0 1 Tf 0.0247 Tc 9.7 0 0 9.7 422.6021 547.33 Tm (400 )Tj EMC ET BT 0.114 g /T1_0 1 Tf -0.035 Tc 9.3877 0 0 9.7 441.36 547.33 Tm (ul )Tj 0.05 Tc 10.0163 0 0 9.7 452.3 547.33 Tm (of )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.003 Tc 9.7 0 0 9.7 463.88 547.33 Tm (PBS )Tj EMC ET BT 0.176 g /T1_0 1 Tf 0.017 Tc 9.7 0 0 9.7 485.026 547.33 Tm (was )Tj 0.114 g -0.02 Tc 1.978 0 Td (then )Tj 0.0076 Tc -21.928 -1.138 Td (layered )Tj 0.176 g 0.0101 Tc 3.339 0 Td (on )Tj 0.114 g -0.015 Tc 1.492 0 Td (the )Tj 0.176 g 0.0133 Tc 1.576 0 Td (cell )Tj 0.0062 Tc 1.94 0 Td (preparation )Tj -0.0112 Tc 5.085 0 Td (for )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0266 Tc 9.7 0 0 9.7 437.1662 536.2914 Tm (30 )Tj EMC ET BT /T1_0 1 Tf -0.006 Tc 9.7 0 0 9.7 451.173 536.2914 Tm (min. )Tj 0.0235 Tc 2.245 0 Td (The )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0071 Tc 9.7 0 0 9.7 492.2428 536.2914 Tm (peroxi\255)Tj EMC ET BT /T1_0 1 Tf 0.0216 Tc 9.7 0 0 9.7 291.2588 525.4856 Tm (dase )Tj 0.0249 Tc 2.631 0 Td (reaction )Tj 0.017 Tc 4.256 0 Td (was )Tj 0.114 g 0.0322 Tc 2.416 0 Td (developed )Tj 0.0115 Tc 5.229 0 Td (with )Tj 0.176 g 0.0097 Tc 2.696 0 Td (the )Tj 0.0023 Tc 2.13 0 Td (use )Tj 0.05 Tc 10.0163 0 0 9.7 500.06 525.48 Tm (of )Tj 0 Tc 9.7 0 0 9.7 516.38 525.48 Tm (a )Tj 0.114 g 0.0134 Tc -23.232 -1.137 Td (carbazole-containing )Tj 0.0183 Tc 9.017 0 Td (buffer )Tj 0.0136 Tc 2.907 0 Td (for )Tj -0.035 Tc 9.4002 0 0 9.7 422.79 514.45 Tm (15 )Tj -0.006 Tc 9.7 0 0 9.7 436.3 514.45 Tm (min. )Tj 0.0358 Tc 2.221 0 Td (The )Tj 0.0215 Tc 2.003 0 Td (cell )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.006 Tc 9.7 0 0 9.7 495.8483 514.45 Tm (prepa\255)Tj EMC ET BT /T1_0 1 Tf 0.0087 Tc 9.7 0 0 9.7 291.1104 503.4017 Tm (rations )Tj 0.006 Tc 3.167 0 Td (were )Tj 0.0142 Tc 2.341 0 Td (exposed )Tj -0.0324 Tc 3.819 0 Td (to )Tj 0.0099 Tc 1.139 0 Td (haematoxylin )Tj 0.0012 Tc 6.002 0 Td (for )Tj 0.0221 Tc 1.569 0 Td (nuclear )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0017 Tc 9.7 0 0 9.7 499.544 503.4017 Tm (stain\255)Tj EMC ET BT /T1_0 1 Tf -0.0119 Tc 9.7 0 0 9.7 291.285 492.6153 Tm (ing )Tj 0.0016 Tc 1.829 0 Td (and )Tj 0.176 g 0.0035 Tc 2.012 0 Td (mounted )Tj 0.114 g -0.0186 Tc 4.126 0 Td (in )Tj 0.176 g 0.0308 Tc 1.34 0 Td (Kaiser's )Tj 0.0133 Tc 3.955 0 Td (glycerin-gelatin )Tj 0.0074 Tc 7.123 0 Td (\(Merck, )Tj 0.114 g 0.0083 Tc -20.38 -1.113 Td (Darmstadt\))Tj 0.286 g 0 Tc 4.61 0 Td (. )Tj 0.176 g 0.0235 Tc 0.829 0 Td (The )Tj 0.114 g 0.0208 Tc 2.236 0 Td (percentage )Tj 0.05 Tc 10.0163 0 0 9.7 415.58 481.81 Tm (of )Tj 0.0125 Tc 9.7 0 0 9.7 430.33 481.81 Tm (positive )Tj 0.176 g 0.0179 Tc 3.874 0 Td (cells )Tj -0.0049 Tc 2.557 0 Td (with )Tj 0 Tc 2.44 0 Td (a )Tj 0.114 g -0.001 Tc -23.225 -1.113 Td (margin )Tj 0.0134 Tc 3.365 0 Td (membrane )Tj 0.176 g 0.0112 Tc 4.837 0 Td (staining )Tj 0.0094 Tc 3.702 0 Td (pattern )Tj -0.035 Tc 9.3585 0 0 9.7 439.81 471.01 Tm (\(9] )Tj -0.0078 Tc 9.7 0 0 9.7 455.75 471.01 Tm (was )Tj 0.0076 Tc 2.07 0 Td (determined )Tj 0.114 g -0.0254 Tc -19.041 -1.139 Td (by )Tj 0.176 g 0.0123 Tc 1.4 0 Td (counting )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0265 Tc 9.7 0 0 9.7 343.3852 459.9617 Tm (200 )Tj EMC ET BT 0.114 g /T1_0 1 Tf 0.0171 Tc 9.7 0 0 9.7 362.63 459.9617 Tm (to )Tj ET BT /Suspect <>BDC 0.176 g /T1_0 1 Tf 0.0094 Tc 9.7 0 0 9.7 374.5222 459.9617 Tm (500 )Tj EMC ET BT /T1_0 1 Tf 0.0158 Tc 9.7 0 0 9.7 393.5924 459.9617 Tm (mononuclear )Tj 0.0179 Tc 5.782 0 Td (cells )Tj 0.114 g -0.0186 Tc 2.327 0 Td (in )Tj 0.176 g 0 Tc 1.21 0 Td (a )Tj 0.015 Tc 0.851 0 Td (routine )Tj 0.114 g 0.0162 Tc -20.766 -1.163 Td (light )Tj 0.0073 Tc 2.282 0 Td (microscope. )Tj /T1_1 1 Tf 0.0098 Tc 9.8 0 0 9.8 290.02 410.53 Tm (Immunofluorescence )Tj 0.0095 Tc 8.932 0 Td (staining )Tj /T1_0 1 Tf 0.0151 Tc 9.7 0 0 9.7 299.01 386.28 Tm (When )Tj -0.0094 Tc 2.848 0 Td (using )Tj -0.0008 Tc 2.537 0 Td (first-step )Tj 0.0045 Tc 3.993 0 Td (monoclonals )Tj 0.05 Tc 10.5727 0 0 9.7 443.66 386.28 Tm (of )Tj 0.0247 Tc 9.7 0 0 9.7 455.93 386.28 Tm (IgM )Tj 0.0022 Tc 2.151 0 Td (class )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0082 Tc 9.7 0 0 9.7 499.5703 386.28 Tm (\(anti\255)Tj EMC ET BT /T1_0 1 Tf 0.0214 Tc 9.7 0 0 9.7 290.1085 375.2414 Tm (Leu )Tj 0 Tc 10.3 0 0 10.3 310.69 375.24 Tm (7 )Tj 0.0139 Tc 9.7 0 0 9.7 320.54 375.24 Tm (and )Tj 0.0167 Tc 1.979 0 Td (anti-Leu )Tj 0.05 Tc 12.224 0 0 9.7 379.82 375.24 Tm (llb )Tj 0.0133 Tc 9.7 0 0 9.7 398.78 375.24 Tm (antibodies\), )Tj 0.0169 Tc 5.375 0 Td (FITC-conjugated )Tj 0.176 g 0.0089 Tc -16.557 -1.137 Td (goat )Tj 0.0029 Tc 2.126 0 Td (anti-mouse )Tj 0.0229 Tc 4.853 0 Td (Ig )Tj -0.0078 Tc 1.293 0 Td (was )Tj 0.114 g -0.0084 Tc 1.956 0 Td (used )Tj 0.176 g 0.0203 Tc 2.192 0 Td (as )Tj 0.114 g -0.015 Tc 1.295 0 Td (the )Tj 0.176 g 0.0142 Tc 1.571 0 Td (second)Tj 0.286 g 0 Tc 2.873 0 Td (-)Tj 0.176 g -0.0001 Tc 0.343 0 Td (step )Tj -0.0102 Tc 2.018 0 Td (reagent. )Tj 0.0235 Tc -20.543 -1.114 Td (The )Tj -0.0032 Tc 2.077 0 Td (cell )Tj 0.0153 Tc 1.94 0 Td (preparations )Tj 0.006 Tc 5.614 0 Td (were )Tj 0.114 g 0.0115 Tc 2.492 0 Td (incubated )Tj 0.176 g 0.0012 Tc 4.5 0 Td (for )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0018 Tc 9.7 0 0 9.7 467.8925 353.4053 Tm (30 )Tj EMC ET BT /T1_0 1 Tf -0.0078 Tc 9.7 0 0 9.7 482.3843 353.4053 Tm (min )Tj 0.114 g -0.0132 Tc 2.079 0 Td (with )Tj 0.176 g -0.0162 Tc -21.902 -1.137 Td (25 )Tj ET BT /Suspect <>BDC 0.114 g /T1_0 1 Tf -0.035 Tc 9.1577 0 0 9.7 304.27 342.37 Tm (Jll )Tj EMC ET BT /T1_0 1 Tf 0.0034 Tc 9.7 0 0 9.7 317.29 342.37 Tm (portions )Tj 0.176 g 0.05 Tc 10.0163 0 0 9.7 353.9 342.37 Tm (of )Tj 0.114 g 0.0097 Tc 9.7 0 0 9.7 366.7 342.37 Tm (monoclonal )Tj 0.0124 Tc 5.311 0 Td (antibodies )Tj 0.176 g 0.0052 Tc 4.7 0 Td (\(dilution )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0077 Tc 9.7 0 0 9.7 502.9365 342.37 Tm (1/80 )Tj EMC ET BT /T1_0 1 Tf -0.0235 Tc 9.7 0 0 9.7 290.5259 331.5642 Tm (for )Tj 0.009 Tc 1.59 0 Td (Leu )Tj 0 Tc 2.073 0 Td (7 )Tj 0.0016 Tc 0.99 0 Td (and )Tj ET BT /Suspect <>BDC 0.114 g /T1_0 1 Tf -0.0077 Tc 9.7 0 0 9.7 355.5838 331.5642 Tm (1/20 )Tj EMC ET BT 0.176 g /T1_0 1 Tf -0.0235 Tc 9.7 0 0 9.7 377.6513 331.5642 Tm (for )Tj 0.009 Tc 1.614 0 Td (Leu )Tj 0.114 g 0.0032 Tc 2.172 0 Td (11b )Tj -0.035 Tc 9.2582 0 0 9.7 433.6 331.56 Tm (in )Tj ET BT /Suspect <>BDC 0.176 g /T1_0 1 Tf 0.0218 Tc 9.7 0 0 9.7 445.4 331.56 Tm (PBS )Tj EMC ET BT /T1_0 1 Tf 0.0093 Tc 9.7 0 0 9.7 468.389 331.56 Tm (containing )Tj 0 Tc 4.756 0 Td (4 )Tj 0.114 g -23.091 -1.112 Td (% )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0016 Tc 9.7 0 0 9.7 302.1213 320.7736 Tm (BSA\), )Tj EMC ET BT /T1_0 1 Tf 0.0003 Tc 9.7 0 0 9.7 330.7072 320.7736 Tm (washed )Tj -0.0112 Tc 3.404 0 Td (for )Tj /T1_1 1 Tf 0 Tc 10.7 0 0 10.7 379.09 320.77 Tm (5 )Tj /T1_0 1 Tf 0.0046 Tc 9.7 0 0 9.7 387.58 320.77 Tm (min )Tj 0.0062 Tc 1.973 0 Td (in )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.003 Tc 9.7 0 0 9.7 418.038 320.77 Tm (PBS )Tj EMC ET BT /T1_0 1 Tf 0.0139 Tc 9.7 0 0 9.7 439.3392 320.77 Tm (and )Tj 0.0048 Tc 1.889 0 Td (then )Tj 0.0084 Tc 2.493 0 Td (incubated )Tj -0.0049 Tc -19.787 -1.138 Td (with )Tj 0.0098 Tc 2.248 0 Td (FITC )Tj 0.0193 Tc 2.666 0 Td (anti-mouse )Tj 0.0198 Tc 5.049 0 Td (immunoglobulin )Tj 0.0083 Tc 7.395 0 Td (\(dilution )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0009 Tc 9.7 0 0 9.7 497.6556 309.7314 Tm (1/320 )Tj EMC ET BT /T1_0 1 Tf 0.0062 Tc 9.7 0 0 9.7 289.8331 298.9353 Tm (in )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0094 Tc 9.7 0 0 9.7 304.5092 298.9353 Tm (PBS )Tj EMC ET BT /T1_0 1 Tf 0.0175 Tc 9.7 0 0 9.7 329.4188 298.9353 Tm (containing )Tj 0 Tc 5.102 0 Td [(4 )-580(% )]TJ ET BT /Suspect <>BDC /T1_0 1 Tf 0.0152 Tc 9.7 0 0 9.7 406.9897 298.9353 Tm (BSA\) )Tj EMC ET BT /T1_0 1 Tf 0.026 Tc 9.7 0 0 9.7 436.9239 298.9353 Tm (for )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0266 Tc 9.7 0 0 9.7 456.3627 298.9353 Tm (30 )Tj EMC ET BT /T1_0 1 Tf -0.006 Tc 9.7 0 0 9.7 473.4929 298.9353 Tm (min. )Tj 0.0126 Tc 2.598 0 Td (After )Tj 0.0165 Tc -21.547 -1.139 Td (being )Tj 0.0101 Tc 2.72 0 Td (washed )Tj -0.035 Tc 9.5888 0 0 9.7 350.08 287.88 Tm (in )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.003 Tc 9.7 0 0 9.7 361.4 287.88 Tm (PBS )Tj EMC ET BT /T1_0 1 Tf 0.0136 Tc 9.7 0 0 9.7 383.4093 287.88 Tm (for )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0131 Tc 9.7 0 0 9.7 399.7441 287.88 Tm (10 )Tj EMC ET BT /T1_0 1 Tf 0.0022 Tc 9.7 0 0 9.7 413.2659 287.88 Tm (min, )Tj 0.0097 Tc 2.301 0 Td (the )Tj 0.0133 Tc 1.651 0 Td (cell )Tj 0.0108 Tc 1.915 0 Td (preparations )Tj 0.0308 Tc -18.584 -1.112 Td (were )Tj 0.0282 Tc 2.844 0 Td (mounted )Tj 0.0062 Tc 4.522 0 Td (in )Tj 0.0343 Tc 1.637 0 Td (PBS-glycerine. )Tj 0.05 Tc 9.8256 0 0 9.7 448.72 277.09 Tm (The )Tj 0.0302 Tc 9.7 0 0 9.7 472.71 277.09 Tm (cells )Tj 0.0308 Tc 2.779 0 Td (were )Tj 0.003 Tc -21.659 -1.138 Td (examined )Tj 0.0002 Tc 4.291 0 Td (under )Tj 0 Tc 2.637 0 Td (a )Tj 0.0102 Tc 0.797 0 Td (Leitz )Tj 0.0062 Tc 2.469 0 Td (epifluorescence )Tj -0.0026 Tc 6.738 0 Td (microscope. )Tj 0.0111 Tc 5.214 0 Td (The )Tj 0.0125 Tc -22.16 -1.089 Td (percentage )Tj 0.05 Tc 10.5727 0 0 9.7 336.86 255.49 Tm (of )Tj 0.0195 Tc 9.7 0 0 9.7 349.93 255.49 Tm (positive )Tj 0.0241 Tc 3.751 0 Td (cells )Tj -0.0078 Tc 2.433 0 Td (was )Tj 0.0186 Tc 2.045 0 Td (determined )Tj 0.024 Tc 5.107 0 Td (by )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0031 Tc 9.7 0 0 9.7 494.072 255.49 Tm (count\255)Tj EMC ET BT /T1_0 1 Tf 0.0005 Tc 9.7 0 0 9.7 289.6057 244.4514 Tm (ing )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0141 Tc 9.7 0 0 9.7 305.4652 244.4514 Tm (200 )Tj EMC ET BT /T1_0 1 Tf -0.011 Tc 9.7 0 0 9.7 323.9146 244.4514 Tm (cells. )Tj 0.0358 Tc 2.426 0 Td (The )Tj 0.0104 Tc 1.989 0 Td (primary )Tj 0.0039 Tc 3.601 0 Td (antibody )Tj 0.017 Tc 3.919 0 Td (was )Tj 0.0104 Tc 1.971 0 Td (omitted )Tj -0.0112 Tc 3.487 0 Td (for )Tj -0.0026 Tc 1.543 0 Td (the )Tj 0.012 Tc -22.49 -1.114 Td (negative )Tj 0.176 g 0.0081 Tc 3.852 0 Td (controls. )Tj 0.114 g /T1_1 1 Tf 0.0061 Tc 9.8 0 0 9.8 289.18 198.85 Tm (Statistical )Tj 0.0151 Tc 4.454 0 Td (methods )Tj /T1_0 1 Tf 0.034 Tc 9.7 0 0 9.7 297.9 173.64 Tm (Student's )Tj 0 Tc 4.322 0 Td (t )Tj 0.0089 Tc 0.668 0 Td (test )Tj 0.176 g 0.0114 Tc 1.822 0 Td (\(two-tails\) )Tj 0.114 g 0.017 Tc 4.711 0 Td (was )Tj 0.0054 Tc 2.005 0 Td (used. )Tj 0.0381 Tc -4.186 -3.488 Td (Results )Tj 0.0095 Tc -9.357 -2.525 Td (There )Tj 0.006 Tc 2.729 0 Td (were )Tj 0.0177 Tc 2.326 0 Td (no )Tj 0.0114 Tc 1.372 0 Td (significant )Tj 0.0076 Tc 4.657 0 Td (difference )Tj 0.0036 Tc 4.489 0 Td (between )Tj -0.0274 Tc 3.807 0 Td (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0124 Tc 9.7 0 0 9.7 500.8628 115.3139 Tm (vari\255)Tj EMC ET BT /T1_0 1 Tf 0.0085 Tc 9.7 0 0 9.7 288.8693 104.2753 Tm (ous )Tj 0.0101 Tc 1.805 0 Td (asbestos )Tj 0.0128 Tc 3.812 0 Td (groups )Tj 0.0163 Tc 3.199 0 Td (regarding )Tj 0.0027 Tc 4.37 0 Td (age, )Tj 0.0343 Tc 2.09 0 Td (but )Tj -0.0026 Tc 1.754 0 Td (the )Tj 0.0136 Tc 1.609 0 Td (normal )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0085 Tc 9.7 0 0 9.7 501.503 104.2753 Tm (con\255)Tj EMC ET BT /T1_0 1 Tf 0.0081 Tc 9.7 0 0 9.7 288.9372 93.4792 Tm (trols )Tj 0.0225 Tc 2.302 0 Td (were )Tj 0 Tc 2.465 0 Td (a )Tj 0.0135 Tc 0.942 0 Td (little )Tj 0.0128 Tc 2.382 0 Td (younger. )Tj 0.0482 Tc 4.125 0 Td (The )Tj 0.0063 Tc 2.134 0 Td (mean )Tj 0.0152 Tc 2.697 0 Td (values )Tj 0.0012 Tc 3.133 0 Td (for )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0059 Tc 9.7 0 0 9.7 500.5815 93.4792 Tm (ESR )Tj EMC ET BT /T1_0 1 Tf 0.0139 Tc 9.7 0 0 9.7 288.6074 82.4406 Tm (and )Tj -0.0112 Tc 2.077 0 Td (for )Tj 0.0096 Tc 1.741 0 Td (various )Tj 0.0138 Tc 3.625 0 Td (subsets )Tj 0.05 Tc 10.0163 0 0 9.7 395.18 82.44 Tm (of )Tj 0.0179 Tc 9.7 0 0 9.7 409.12 82.44 Tm (lymphocytes )Tj 0.027 Tc 5.862 0 Td (are )Tj -0.0008 Tc 1.833 0 Td (given )Tj -0.035 Tc 9.2582 0 0 9.7 511.36 82.44 Tm (in )Tj 0.0042 Tc 9.7 0 0 9.7 288.94 71.4 Tm (table )Tj -0.035 Tc 8.5768 0 0 9.4 312.66 71.4 Tm (1. )Tj ET endstream endobj 3 0 obj <>/Filter/JBIG2Decode/Height 3505/ImageMask true/Length 27963/Name/X/Subtype/Image/Type/XObject/Width 2480>>stream D|%{hu5!|fyY{g8?->| sOy%Mth 0ٞH7~WhԋK?=0Mrr_545c[r@f3i#vMb'Ŏ/d2\19$=Nxl<uOʗ//[g1QF YQ ]m '8s29"j{y @ʐsvy†CkVĦfrk5lfwk,;kΌ!%+UN`gb`OєX iJr`zZ"c BD =NV{0{V~3}kM&X XMOs A^uOc };;x#6/1S2UeՙS'͹%tڷA-ˑ*~Qc%bW20hsoxK7=VW'H ?USx$ .u)'Fm&((\ RnurocLWnk.+mۇM`E$}&Ȟ.hIVXB@jZc9ːg,;Ipiot{+{ Uo M[M9QQ=v#@[ G!j\Mժ@HaL|: H槊w. jTNQ+/V?znyєkG kw 9py@lZC-@[t+# ofznA z0~GIME&P mٙ(E z^ce/,/Swt5 |Dž2oxZ0+u8` w)T+qk!Z gJ.ܭ7\*7Ғx?_W@ `KTDyp=Rnǜ3=;)5Ux6ͽY(voӻ~tS{61u01,QNPL$]uȴ/1i])]*XK*ҁ%l&DpM]-[Ǖuj~*8Ҏ8dUhѪ|T)HC̮B5OG`ysG@I߯lņ[IxN8v]:[d6=>Kv\N?|}IYμԷ S5P-Af[N=8`-zd>|Rh$=Gk&iƙN9% S@F m &6 @"#?!* gs_ Yu6oA Ioa޿=|e? NV"n2 cy6"Ysy`^6d܆aOm[ЊF#9.JE:M|‘pU*9w+"fQ-C880a/n www TRl_0~qC"?WLs+<ɈI%(_CHJ2 ]oPJ"6֟}MC$E/nRW[p69;8T-~;/!tz.}jjv("['Ƶy l!KEg 7GFYn=1h]#&`>2 sZ<,[@P{ҫw0[%%K<50- o'4Av#8r%`b1J̿f qʼyr$VV÷Kq-|uSC1Lki7%FL)&pϑ^Q>7{ym6Ү3{[*/E+s.FI%\ e䛤҉!D8's+#ŀ i1qb;rc dq{+P]iPWeXTaqL{:J_I [iu9$ t;y{aɭleࡿRtu, Nj-1#*KU}93"(r`"h{2%rqB%u f[A 80sUuBo:i>A?ܽ{9d=m+-z(W$ Ohtɣv 4÷QVNZT\|4%;P9 qϼsԪTfִ}4ljͥh#9k0TxTAQilvJeBlGDxwkkGAa޷or9H&ktlfOnP>ib4qx99 ԥ#2 T޾8FyXQ%\4P/ cq<")G=7GEJq\V(~'_5XO-QYB!69% *,ܧ7QNh% :!j'XyVn_`0|+Pȓ@ (t(S &qkj8PrG;\lcn7(uH4@9< ܐgMGݴ\'~=~v<,LǶXr9ٷ+-Qf7 GWd? ~]U̢i)51' Rk@jl= Gl[Ł@9=DzvP:i|[_;|ஞt_x6}? xH=mpxv4B羀guqkUD4)U;v_(} P?/Ƣ*U*V֭~'M[B_?S4q x:i|%۶D1͢S3gCpUՑi#33ZD]^ 6bk2FZj[QXè7fcF]ŽJ(P̠r?'wr?l`z#2=hUof~uhdH5/W*M/i =Ӑ+썙_oL^3pHk) uH5Vn ŦM{*L9EtJjj J(ZDf}(8! ܜ8V\r- WrKI0Hn.cY3xg휁j&9prPFkf~Z? %buЊѸ .rI|wHũsbGU"G_Ԝ:Bu/4$eҩliۗڤ /]DJ.YpX-pr[;a(.˕pBeK@SR֪nq8W|$LwʩiDǺd-dj[I/c:DXڬ@Cow#3 ;/͕&ZkPG"?&* ZW#ICwçuXj8=7g.7Tzh{Ea:T㻬fiYB4C H-y[FMTr gnK>FBM MlP'̐ "Yԫ?ՇXqR\wt@\SQC`b~IZ2y0xb&a{ݞDd<4a&1؛LkA0j/B_B;G_S>&w8"Z2 Z*nʤ}5z=̤8A~S^J;sUNc]D+9ߑ$$J<-S){{ }1,/pr~nԿ1ߑbQskt4w$*_@5y2N7HH/ ٽ?{]HwHk B\riےLPjLj&éwf%'Qiς8FzȔj޸G/d.˾ \VwJEԎ(Qٙ,8yx(Aֈ .~8wKvӘjq0~2t^7oG/ZF< x fѠyj}1-څjZCrN+es *>au)&[hM HS+>Mׅzͱd Pɬ ̄F(Zw;|Pi ]n Aѕ4:m*|]%^A;]6;F>#7yXh^.ΚnoO+$bt8m['LѣTr29B~!1%L2kP~m#wjOjM"8vJvyoa 6m (QK7}w-N~b?z]Mhk<Ù+L g~l\W ;/{)CZDWշp6P½՚(<6%/7F?%unhOZe !֭;a]n 4Ip"ܖ *!GµUS"tr MG`g!yw[Is>Uwu<_ ^a*)◎wTAw ވ C rw @ˠLD\S b"ْ#l^8BO( ` ~s=Vz ? 6V|N#>;Xv dߦaiA 8}2c2/=ɈHP|3y$o叫52)Վ-)ZP4&LBYUL|_;Mp^`a 7NqWS245k=HE@BJ+jԋqGZ?83a %Ӭ,ڢdn4V&X&0.>ۨՉ fE'}ۏn4c KgϬWclpme.L#᭔{T8*8 jgݮq"19mẃ2sWWJpǖzkM Vēg~NC10S5)u){ =)=};"]4zӞb 8dt1ߤ~=^Gww`e(iRU1K`u 2ȒNdYk(lekb\ $Hg5C8 wXQ "jqp$H'%٬kX("mN9}5Aʴ7ljuBpETaT飃dS;}Փ6)83:$JwU9ZbsyLQ=վdR0u!B6[ْb:rDW3 OS& 5.IJ9|مd5VtV~Ǘؤ)cU38ieb0Y(LEiD%J6n]oIY Z:cS4=;B 8zq%8 Z_qj!uס#'!M:Q;THV0)=ܳn^ תaC /+dZ)O#T˘"?B~,_G^cwkPb '=?_~,'5Y+luȼ'.v VB<@O?;^s536?4ڌA)ʽaϠ&ڽ苩llJrnj?RB֩a}{ BKJ~e;4? Mjez~~(;4-o Dq<7>Q,Nv0tgl}3xךK(Pr߃9̤[#gIr3CS],s} r1$ֳμb#LQWnSm I`r _$eTeS 򕑼G!; 7}[(PeW[JX5睕+MDI [ 7y6'ƼSrX_jbtaSzG=W|-|Yh>.'8 oBJ;3>gÉzB{5^eW:jىYKEanzsiISNb N0EZN\!N\Lv6iod"0J&aVu84dmmy<'<+31QI`6}0|BK$T~*vRLY sNh-TyĤv irPu7Tu#C'Z^P^N/{Dq!*$#'ۃC:们0?#-0.cDӗ!)p`T8TOXI/;nQLkVşq~.3J?m8YoǪdQ㎩^Qɤ Γ@<inJolݘHYv:%FJmxl`@ª L:%c5QQ≰uQRVf9,YSWmmBzkJ>aBe'H|kb}NINqS «iX!z]V#BY͡~\G)r,tq43T{$Ftq$uބ6uPk t!qLb`?1ޙR=S{tbjA;ƅ.g5$yk7+yv8ł?wI'*bQ;ʠP"fkߍt"-̭T_p*Xix,>LyEیDҒʼnЎ= U uXaX42^BLR$Q8`St įMm!$`=K+a"&r^\Irՠh?bfh ލg[I@`9z(_7O EPTi[=(vgb^Fѹ~>֒保d\] JIEuhnTHk0B%LexޥzYmYqFً%G5e|X<;7`viZuoJ^0ԍw4+,B߳rqS]CoMU;iNtbjU9UZ)iu lh@͌t>SBQNӽ_OW*<A/8S,8Cڵ9R"S'ģaI2v"?='EbvmJ]3Z-޾ 2Wυ^ҩ)\k~C2:JWDĂ6c]0dr4+r {YuҴ'RZp=QAorۚVB>G6/߷ :D2{Ri6@/s?dF2<4tsAU#>`^r~osLgQ1֞s ./Y"")T-FSZ,0h8̬zVos\Tۧ}D ΀ :DBh n9_[My?c%npn\G%3Q햋)RcXnϙо9%!{1iQZH7CՁ|\ )dz=*.OsM:..~pKUw?ҰuA#r`@-! HPEy(p&pn^e= A1 {TgN˻=l)D{a^nY; $91 `VXƘACrqj@y'fa5Ep|.҅CI2I ,ZA5Twkt " o)KRT 6d =:&UۍBU&%vQ4 :4:\(182`B`:Kt˓20ʦC#(5CL^XimV8swҚcb2 B =XHõC­ݾF缸Lu៟]#? "3AW)o-q;s50,&*3mҖ0f␙)ͬĒ=L[Aqaw) !ώ¶iGWB[}CDFEil͂`(yo#Kq_DT._;T^xy?xřҨRb"u)'HKBjL-rgeM(ADpFjy+]'lק{K%w1{$oE'6rU’(oFI]IAU;eӬ {>aϓ;^Su)W$"u`^$ ZnB]z ׮36処#h6vqST)! D0`詧 rK{!9:JAZ3= p '6T=CB׿y9Bc[@^Fuo>H$Wc4XbJO$nc8OQKC^iVmD:GI)i2W~QCqYM9-lK.it41m} ;ۑu[;>@H!.&gz vfl*Lz)CUT{_5(>mc:5ѴSob:yF`m/xPÙu HLjN!`Y8% Ex# wE/׽dh65z*-)8SJ9=dׇAz=dJi[|eazwNwϑ'y'n.G,g; #?23[# _c0cG=W~_*^Rf@s7cu |Cn{0m7+o|.xUđqz*~ ,'uwxР흝M" )KmS5}sKýe<)ٴÑ, )0Ì7Jcrt|dYg./7?hMϛETO%f7v%& ?\\ލI>6pfi4׸֨.MϬ0|v$o7/hn7'Hє^#´ciX{hxs Cx/?2x b{Z+:bC4jZ/=!c02R a㛼`DEĦS NSM謚O1i̊ݬn&PuqH2zSh|+j{Nrx@*!SIUi٠tK-⫼! mz DBM1X0Q?:[rPc@ 93aFP+)c9g0 #C޺K04*[|)&]Ӱe _4Za2+{` Y5&l#Te떭jyKN.WIoC0THZIEbL>%JgоZg7E[jKÏ$Ϭ0(Lwͭ~ܙ Oj MFSG$6/{8 -$)uoF$oϝE(^D&qY"}7 ҉w-4ߊk@GL0KD* bP:+sL7Q nbq#_˅$iV(sn[UE5#T.}fs LBzۜ4 iܐ( { L~iݾBpG߿&]^1GZ$ǚ #t5N2cΗޟ~Q[Q~Qbml{b=WXN7|/?qdÊ ͎(\e ; v+7QځŰ/m/7ֹq]o.K-|D HK6k5njȆXImi-QA_BzWQ!rP]P<A~*M&@Z 7j/cWB$ dR#OuUz7>R֌V&ʄo+ %܊ /Ҟr!~ ߭|_bJdʗviC&yfއ d8P-…C@B f@].LiGym5_R C#k =wjiܚ9>~a_[{l$4%6I])E ])AnvߏFBrP$O1@,^Qċ!-YKgBLCE e#ǸrKT}D*差\e‚t -zV>Ӛg!oF5)fZOZ7=UK<l1LH{ Y N \P͗g Jvh:=(`I/Lzƨ~NWS1if|ot@Bv`*kAZ=rc>kpy8+O <e'E>b|x3? X v[yOm%lVw`⟦';(BI6ler?ޜ1$լHD9`ˆ_kC,YH&T 3V FN|޲a['S>`π=ا& kPiێ &Eғ=~9{lΛ+<&jzs62ڙ%\L\U;:ELRgG(r6Dg&1&>T9ȥrXw҅6ÓJ1HCn8_nО+5e1 }Dϰ^"6 B4,u.}V蒒#2|z3MUAU§i*w̓$Ӎ^ ( S&zrO6g%EzI'M*D+Y{J]7+GFۇrʢWFies$d7\zt50~w#Ke#BrYlĻBu֫!þ ./;:6 /|U+嫕U0ۉMpo շ["+u@.W< zWoUC%ۍJ#/QaXqq)Pr7?Q r[6@m"wc.j5 ܆l\[H8opZǁyq [KxuL:M { ՝k7ۯ\XR(-#̔%0N>M a~Ҡ^EVx=SK7[1L 1IGßKJ~é4EϽ1=UF>A(7Tth ,K@.ȕ/a3Ada[Qp- &w,W)dT@5|$R"I /7<@{t,[E=oE5Wev|/C(FݙPז!!Li$}U$EMY3%J>U J⩞E5iąS-XRj֙CR )OZ:滒<qm5TIZ'ؾJ we}AlvUFhasu.4KtAn}Ya)&"{ Ó{kNՑ6//ĐcEeȨ_CmNaw^O-C'~Dƴ pxHx͝P4jδqWmc6I;K{[R,Tֻҍ#;xj5{[sy A&Wgw؟gRQFCz,mhq>[40" (޷P}CuS(p)a rFB%/r  $+4> Czs,B-ق-W d RI<,Z8)դg`pXc&R=ۑ@"`alJ&ERɔ&%51M[kHw*5B$֦ ҘҐm9Z=, ƽ5R #?9$u|-ԃPk[)t r}E~=8 s>![n%QF׺c3CdPpnoڦ7*e-GSN9;1՟[wJƛZ4zus?:l=|IR@E!dMztXЌ0%nG`s 0hiǛ3L4:z ԯ󬷊CK-=}cp4ndx*U lLW g(yԜpJ;t| $&p*([+˝q7'VT7̯a*hٔS!'~ۨ9iRFH!JL]Wg>sǛt0ô .kc^C>L>)vX-_dD&IQG$k#q>E'Ѫi 4£pN_}~ȶH'!,;(kঽc e T[=iC$77B$g+YƂU!,X%4~;tqvHQD>-TbD`td4,w 6JXzZKbP52ޭD-?tO=mq~De;-Z^^gWA(%0:>m>"@yo}I^UbeWeWO4!889wecPW#ޭ?-{_ %n@ .#$^M C2< Ð2І{a R$݌Rm'fɤ Ќu.{n5:~Λwsu5A,Z/l:Tj@"'1 BQRN!✷ʘE(I+VQv}ua0΃I,$&G>(jucb\C N.0#iR"Z#sܬjuYD0 @?ȶuJER-'!ԃA ]bs]7e bu \ŷ` Ac$7|_ብ4Zfp6e6q p&AbKN|@W+fqm,17` zF-Hi|''/f^-9r!J9mBۆ}>z3m47| Z{K `m˦IOĥD<21&DUp{*_he1 Z:;}:<#v5A4K֐yjȦb$-:.0 /d6p*9>kBU|XP%&`qV{Q\HmN:&S{%+?􈿜l%.3CU#THme=\f!>3>@:#q, F.&c4i\_ud#{i 'c)Uex8~k>"6sNrhg!/Q*C֏ʸ $Q"oMOr-Ň]4NȾ] H<> Y_CHF6=ZccylZiُ+}AaHrK ܑ5vh09%N8aTOT:>{74 f*伓Ep0)^"ߥɑ;ҘOvH9ج 9P-pc3e3;JI @i|hH#$[' ~^cγZ&dJVEfJUa-uG_27Sp>vhgÄ5t|M+ZW\G3|@(d@DOp8.}rM 4Yp <~emp'ۖ4P=FQ(Cpqnm<X&Ga ~ d\F +/9ZM3\ثAɾ<]M̸{iFF j`fnߐfHDmzw`=񁀝G4S(DXr~gSp;PTŽBq?}PJ]8KW&̀|5n!0MA74N>!+f[կH; #A;=$DirfBBl%ZJq04OzUZ ,՚^ͫZ2D%ÒͫGy}.[NkjV*sѼ "DكAC_ݬB6'+p:AJ LI0:LV⿟+:&{+ l.ozZco [SӖ- 89z??B*wI.ŁKlgUmeN}6* H^*_S'1nt/-8Q{Ikk5as+g E&7[64V CW cP,C3Х$[o$`73f~R.Pߙ7䘷Yᅓ.ڼdSwj@\aH2o38:||K7vsn, 0ub"SMst$8,Ok'm ( dk Vv$>cۨUےMؕ i&oۚɤJ0Q{%|˽lA7rc31' ?>cm (5'ƾaZJVim*c9"8nwOl2leTp؝_><&N (+Z\Y?%r״R#2N'|/A=p1H2 8BoU[8C&*uʸͰ"rǁuXWvSeH6U /Z0b 9v{]d~n$ X,sE41z <)ô/5.$S"(WMgf%_G~$3 y9V 3NyaG-& _HW&.ZBܦx's"i<#7Ǫz3bHc /!$}Z@4~=U#x$ i_JC2H8<[C+kQ Z) QEޜ.7/j:Ri% 5ϥ|m1שX#Wu8jOR^p^|THQC,&28+_eJF0Rs*-dܢ 5d0 N̰N*r%Jg$4$G,/Kp @x=oAB1BFXFj";C9Ji{ 6 _.|^mt)P֫OI;nD,3FIpÑHPp=Asҽ<ř̺1fqg1AZt#/#[eYxΚ"h9Ғy˜ID+85*- -lե=QW?ղ[myeuw\!?Ebmn:hA1{@X$ŗЂ@Bf/R?[\ |)ȓZZH!~"k)89nƿ` a$tNt힆h: |;u~2'$KiXf(u5LI=ZV[ GKWZpl@ca4BpWX>ӖB;R%/av_`h삊q\ovG9Z \Ku}אjJ 3env/\-]ͩ>Fv?Bqf'}lӉ./nH% )Oh^Dz* E4Y&!ᥪ:vajINC%$sVV{?J6mF8;j"C7qnwKfu6~_-pDesY0?4#.f\v?[{˒S奍-껷& &BGJHW鏭r =Y/F<ѝB?1hkʱg5SSNʙeHojg<Í5F&mf$ >kR`yI˧HP8Oާ–~ŵF@ YWݰ0"veaC7˦ 2-X2 'NCkjsL}I$|^X` $v_?cynWSU*˳ tMPba*ܨiW]k0W] 8HBv^z *1k` Zlv S帻`j3;1_2MwO]d}S?p{dtt6~V$xQ'{Ap6gNo?r$D' (ET^HpLUȝq^"d-82@gC!ƒe yf&O0EX>0:M+l-|F"{Ujn=J9fi;8k)+؋U"]O-əJu!{{8"9͕*c)3!`h9:eӏ$hk=_ ]Wh[u c(zk.>Zj'rkYZu(b RX'hQZ 0枫&(OILoNE dT&yi㈣4̡mF~[qWDӕf|Ș>l~رY|ʓ2˜+^#os{+/5ׇVߎ{7)=&hׂr/NO=e=|Q Ղ}#3MJׯ Fei'"4NG:\]1?0 ΔzoXۨ*qqx3'Ch Qįsx\aߐ: v睽˜{P] X`^KoV(n͕’-\$|UyYUĔ,ʋ=O'Wv՞>LdX{V~VYÕqlݪl%p}4du\J*pw] \Dj` -rQIʰ3dd{SG|S^e >YoJ_HŇ=2sdY gf:Gch4qhcd)k<<~~BߜDH|wkEB4EӝKz6 Rx"5=i(!m$nM3˷ܽwZ4J:?+ٿkWz/y$J8nbZFW" ,"vU%rH-1ն3 s(|+pW |_6&;# H0uvtRP(fٌWLfqu\1YHI.Uo V:Q7"˴Fzz"}"+v.Eh;1pTޜqyL!# %ŹGd}~9ȡ9ϳHLҶ:hio>ӛGSXAۮ9S:SB|;].Sڦfe6NX#.h@rVzY .:ܛpnsvUw|sօߎ,e]_ :Ň@Rth~O "Uԉ*(+ҩ=1VGYLJ #s*)~E_dKlw+*!P]9;3yjAqARYݴBPT!h>T4܀FEhh^~cX/\3Kґit`ܵuJI2Rut+?\렫3(_Yӻh>stream h22U0P02S0U02W0W0650U0Q0200= endstream endobj 5 0 obj <>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Type/Page>> endobj 6 0 obj <>stream q 0.082 0.082 0.082 rg 597.1906281 0 0 844.013382 0 0 cm /Im0 Do Q BT /Suspect <>BDC 0.126 g /T1_0 1 Tf 0.05 Tc 3 Tr 8.7143 0 0 8.4 62.99 753.8396 Tm (940 )Tj EMC ET BT /T1_0 1 Tf 7.9693 0 0 7.7 263.89 754.3196 Tm (M. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0298 Tc 7.7 0 0 7.7 278.05 754.3196 Tm (OZESMI )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.2365 0 0 7.7 311.55 754.3196 Tm (ET )Tj 7.7577 0 0 7.7 326.03 754.3196 Tm (AL. )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0131 Tc 9.1 0 0 9.1 143.94 728.3096 Tm (Table )Tj EMC ET BT /T1_1 1 Tf 0 Tc 9.1 0 0 9.1 171.1581 728.3096 Tm (1)Tj 0.255 g 0.534 0 Td (. )Tj 0.126 g 0.707 0 Td (-)Tj -0.0326 Tc 1.095 0 Td (Age, )Tj -0.0104 Tc 2.529 0 Td (erythrocyte )Tj -0.0097 Tc 5.321 0 Td (sedimentation )Tj -0.0132 Tc 6.658 0 Td (rate )Tj -0.0244 Tc 2.198 0 Td (\(ESR\) )Tj -0.0284 Tc 3.13 0 Td (and )Tj -0.0024 Tc 2.124 0 Td (various )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0045 Tc 9.1 0 0 9.1 426.3039 728.3096 Tm (lymphocyte )Tj EMC ET BT /T1_1 1 Tf -0.0106 Tc 9.1 0 0 9.1 143.9309 718.9184 Tm (subsets )Tj -0.0134 Tc 3.855 0 Td (\(within )Tj -0.0162 Tc 3.279 0 Td (bracket )Tj -0.0013 Tc 3.582 0 Td (deviations\) )Tj ET BT /Suspect <>BDC 0.463 g /T1_1 1 Tf 0 Tc 9.1 0 0 9.1 299.3225 718.9184 Tm (\267 )Tj EMC /Suspect <>BDC 0.126 g /T1_0 1 Tf -0.0025 Tc 8.4 0 0 8.4 228.99 698.9396 Tm (Units )Tj EMC ET BT /T1_0 1 Tf -0.0002 Tc 8.4 0 0 8.4 271.1832 698.9396 Tm (Normals )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0041 Tc 8.4 0 0 8.4 324.0864 698.6876 Tm (Pleural )Tj EMC /Suspect <>BDC -0.035 Tc 9.0396 0 0 9.2 374.89 698.2096 Tm (Diffuse )Tj EMC ET BT /T1_0 1 Tf 8.8916 0 0 8.9 424.52 698.2096 Tm (Asbestos )Tj -0.0118 Tc 8.4 0 0 8.4 271.29 689.0596 Tm (\(conlrol\) )Tj -0.0007 Tc 6.262 -0.057 Td (plaques )Tj 0.0028 Tc 6.279 0 Td (pleural )Tj -0.0023 Tc 5.693 -0.029 Td (effusion )Tj -0.035 Tc 8.5892 0 0 10.4 328.35 678.2296 Tm (\(PP\) )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0258 Tc 8 0 0 8 375.63 678.9496 Tm (filiusic; )Tj EMC ET BT /T1_0 1 Tf -0.0325 Tc 8.4 0 0 8.4 426.12 678.4696 Tm (\(BAPE\) )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.05 Tc 9.7093 0 0 8.2 379.09 668.8296 Tm (\(Illf\) )Tj EMC ET BT /T1_0 1 Tf 0 Tc 8.4 0 0 8.4 143.03 649.5696 Tm (n )Tj /T1_1 1 Tf -0.035 Tc 8.4663 0 0 9.1 277.58 648.8496 Tm (24 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.8746 0 0 8.4 329.37 648.6096 Tm (20 )Tj EMC ET BT /T1_0 1 Tf 0.0174 Tc 8.4 0 0 8.4 382.83 648.3696 Tm (15 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0461 Tc 8.4 0 0 8.4 430.5084 648.126 Tm (10 )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.4868 0 0 8.4 143.26 639.6996 Tm (Age )Tj 8.4 0 0 8.4 225.62 639.2196 Tm (yrs )Tj 0.0238 Tc 6.018 0 Td (46.8 )Tj 0.05 Tc 8.4542 0 0 8.4 328.11 638.7296 Tm (65)Tj 0.255 g 0 Tc 8.4 0 0 8.4 337.43 638.7296 Tm (.)Tj 0.126 g 0.239 0 Td (9 )Tj 0.0364 Tc 5.101 0 Td (61.7 )Tj 5.705 -0.029 Td (62.4 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0251 Tc 8.4 0 0 8.4 274.178 629.3384 Tm (\(15.0\) )Tj EMC ET BT /T1_0 1 Tf 0.0423 Tc 8.4 0 0 8.4 325.712 629.0948 Tm (\(16.7\) )Tj 0.0137 Tc 6.564 -0.029 Td (\(19.6\) )Tj 0.0251 Tc 5.59 -0.029 Td (\(24.2\) )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.6577 0 0 8.4 142.75 619.9496 Tm (ESR )Tj EMC /Suspect <>BDC 0.0227 Tc 8.4 0 0 8.4 223.45 620.1896 Tm (mm\267h-)Tj 0 Tc 5.3001 0 0 5.3001 247.12 622.5996 Tm (1 )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.428 0 0 8.4 328.16 618.9896 Tm (14.4 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0371 Tc 8.4 0 0 8.4 381.86 618.7496 Tm (20.2* )Tj EMC ET BT /T1_0 1 Tf 0.033 Tc 8.4 0 0 8.4 429.74 618.506 Tm (31.6*** )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0379 Tc 8.4 0 0 8.4 325.706 609.3584 Tm (\(19.40\) )Tj EMC /Suspect <>BDC 0.0137 Tc 6.536 -0.029 Td (\(26.0\) )Tj EMC ET BT 0.196 g /T1_0 1 Tf 0.0309 Tc 8.4 0 0 8.4 427.5644 608.8628 Tm (\(34.9\) )Tj 0.126 g 0.05 Tc 8.6591 0 0 8.4 142.51 599.9696 Tm (Leu )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 8.6125 0 0 8.4 160.32 599.9696 Tm (10 )Tj EMC ET BT /T1_0 1 Tf 8.511 0 0 8.4 172.56 599.9696 Tm (\(HLA)Tj 0.255 g 0 Tc 8.4 0 0 8.4 194.47 599.9696 Tm (-)Tj 0.126 g 0.05 Tc 8.4132 0 0 8.4 197.42 599.9696 Tm (DQ\) )Tj 0 Tc 8.5 0 0 8.5 233.49 599.7196 Tm (% )Tj 0.0138 Tc 8.4 0 0 8.4 276.39 599.4796 Tm (11.5 )Tj 0.05 Tc 8.428 0 0 8.4 327.92 599.2396 Tm (11.4 )Tj 0.0234 Tc 8.4 0 0 8.4 382.35 598.9996 Tm (13.7 )Tj 0.0138 Tc 5.675 -0.029 Td (13.3 )Tj 0.0131 Tc -18.208 -1.089 Td (\(7.6\) )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0309 Tc 8.4 0 0 8.4 324.0204 589.3648 Tm (\(10.2\) )Tj EMC ET BT /T1_0 1 Tf 0.0194 Tc 8.4 0 0 8.4 380.3676 589.1212 Tm (\(17.2\) )Tj 0.0437 Tc 5.819 0 Td (\(123\) )Tj 0.05 Tc 8.5123 0 0 8.4 142.51 580.2196 Tm (Leu )Tj 0 Tc 8.4 0 0 8.4 159.38 580.2196 Tm (4 )Tj 0.0408 Tc 0.995 0 Td (\(all )Tj 0.0461 Tc 1.781 0 Td (T-cells\) )Tj 0 Tc 8.5 0 0 8.5 234.94 579.9796 Tm (% )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0279 Tc 8.4 0 0 8.4 275.86 579.7396 Tm (63)Tj 0.255 g 0 Tc 1.11 0 Td (.)Tj 0.126 g 0.211 0 Td (0 )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 9.2453 0 0 8.4 327.12 579.2596 Tm (56)Tj 0.345 g 0 Tc 8.4 0 0 8.4 336.95 579.2596 Tm (.)Tj 0.126 g 0.0384 Tc 0.261 0 Td (8* )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0422 Tc 8.4 0 0 8.4 381.5624 579.2596 Tm (50.1*** )Tj EMC ET BT /T1_0 1 Tf 0.0492 Tc 8.4 0 0 8.4 431.6432 579.016 Tm (59.4 )Tj 0.0194 Tc -18.804 -1.119 Td (\(11.4\) )Tj 0.0366 Tc 6.136 -0.029 Td (\(16.2\) )Tj 6.163 -0.029 Td (\(19.3\) )Tj -0.0093 Tc 6.192 0 Td (\(13.1\) )Tj 0.05 Tc 8.5123 0 0 8.4 142.27 559.9896 Tm (Leu )Tj 0.0373 Tc 8.4 0 0 8.4 159.36 559.9896 Tm (2a\(suppr/cytotox\) )Tj 0 Tc 8.5 0 0 8.5 233.98 559.7496 Tm (% )Tj 0.05 Tc 8.8746 0 0 8.4 275.43 559.2696 Tm (24)Tj 0.255 g 0 Tc 8.4 0 0 8.4 284.94 559.2696 Tm (.)Tj 0.126 g 0.273 0 Td (1 )Tj 0.0441 Tc 4.758 0 Td (27.5 )Tj 6.45 -0.029 Td (23.5 )Tj 0.0345 Tc 5.992 -0.029 Td (26.4 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0172 Tc 8.4 0 0 8.4 276.8256 550.1136 Tm (\(9)Tj 0.345 g 0 Tc 0.91 0 Td (.)Tj 0.126 g -0.0087 Tc 0.211 0 Td (0\) )Tj EMC ET BT /T1_0 1 Tf 0.031 Tc 8.4 0 0 8.4 323.5548 549.87 Tm (\(17)Tj 0.255 g 0 Tc 1.454 0 Td (.)Tj 0.126 g 0.05 Tc 9.088 0 0 8.4 337.45 549.8796 Tm (8\) )Tj 0.0137 Tc 8.4 0 0 8.4 380.13 549.6396 Tm (\(18.7\) )Tj -0.0093 Tc 5.79 -0.029 Td (\(13.1\) )Tj 0.05 Tc 8.5123 0 0 8.4 142.03 540.2496 Tm (Leu )Tj 0.037 Tc 8.4 0 0 8.4 159.07 540.2496 Tm (3a\(helper/inducer\) )Tj 0 Tc 8.5 0 0 8.5 233.25 540.2496 Tm (% )Tj 0.0429 Tc 8.4 0 0 8.4 274.96 539.7596 Tm (42.9 )Tj 0.05 Tc 8.4327 0 0 8.4 326.73 539.5196 Tm (41.7 )Tj 0.0474 Tc 8.4 0 0 8.4 381.09 539.2796 Tm (32.8*** )Tj 0.0378 Tc 5.992 -0.029 Td (33.3*** )Tj 0.0251 Tc -18.835 -1.089 Td (\(12.2\) )Tj 0.0423 Tc 6.164 0 Td (\(18.5\) )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0194 Tc 8.4 0 0 8.4 379.8888 529.6448 Tm (\(22.0\) )Tj EMC ET BT /T1_0 1 Tf -0.015 Tc 8.4 0 0 8.4 428.7684 529.4012 Tm (\(17.2\) )Tj 0.05 Tc 8.5123 0 0 8.4 141.79 520.4996 Tm (Leu )Tj 8.6125 0 0 8.4 159.35 520.4996 Tm (12 )Tj 0.0386 Tc 8.4 0 0 8.4 171.59 520.4996 Tm (\(B-cells\) )Tj 0 Tc 8.5 0 0 8.5 233.98 520.4996 Tm (% )Tj 0.05 Tc 8.4796 0 0 8.4 279.3 520.0196 Tm (4.2 )Tj 0 Tc 8.4 0 0 8.4 331.23 519.7796 Tm (5)Tj 0.255 g 0.624 0 Td (.)Tj 0.126 g 0.215 0 Td (2 )Tj 0.042 Tc 5.62 -0.029 Td (4.8 )Tj 0.0323 Tc 5.696 0 Td (6.3 )Tj 0.0459 Tc -18.719 -1.118 Td (\(4)Tj 0.345 g 0 Tc 0.88 0 Td (.)Tj 0.126 g 0.0172 Tc 0.187 0 Td (2\) )Tj -0.0114 Tc 5.44 -0.029 Td (\(8)Tj 0.255 g 0 Tc 0.851 0 Td (.)Tj 0.126 g 0.0172 Tc 0.187 0 Td (2\) )Tj -0.0084 Tc 5.126 -0.03 Td (\(4.1\) )Tj -0.035 Tc 8.3598 0 0 8.4 433.35 509.4196 Tm (\(5.6\) )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0 Tc 8.4 0 0 8.4 141.42 489.6796 Tm (* )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.6053 0 0 8.4 150.32 489.6796 Tm (** )Tj 0.0453 Tc 8.4 0 0 8.4 164.05 489.6796 Tm (***)Tj 0.255 g 0 Tc 1.663 0 Td (; )Tj 0.126 g 0.033 Tc 0.805 0 Td (Statistically )Tj 0.0396 Tc 5.624 0 Td (significant )Tj 0.0148 Tc 5.135 0 Td (from )Tj 0.0422 Tc 2.561 0 Td (normals )Tj 0.05 Tc 8.5668 0 0 8.4 330.78 489.6796 Tm (at )Tj 0.0362 Tc 8.4 0 0 8.4 342.16 489.6796 Tm (the )Tj /T1_2 1 Tf -0.035 Tc 8.6261 0 0 9.4 357.5 489.6796 Tm (5, )Tj /T1_0 1 Tf 0.0094 Tc 8.4 0 0 8.4 369.1 489.6796 Tm (1, )Tj 0.0437 Tc 1.343 0 Td (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0308 Tc 8.4 0 0 8.4 397.7188 489.6796 Tm (0.5 )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 9.1601 0 0 8.4 413.47 489.6796 Tm (per )Tj 8.4613 0 0 8.4 429.99 489.6796 Tm (cent )Tj 0.0295 Tc 8.4 0 0 8.4 449.75 489.6796 Tm (level, )Tj 0.0357 Tc -36.744 -1.089 Td (respectively )Tj /T1_2 1 Tf 0.0327 Tc 9.8 0 0 9.8 58.86 453.0796 Tm (Lymphoid )Tj 0.0241 Tc 4.552 0 Td (cell )Tj 0.0144 Tc 1.81 0 Td (phenotypes. )Tj 0.0293 Tc 5.282 0 Td (B-cells )Tj /T1_0 1 Tf -0.0152 Tc 10.1 0 0 10.1 68.13 431.1596 Tm (All )Tj 0.0061 Tc 1.637 0 Td (asbestos )Tj 0.0069 Tc 3.745 0 Td (groups )Tj -0.0103 Tc 3.168 0 Td (\(PP, )Tj 0.0211 Tc 2.105 0 Td (DPF )Tj 0.0112 Tc 2.236 0 Td (and )Tj -0.0071 Tc 1.842 0 Td (BAPE\) )Tj -0.0014 Tc 3.26 0 Td (combined )Tj -0.0162 Tc -18.898 -1.096 Td (had )Tj 0 Tc 1.755 0 Td (a )Tj -0.0067 Tc 0.807 0 Td (significantly )Tj -0.0044 Tc 5.282 0 Td (higher )Tj -0.0027 Tc 2.816 0 Td (percentage )Tj 0.0457 Tc 4.638 0 Td (of )Tj 0 Tc 1.174 0 Td (B )Tj -0.0112 Tc 0.996 0 Td (cells )Tj -0.035 Tc 10.0046 0 0 10.1 257.63 420.0896 Tm (than )Tj 10.0715 0 0 10.1 278.34 420.0896 Tm (the )Tj -0.0122 Tc 10.1 0 0 10.1 58.98 409.4896 Tm (normal )Tj 0.0028 Tc 3.162 0 Td (controls )Tj -0.0078 Tc 3.647 0 Td (\(p<0.01\). )Tj /T1_2 1 Tf 0.0087 Tc 9.8 0 0 9.8 58.56 378.4296 Tm (T-cells )Tj /T1_0 1 Tf -0.0053 Tc 10.1 0 0 10.1 67.1 353.3796 Tm (The )Tj -0.0202 Tc 2.033 0 Td (mean )Tj 0.0026 Tc 2.627 0 Td (percentage )Tj 0.05 Tc 10.8872 0 0 10.1 162.44 353.3796 Tm (of )Tj 0.0017 Tc 10.1 0 0 10.1 175.94 353.3796 Tm (T-cells )Tj -0.0184 Tc 3.263 0 Td (\(Leu )Tj 0.0168 Tc 2.296 0 Td (4\) )Tj 0.0001 Tc 1.338 0 Td (was )Tj 0.0013 Tc 2.02 0 Td (lower )Tj 0.0021 Tc -20.599 -1.072 Td (in )Tj -0.0247 Tc 1.269 0 Td (the )Tj 0.0478 Tc 1.62 0 Td (PP )Tj 0.0036 Tc 1.567 0 Td (and, )Tj 0.0016 Tc 2.157 0 Td (particularly, )Tj 0.0021 Tc 5.331 0 Td (in )Tj -0.0247 Tc 1.293 0 Td (the )Tj -0.0027 Tc 1.644 0 Td (DPF )Tj 0.0046 Tc 2.237 0 Td (group )Tj -0.0162 Tc 2.82 0 Td (than )Tj -0.035 Tc 9.6209 0 0 10.1 281.18 342.5496 Tm (in )Tj -0.0128 Tc 10.1 0 0 10.1 58.01 331.7096 Tm (the )Tj -0.0027 Tc 1.55 0 Td (normal )Tj 0.0028 Tc 3.162 0 Td (controls )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0086 Tc 10.1 0 0 10.1 142.1935 331.7096 Tm (\(p<0.05 )Tj EMC ET BT /T1_0 1 Tf 0.0112 Tc 10.1 0 0 10.1 177.3617 331.7096 Tm (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0036 Tc 10.1 0 0 10.1 195.5417 331.7096 Tm (p<0.005, )Tj EMC ET BT /T1_0 1 Tf -0.0033 Tc 10.1 0 0 10.1 234.76 331.7096 Tm (respectively\), )Tj 0.0339 Tc -17.546 -1.073 Td (but )Tj -0.0156 Tc 1.928 0 Td (there )Tj 0.012 Tc 2.552 0 Td (was )Tj 0.0285 Tc 2.169 0 Td (no )Tj 0.0053 Tc 1.633 0 Td (significant )Tj -0.0011 Tc 4.821 0 Td (difference )Tj -0.0007 Tc 4.612 0 Td (between )Tj -0.0128 Tc 3.954 0 Td (the )Tj -0.0097 Tc -21.674 -1.096 Td (BAPE )Tj -0.0014 Tc 2.856 0 Td (group )Tj 0.0112 Tc 2.669 0 Td (and )Tj -0.0074 Tc 1.788 0 Td (control )Tj -0.0082 Tc 3.125 0 Td (group. )Tj 0.0066 Tc 2.933 0 Td (The )Tj -0.0122 Tc 1.89 0 Td (mean )Tj -0.0029 Tc 2.479 0 Td (value )Tj -0.0204 Tc 2.494 0 Td (for )Tj -0.035 Tc 10.0715 0 0 10.1 277.38 309.7996 Tm (the )Tj 0.0478 Tc 10.1 0 0 10.1 57.27 299.1996 Tm (PP )Tj 0.0046 Tc 1.474 0 Td (group )Tj 0.0001 Tc 2.749 0 Td (was )Tj 0.0132 Tc 1.948 0 Td (lower )Tj -0.0083 Tc 2.676 0 Td (than )Tj 0.0025 Tc 2.098 0 Td (that )Tj -0.0085 Tc 1.899 0 Td (for )Tj -0.0247 Tc 1.582 0 Td (the )Tj -0.0017 Tc 1.548 0 Td (BAPE )Tj 0.0046 Tc 2.929 0 Td (group )Tj -0.0019 Tc 2.704 0 Td (but )Tj 0.0188 Tc -21.603 -1.072 Td (not )Tj 0.0013 Tc 1.847 0 Td (significantly )Tj -0.0085 Tc 5.603 0 Td (so, )Tj 0.0112 Tc 1.673 0 Td (and )Tj 0.0192 Tc 2.051 0 Td (lower )Tj -0.0162 Tc 2.891 0 Td (than )Tj -0.0247 Tc 2.313 0 Td (the )Tj 0.0211 Tc 1.762 0 Td (DPF )Tj -0.0133 Tc 2.428 0 Td (group )Tj -0.0112 Tc -20.555 -1.097 Td (\(p<0.05\); )Tj 0.0111 Tc 4.158 0 Td (the )Tj -0.0122 Tc 1.693 0 Td (mean )Tj 0.003 Tc 2.599 0 Td (value )Tj 0.0154 Tc 2.589 0 Td (for )Tj 0.0111 Tc 1.63 0 Td (the )Tj -0.0027 Tc 1.691 0 Td (DPF )Tj -0.0014 Tc 2.238 0 Td (group )Tj 0.0001 Tc 2.772 0 Td (was )Tj -0.0144 Tc 2.014 0 Td (sig\255)Tj 0.0202 Tc -21.421 -1.073 Td (nificantly )Tj 0.0371 Tc 4.833 0 Td (lower )Tj 0.0076 Tc 3.201 0 Td (than )Tj 0.0263 Tc 2.574 0 Td (that )Tj 0.0273 Tc 2.352 0 Td (for )Tj 0.023 Tc 2.011 0 Td (the )Tj 0.0221 Tc 2.072 0 Td (BAPE )Tj 0.0224 Tc 3.405 0 Td (group )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0095 Tc 10.1 0 0 10.1 57.1892 255.6282 Tm (\(p<0.005\). )Tj EMC ET BT /T1_0 1 Tf 0.0055 Tc 10.1 0 0 10.1 65.451 244.3061 Tm (For )Tj -0.0128 Tc 1.743 0 Td (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0025 Tc 10.1 0 0 10.1 98.3063 244.3061 Tm ("helper/inducer" )Tj EMC ET BT /T1_0 1 Tf 10.1 0 0 10.1 167.966 244.3061 Tm (\(Leu )Tj 0.0003 Tc 2.218 0 Td (3a\) )Tj -0.0138 Tc 1.6 0 Td (T-cells, )Tj -0.0074 Tc 3.29 0 Td (groups )Tj -0.0147 Tc 3.032 0 Td (DPF )Tj 0.0112 Tc -21.176 -1.073 Td (and )Tj -0.0097 Tc 1.769 0 Td (BAPE )Tj -0.009 Tc 2.915 0 Td (both )Tj -0.0043 Tc 2.119 0 Td (had )Tj 0 Tc 1.779 0 Td (a )Tj -0.0067 Tc 0.807 0 Td (significantly )Tj -0.0106 Tc 5.275 0 Td (lower )Tj -0.0089 Tc 2.557 0 Td (value )Tj -0.0162 Tc 2.503 0 Td (than )Tj -0.035 Tc 10.0715 0 0 10.1 276.66 233.4596 Tm (the )Tj -0.004 Tc 10.1 0 0 10.1 56.49 222.8696 Tm (controls )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0015 Tc 10.1 0 0 10.1 94.2842 222.8696 Tm (\(p<0.005\). )Tj EMC ET BT /T1_0 1 Tf 0.0066 Tc 10.1 0 0 10.1 142.4713 222.8696 Tm (The )Tj 0.0478 Tc 2.054 0 Td (PP )Tj 0.0061 Tc 1.641 0 Td (group, )Tj -0.0124 Tc 3.178 0 Td (however, )Tj 0.012 Tc 4.149 0 Td (was )Tj 0.0069 Tc 2.098 0 Td (not )Tj -0.0027 Tc -21.637 -1.073 Td (significantly )Tj 0.0093 Tc 5.321 0 Td (different )Tj -0.0103 Tc 3.837 0 Td (from )Tj -0.0009 Tc 2.346 0 Td (the )Tj 0.0045 Tc 1.59 0 Td (control )Tj -0.0034 Tc 3.196 0 Td (group, )Tj 0.0339 Tc 2.943 0 Td (but )Tj -0.0037 Tc 1.689 0 Td (there )Tj 0.0001 Tc -20.933 -1.072 Td (was )Tj 0 Tc 1.947 0 Td (a )Tj 0.0053 Tc 0.902 0 Td (significant )Tj 0.0016 Tc 4.678 0 Td (difference )Tj -0.0007 Tc 4.492 0 Td (between )Tj 0.0001 Tc 3.761 0 Td (PP )Tj 0.0112 Tc 1.521 0 Td (and )Tj -0.0009 Tc 1.915 0 Td (the )Tj -0.0155 Tc 1.638 0 Td (com)Tj 0.255 g 0 Tc 1.715 0 Td (\255)Tj 0.126 g 0.0017 Tc -22.589 -1.073 Td (bined )Tj 0.0092 Tc 2.712 0 Td (DPF )Tj 0.0231 Tc 2.331 0 Td (and )Tj -0.0097 Tc 2.033 0 Td (BAPE )Tj 0.0021 Tc 3.048 0 Td (groups )Tj -0.0078 Tc 3.287 0 Td (\(p<0.01\), )Tj 0.0239 Tc 4.179 0 Td (PP )Tj -0.0044 Tc 1.649 0 Td (having )Tj 0 Tc 3.234 0 Td (a )Tj 0.0004 Tc -22.474 -1.097 Td (higher )Tj -0.0094 Tc 3.028 0 Td (value. )Tj 0.0177 Tc 2.891 0 Td (No )Tj 0.0029 Tc 1.746 0 Td (significant )Tj -0.0011 Tc 4.678 0 Td (difference )Tj 0.0001 Tc 4.538 0 Td (was )Tj -0.0039 Tc 2.041 0 Td (found )Tj -0.0204 Tc 2.838 0 Td (for )Tj -0.0128 Tc -21.759 -1.049 Td (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0051 Tc 10.1 0 0 10.1 71.8622 168.6932 Tm ("suppressor/cytotoxic" )Tj EMC ET BT /T1_0 1 Tf 0.0055 Tc 10.1 0 0 10.1 168.4889 168.6932 Tm (\(Leu )Tj 0.0033 Tc 2.271 0 Td (2a\) )Tj -0.007 Tc 1.643 0 Td (T-cells. )Tj 0.006 Tc -14.186 -1.121 Td (There )Tj -0.0097 Tc 2.94 0 Td (were )Tj 0.0047 Tc 2.504 0 Td (no )Tj 0.0053 Tc 1.608 0 Td (significant )Tj 0.0007 Tc 4.797 0 Td (differences )Tj -0.0007 Tc 5.042 0 Td (between )Tj -0.0128 Tc 3.953 0 Td (the )Tj -0.0026 Tc -21.749 -1.073 Td (groups )Tj 0.0072 Tc 3.131 0 Td (regarding )Tj -0.0009 Tc 4.361 0 Td (the )Tj 0.0283 Tc 1.595 0 Td (Leu )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0186 Tc 10.1 0 0 10.1 168.7515 146.5338 Tm (10+ )Tj EMC ET BT /T1_0 1 Tf -0.0099 Tc 10.1 0 0 10.1 188.9717 146.5338 Tm (\(HLA-DQ\), )Tj 0.0001 Tc 5.134 0 Td (HLA-DR+, )Tj 0.0164 Tc -18.359 -1.096 Td (Leu )Tj -0.0067 Tc 2.069 0 Td (12+ )Tj 0.0127 Tc 1.955 0 Td (cells )Tj 0.0052 Tc 2.335 0 Td (\(the )Tj 0 Tc 2.01 0 Td (B )Tj 0.0008 Tc 1.116 0 Td (cells\) )Tj 0.05 Tc 10.3289 0 0 10.1 177.61 135.4596 Tm (or )Tj 0.0164 Tc 10.1 0 0 10.1 190.66 135.4596 Tm (Leu )Tj -0.035 Tc 10.0795 0 0 10.1 211.56 135.4596 Tm (7+ )Tj -0.0007 Tc 10.1 0 0 10.1 226.49 135.4596 Tm (and )Tj 0.0164 Tc 1.888 0 Td (Leu )Tj 0.05 Tc 11.2721 0 0 10.1 267.2 135.4596 Tm (llb+ )Tj 0.0271 Tc 9.7 0 0 9.7 55.51 124.3796 Tm (\(NK )Tj -0.0007 Tc 10.1 0 0 10.1 76.95 124.3796 Tm (and )Tj 0 Tc 1.794 0 Td (K )Tj 0.0127 Tc 1.092 0 Td (cells )Tj 0.0105 Tc 2.26 0 Td (subsets\). )Tj -0.0053 Tc -6.408 -1.097 Td (The )Tj 0.0074 Tc 2.263 0 Td (changes )Tj 0.0021 Tc 4.007 0 Td (in )Tj 0.0045 Tc 1.529 0 Td (Leu )Tj 0.0237 Tc 2.331 0 Td (3a )Tj 0.0231 Tc 1.67 0 Td (and )Tj -0.0247 Tc 2.249 0 Td (the )Tj -0.0093 Tc 1.909 0 Td (non)Tj 0.255 g 0 Tc 1.54 0 Td (-)Tj 0.126 g 0.0029 Tc 0.307 0 Td (significant )Tj -0.0045 Tc -18.711 -1.049 Td (changes )Tj 0.0021 Tc 3.553 0 Td (in )Tj 0.0164 Tc 1.148 0 Td (Leu )Tj 0.0296 Tc 1.954 0 Td (2a )Tj -0.0001 Tc 1.303 0 Td (subsets )Tj -0.0027 Tc 3.246 0 Td (followed )Tj -0.007 Tc 3.911 0 Td (each )Tj 0.0044 Tc 2.194 0 Td (other )Tj -0.035 Tc 10.0925 0 0 10.1 254.74 102.7096 Tm (to )Tj 0.0048 Tc 10.1 0 0 10.1 265.7 102.7096 Tm (some )Tj -0.0079 Tc -20.881 -1.073 Td (extent, )Tj 0.0112 Tc 2.98 0 Td (and )Tj 0.0029 Tc 1.797 0 Td (hence )Tj -0.0097 Tc 2.693 0 Td (there )Tj -0.0177 Tc 2.338 0 Td (were )Tj 0.0047 Tc 2.265 0 Td (no )Tj -0.0113 Tc 1.35 0 Td (differences )Tj -0.0087 Tc 4.708 0 Td (between )Tj -0.0128 Tc 3.667 0 Td (the )Tj -0.0086 Tc -21.791 -1.121 Td (various )Tj 0.0117 Tc 3.308 0 Td (groups )Tj -0.0085 Tc 3.216 0 Td (for )Tj -0.0128 Tc 1.63 0 Td (the )Tj 0.0164 Tc 1.57 0 Td (Leu )Tj 0.0107 Tc 2.021 0 Td (3a/Leu )Tj 0.0296 Tc 3.225 0 Td (2a )Tj -0.0059 Tc 1.34 0 Td (ratio. )Tj -0.0077 Tc 2.522 0 Td (In )Tj -0.0027 Tc 1.293 0 Td (normal )Tj -0.002 Tc -20.155 -1.072 Td (controls, )Tj -0.0113 Tc 3.918 0 Td (this )Tj 0.0075 Tc 1.86 0 Td (ratio )Tj -0.0118 Tc 2.289 0 Td (was )Tj -0.018 Tc 2.041 0 Td (1.89; )Tj -0.035 Tc 9.9526 0 0 10.1 181.24 69.7196 Tm (in )Tj -0.0128 Tc 10.1 0 0 10.1 193.82 69.7196 Tm (the )Tj 0.0478 Tc 1.595 0 Td (PP )Tj -0.0014 Tc 1.547 0 Td (group )Tj -0.018 Tc 2.835 0 Td (1.66; )Tj -0.035 Tc 9.9526 0 0 10.1 278.53 69.7196 Tm (in )Tj -0.0128 Tc 10.1 0 0 10.1 311.57 453.0796 Tm (the )Tj -0.0017 Tc 1.596 0 Td (BAPE )Tj -0.0074 Tc 2.929 0 Td (group )Tj -0.018 Tc 2.739 0 Td (1.52; )Tj 0.035 Tc 2.314 0 Td (and )Tj -0.0218 Tc 1.861 0 Td (in )Tj 0.0111 Tc 1.15 0 Td (the )Tj 0.0211 Tc 1.595 0 Td (DPF )Tj 0.0165 Tc 2.189 0 Td (group )Tj -0.0172 Tc 2.787 0 Td (1.66. )Tj 0.0174 Tc 2.296 0 Td (For )Tj -0.0161 Tc -21.488 -1.097 Td (all )Tj -0.0097 Tc 1.367 0 Td (three )Tj -0.0109 Tc 2.305 0 Td (asbestos )Tj -0.0074 Tc 3.602 0 Td (groups )Tj -0.0116 Tc 3.05 0 Td (combined, )Tj 0.0111 Tc 4.442 0 Td (the )Tj -0.0042 Tc 1.589 0 Td (figure )Tj -0.0238 Tc 2.728 0 Td (was )Tj -0.0172 Tc 1.922 0 Td (1.63, )Tj -0.0074 Tc -20.996 -1.097 Td (which )Tj -0.0118 Tc 2.956 0 Td (was )Tj 0.0188 Tc 2.051 0 Td (not )Tj 0.0008 Tc 1.799 0 Td (statistically )Tj 0.0034 Tc 5.059 0 Td (different )Tj -0.0024 Tc 3.933 0 Td (from )Tj -0.0055 Tc 2.536 0 Td (that )Tj 0.05 Tc 10.6081 0 0 10.1 516.18 430.9196 Tm (of )Tj -0.0009 Tc 10.1 0 0 10.1 529.98 430.9196 Tm (the )Tj -0.0074 Tc -21.671 -1.072 Td (normal )Tj -0.0049 Tc 3.211 0 Td (controls. )Tj /T1_2 1 Tf 0.0239 Tc 9.8 0 0 9.8 310.47 396.0096 Tm (ESR: )Tj /T1_0 1 Tf 0.0185 Tc 10.1 0 0 10.1 336.56 396.0096 Tm (The )Tj 0.196 g 0.0025 Tc 2.048 0 Td (erythrocyte )Tj 0.126 g 0.0001 Tc 5.051 0 Td (sedimentation )Tj 0.018 Tc 6.068 0 Td (rate )Tj -0.0042 Tc 2.066 0 Td (differed )Tj 0.196 g -0.0065 Tc 3.619 0 Td (sig\255)Tj 0.126 g 0.0149 Tc -21.397 -1.05 Td (nificantly )Tj 0.0112 Tc 4.724 0 Td (between )Tj 0.0111 Tc 4.192 0 Td (the )Tj 0.0478 Tc 2.001 0 Td (PP )Tj 0.035 Tc 1.877 0 Td (and )Tj 0.0111 Tc 2.297 0 Td (the )Tj -0.0017 Tc 2.049 0 Td (BAPE )Tj 0.0105 Tc 3.334 0 Td (group )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0033 Tc 10.1 0 0 10.1 310.7646 374.0825 Tm (\(p<0.005\) )Tj EMC ET BT /T1_0 1 Tf -0.0007 Tc 10.1 0 0 10.1 354.3663 374.0825 Tm [(and )-108(between )]TJ 0.0111 Tc 5.515 0 Td (the )Tj 0.0239 Tc 1.571 0 Td (PP )Tj 0.0046 Tc 1.474 0 Td (group )Tj -0.0007 Tc 2.693 0 Td (and )Tj -0.0009 Tc 1.867 0 Td (the )Tj -0.0048 Tc 1.566 0 Td (combined )Tj 0.0046 Tc -19.048 -1.049 Td (group )Tj 0.05 Tc 10.6081 0 0 10.1 337.74 363.4996 Tm (of )Tj -0.0097 Tc 10.1 0 0 10.1 350.08 363.4996 Tm (BAPE )Tj 0.0231 Tc 2.879 0 Td (and )Tj 0.0211 Tc 1.842 0 Td (DPF )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0068 Tc 10.1 0 0 10.1 420.3255 363.4996 Tm (\(p<0.005\). )Tj EMC ET BT /T1_2 1 Tf 0.0102 Tc 9.8 0 0 9.8 310.2 340.3796 Tm (Correlations: )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0083 Tc 10.1 0 0 10.1 369.33 340.3796 Tm (ESR )Tj EMC ET BT /T1_0 1 Tf 0.0011 Tc 10.1 0 0 10.1 392.4085 340.3796 Tm (correlated )Tj -0.0024 Tc 4.419 0 Td (with )Tj 0.0074 Tc 2.209 0 Td (changes )Tj -0.035 Tc 9.9526 0 0 10.1 496.69 340.3796 Tm (in )Tj 0.0111 Tc 10.1 0 0 10.1 508.55 340.3796 Tm (the )Tj 0.0071 Tc 1.626 0 Td (per\255)Tj 0.0078 Tc -21.278 -1.05 Td (centage )Tj -0.0049 Tc 3.655 0 Td (numbers )Tj 0.05 Tc 10.8872 0 0 10.1 387.35 329.7796 Tm (of )Tj 0 Tc 10.1 0 0 10.1 402.34 329.7796 Tm (B )Tj 0.0035 Tc 1.258 0 Td (cell )Tj -0.0025 Tc 2 0 Td (\(Leu )Tj -0.0122 Tc 2.552 0 Td (12+\) )Tj 0.0021 Tc 2.435 0 Td (in )Tj -0.035 Tc 10.0715 0 0 10.1 500.12 329.7796 Tm (the )Tj -0.0014 Tc 10.1 0 0 10.1 517.64 329.7796 Tm (group )Tj 0.0062 Tc -20.548 -1.096 Td (BAPE )Tj -0.0038 Tc 3.092 0 Td (\(r=0.51\) )Tj 0.0231 Tc 3.792 0 Td (and )Tj -0.0218 Tc 2.005 0 Td (in )Tj -0.0026 Tc 1.287 0 Td (groups )Tj 0.033 Tc 3.223 0 Td (DPF )Tj 0.0112 Tc 2.378 0 Td (and )Tj -0.0097 Tc 2.009 0 Td (BAPE )Tj -0.0021 Tc 3.023 0 Td (com\255)Tj 0.0077 Tc -20.827 -1.05 Td (bined )Tj -0.0048 Tc 2.8 0 Td (\(r=0.49\), )Tj 0.0339 Tc 4.09 0 Td (but )Tj 0.0307 Tc 1.856 0 Td (not )Tj 0.0021 Tc 1.877 0 Td (in )Tj -0.0014 Tc 1.335 0 Td (group )Tj 0.0092 Tc 2.889 0 Td (DPF )Tj -0.0036 Tc 2.378 0 Td (alone, )Tj 0.0027 Tc 3.013 0 Td (nor )Tj -0.035 Tc 9.9526 0 0 10.1 533.3 308.1096 Tm (in )Tj -0.0074 Tc 10.1 0 0 10.1 309.83 297.0396 Tm (group )Tj 0.0478 Tc 2.65 0 Td (PP )Tj -0.0148 Tc 1.518 0 Td (\(r=-0.03\). )Tj 0.006 Tc 4.152 0 Td (There )Tj -0.0097 Tc 2.725 0 Td (were )Tj 0.0047 Tc 2.242 0 Td (no )Tj -0.0042 Tc 1.35 0 Td (correlations )Tj -0.0127 Tc 5.018 0 Td (between )Tj -0.0007 Tc -19.681 -1.073 Td (any )Tj 0.0223 Tc 1.813 0 Td (other )Tj -0.0005 Tc 2.456 0 Td (lymphocyte )Tj 0.0039 Tc 5.072 0 Td (subsets )Tj 0.0231 Tc 3.247 0 Td (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0203 Tc 10.1 0 0 10.1 455.0579 286.2023 Tm (ESR )Tj EMC ET BT /T1_0 1 Tf 0.0021 Tc 10.1 0 0 10.1 477.6718 286.2023 Tm (in )Tj -0.0007 Tc 1.166 0 Td (any )Tj -0.013 Tc 1.79 0 Td (group. )Tj 0.0099 Tc -10.391 -3.051 Td (Discussion )Tj -0.0315 Tc -8.324 -2.17 Td (In )Tj 0.0011 Tc 1.272 0 Td (persons )Tj 0.196 g 0.0058 Tc 3.493 0 Td (exposed )Tj 0.126 g -0.0117 Tc 3.774 0 Td (to )Tj -0.0041 Tc 1.209 0 Td (asbestos )Tj 0.0018 Tc 3.762 0 Td (several )Tj -0.0052 Tc 3.296 0 Td (immunologi\255)Tj 0.0007 Tc -17.74 -1.072 Td (cal )Tj -0.0072 Tc 1.503 0 Td (derangements )Tj -0.0075 Tc 5.825 0 Td (have )Tj 0.0024 Tc 2.22 0 Td (been )Tj -0.0073 Tc 2.231 0 Td (demonstrated )Tj -0.0231 Tc 5.684 0 Td ([2]. )Tj -0.0173 Tc 1.732 0 Td (The )Tj -0.0104 Tc 1.866 0 Td (most )Tj 0.006 Tc -21.06 -1.05 Td (consistent )Tj -0.0075 Tc 4.767 0 Td (findings )Tj 0.0159 Tc 3.982 0 Td (are )Tj -0.0218 Tc 2.005 0 Td (in )Tj 0.005 Tc 1.478 0 Td (increase )Tj 0.0021 Tc 4.005 0 Td (in )Tj -0.0247 Tc 2.319 0 Td (the )Tj 0.0029 Tc 1.905 0 Td (B-cell )Tj 0.0021 Tc -20.459 -1.072 Td (lymphocyte )Tj 0.0012 Tc 5.267 0 Td (activity, )Tj -0.0104 Tc 3.823 0 Td (with )Tj -0.0044 Tc 2.33 0 Td (increased )Tj 0.0045 Tc 4.291 0 Td (levels )Tj 0.05 Tc 10.3289 0 0 10.1 496.92 201.1996 Tm (of )Tj -0.0086 Tc 10.1 0 0 10.1 510.96 201.1996 Tm (various )Tj -0.0001 Tc -19.985 -1.073 Td (immunoglobulins )Tj 0.0231 Tc 7.747 0 Td (and )Tj -0.0006 Tc 2.193 0 Td (auto-antibodies, )Tj 0.0112 Tc 7.129 0 Td (and )Tj -0.0062 Tc 2.194 0 Td (defective )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0035 Tc 10.1 0 0 10.1 308.6267 179.2826 Tm (T-cell )Tj EMC ET BT /T1_0 1 Tf -0.0018 Tc 10.1 0 0 10.1 337.745 179.2826 Tm (activity, )Tj 0.001 Tc 3.751 0 Td (manifested )Tj -0.035 Tc 10.0818 0 0 10.1 424.79 179.2796 Tm (by )Tj 0.0061 Tc 10.1 0 0 10.1 439.45 179.2796 Tm (weak )Tj 0.0457 Tc 2.543 0 Td (or )Tj 0.0068 Tc 1.335 0 Td (absent )Tj 0.0004 Tc 3.005 0 Td (delayed )Tj 0.0038 Tc -19.837 -1.072 Td (cutaneous )Tj 0.0024 Tc 4.371 0 Td (reactions )Tj -0.0117 Tc 4.029 0 Td (to )Tj 0.196 g 0.0008 Tc 1.137 0 Td (common )Tj 0.126 g 0.0028 Tc 3.862 0 Td (antigens )Tj 0.0017 Tc 3.739 0 Td (such )Tj -0.0103 Tc 2.198 0 Td (as )Tj -0.019 Tc 1.248 0 Td (tuber\255)Tj -0.0055 Tc -20.583 -1.073 Td (culin )Tj -0.0013 Tc 2.395 0 Td (protein )Tj -0.0172 Tc 3.265 0 Td ([17]. )Tj 0 Tc 2.287 0 Td (A )Tj 0.0042 Tc 1.089 0 Td (decrease )Tj 0.0021 Tc 3.84 0 Td (in )Tj 0 Tc 1.168 0 Td (T )Tj -0.0012 Tc 1.001 0 Td (lymphocytes )Tj 0.196 g -0.035 Tc 9.9526 0 0 10.1 515.96 157.6096 Tm (in )Tj 0.126 g 0.0111 Tc 10.1 0 0 10.1 527.57 157.6096 Tm (the )Tj 0.0054 Tc -21.692 -1.097 Td (blood )Tj -0.0203 Tc 3.026 0 Td (has )Tj -0.0056 Tc 1.981 0 Td (been )Tj 0.0047 Tc 2.549 0 Td (reported )Tj 0.0067 Tc 4.126 0 Td ([18-20] )Tj 0.0231 Tc 3.757 0 Td (and )Tj -0.001 Tc 2.156 0 Td (both )Tj -0.0081 Tc 2.464 0 Td (subsets )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0039 Tc 10.1 0 0 10.1 308.5818 135.935 Tm (\("helper/inducer" )Tj EMC ET BT /T1_0 1 Tf -0.019 Tc 10.1 0 0 10.1 384.7964 135.935 Tm ([18] )Tj 0.0231 Tc 2.136 0 Td (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0029 Tc 10.1 0 0 10.1 426.5094 135.935 Tm ("suppressor/cytotoxic" )Tj EMC ET BT /T1_0 1 Tf -0.0152 Tc 10.1 0 0 10.1 524.2168 135.935 Tm ([18, )Tj 0.0043 Tc -21.367 -1.097 Td (21, )Tj -0.0007 Tc 1.621 0 Td (22]\) )Tj -0.016 Tc 2.066 0 Td (seem )Tj -0.0117 Tc 2.444 0 Td (to )Tj 0.0203 Tc 1.124 0 Td (be )Tj 0.0004 Tc 1.324 0 Td (affected. )Tj 0.0066 Tc -7.675 -1.097 Td (The )Tj 0.0004 Tc 2.01 0 Td (number )Tj 0.05 Tc 10.8872 0 0 10.1 372.66 113.7796 Tm (of )Tj 0 Tc 10.1 0 0 10.1 385.96 113.7796 Tm (B )Tj -0.0012 Tc 1.117 0 Td (lymphocytes )Tj -0.0084 Tc 5.515 0 Td (has )Tj 0.0024 Tc 1.766 0 Td (been )Tj -0.0055 Tc 2.31 0 Td (reported )Tj -0.035 Tc 10.0925 0 0 10.1 532.15 113.7796 Tm (to )Tj 0.0441 Tc 10.1 0 0 10.1 308 102.9496 Tm (be )Tj -0.001 Tc 1.335 0 Td (both )Tj 0.0007 Tc 2.183 0 Td (decreased )Tj -0.027 Tc 4.349 0 Td ([23] )Tj 0.0231 Tc 2.017 0 Td (and )Tj -0.0015 Tc 1.861 0 Td (increased )Tj -0.035 Tc 9.3636 0 0 10.1 468.86 102.9496 Tm ([21} )Tj -0.0218 Tc 10.1 0 0 10.1 489.23 102.9496 Tm (in )Tj -0.0128 Tc 1.149 0 Td (the )Tj -0.0006 Tc 1.553 0 Td (blood )Tj 0.05 Tc 10.8872 0 0 10.1 307.88 91.8696 Tm (of )Tj 0.013 Tc 10.1 0 0 10.1 320.76 91.8696 Tm (persons )Tj 0.0058 Tc 3.564 0 Td (exposed )Tj -0.035 Tc 10.0925 0 0 10.1 395.37 91.8696 Tm (to )Tj 0.0009 Tc 10.1 0 0 10.1 407.58 91.8696 Tm (asbestos, )Tj 0.01 Tc 4.064 0 Td (but )Tj -0.0128 Tc 1.784 0 Td (the )Tj 0.196 g 0.0034 Tc 1.638 0 Td (consistent )Tj 0.126 g -0.0179 Tc 4.444 0 Td (re\255)Tj 0.0032 Tc -21.813 -1.097 Td (ports )Tj 0.05 Tc 10.6081 0 0 10.1 331.72 80.7896 Tm (of )Tj -0.0023 Tc 10.1 0 0 10.1 344.24 80.7896 Tm (elevated )Tj -0.0002 Tc 3.698 0 Td (levels )Tj 0.05 Tc 11.1664 0 0 10.1 408.53 80.7896 Tm (of )Tj -0.0001 Tc 10.1 0 0 10.1 421.08 80.7896 Tm (immunoglobulins )Tj -0.0231 Tc 7.423 0 Td ([2, )Tj -0.029 Tc 1.467 0 Td (19, )Tj -0.035 Tc 9.1811 0 0 10.1 526.34 80.7896 Tm (24} )Tj -0.0007 Tc 10.1 0 0 10.1 307.64 69.9596 Tm (and )Tj -0.0032 Tc 1.788 0 Td (auto-antibodies )Tj -0.0062 Tc 6.481 0 Td (such )Tj 0.0135 Tc 2.173 0 Td (as )Tj -0.0075 Tc 1.225 0 Td (rheumatoid )Tj -0.0007 Tc 4.832 0 Td (and )Tj -0.0099 Tc 1.812 0 Td (anti-nuclear )Tj ET endstream endobj 7 0 obj <>/Filter/JBIG2Decode/Height 3505/ImageMask true/Length 16966/Name/X/Subtype/Image/Type/XObject/Width 2480>>stream &+p2"F`Sk9R0嚶JK~A$/{-xɴ{"1-OerXoZ3HfX,8@uWlF8T};'So摛d[[?́St݇}蟿w[<ŧqbR iZ;^Ү:~'IsVҮT89y”qΤ[{V%s镠Mp)eztNu%s|`Dbcz2 NA0 #<ǒϥP!3PdUh?vl#=Fw)J>` w Cɸ;xnF/_^||b.&cfn]_ř}4S  znאp,4nJ5ӿxUt/O3T R KS߫LfvR %}pY62K©Eթݾ{`HPxn0dȎ]_WJesW #Ea!9"e FA?X3L9WRMr D*!7xǣVgڗ@tN9DWz~\q砭wd4m-;e`O \0j<@TN8RkhoҖg~@Hh{ *lhN^)2ofUL@$ ?Ҹ[S2Na apE}.~ehbid^;hN~ [Ty⻾ވN/+Nw]%Q&(O6$tK*e"Epi `:@\NNj͜k F ck(zPr̕ gnF Ecڙ2e<~ގSW΃㎌@]# |S5f 0jM_ڎ %Ǯ_\(('>8hi.GfːQ87N0BເNVɶ9 &1גK%F:F#ڻ8lxn5/}'s B&F$hҿgHc^,?d''pȗf)qQKhw ֯? *%+?3RB[s/.t`]!(QsLN;cuZ>-.. TP#i`?y|24iS8NȹKЌ#ΗG+|Ǘ˽Vc Q<[e U.`+L<.Q!0N}fwE'sq"}7qaj-JX6؞QFZۏz[!w8+0[}?AGCU7]r3 $xpֳ/!44/Ҽ*Y;rdxV +RoԖDi/qvQuRL8kI85jC @ l.gSb&|Gq V:Yhd~xЄ{ʥ_) 6waj>v܇ _mqEǨb7ɖvo9jIDkxQ3&6G& lӍ[.ZPlF;%5ϯeԭ0H&&}{6v)x,k?e2@9hP3rOw=LV9^T(g ۼFsF>Xc.VFYpuBrG>*|Ê_n]}/Utt$#m~ZHPT&zD-j-ZDFCj)W}or$`&J^ږ3[ٶ/VU{7n&6(&*!mGD̛M:ܔ~pyb hO^vXf-*@w u}Gl"oUe=za5mEԿ\mz+Nh w$z1ǛXJ6Af&5X>reKmK(Q7wA1/mItmk4R/H2C@e`jߜ.^X^d\$0eڶ!{FSqClHŧ.6,gYNf`L_"9otČ C QáRѝ x8t*O4ebP: pd#;8;wv:ԙ F9Εʳ.e0wlK8B_eέA+4OUl/?qO jNlQuWOZ[wUu`, ":rD]K]_nj~fʈtATN2%kSE.}z# !t7}9I2tDƟ+9܅v&twҕV(-5\}ǓHG oyؾb̍Wq[a,[M M-%Xn|QN|-54=(7&c5l\wHϘ`H¢-pt3i_4sT.yJ$IQ5Xbٮ-A]wOZnɭp; \D䘪-ϴ/d^0Q$;1/WfeoGgh=#Vȭ-C2;cwߴ񣿔>]7m8o?rM0$W<Մ\XthhLzHފĞyn58}qh&Es | =%I}'xPdUv ҼP`~6LEQ&ɾ(I«bcmc-lSYL\4T3eTaCcdgE?5 ^|r&w)1џ>k5p#ŦrwriŲ>QTopx1'kJeH#)_,zj嘰H/HWWQZ1iN& h޻ 7YA2_DYx%v󤳳?s"me]M6Qösij:f2k1m Dž=n4A%ZP1IG0縝XX v`m\ kA14, [oodF5&so$Qhn`JI,3pKO!wljH/w~<,"H oUY?bA?a!3P"vĸ[ }Nkڥuq%a]C^x\N~|c4 h}[M=,HnV?pOMno/" +!6wI jeg4m iukgV법1 zw zuޖXбA䮮b Q^GOBĂ{ۿ)ݑ\5s,C+4OQZ%+-wznjn-[L띙HYu3=r 9IJ_ Zw $<7('{X9`* nAghɌl…ddB[l0h+G#q"47GPfw^jVejZk{q>!F]%-Q]g\e8E偫(+ËVuX2 M-]PM6}a-w+ נ[`:JȕО#l}>exXv?r^[:9cMD(JXϯB$KAzƟC;nHz9k xh`P7E]lUԱv%vIr![#; .&FTqiؤɳ1F 5gQ0$q~@ku%/#d0gwgǧhX{yseIB4 }'r=jIK ]0{(ssMxqZd[ ʤ*6xՋ|;nvS7y9ڎ&s]~ZT*ơYgӲ'!V Y$_QqŗۍjrӳWY) P\ޟc?O?-!gs;K0X H2 ^{VM!UfhM㬂72Y^^*}S 1 6߈6 "=&:sgNm&|g]{mf'J?5)GPb +Wv̛Ih! w"aP '^gi+Ę@X] &l~ˠ8A<9ՋRfBѲq..ulOP<?uӂFץdUk:y*6Q`>樁.qn Z{cԅgcB-q& Uړ715*w ]D7Y^':x\@ELH?7.>blj?|XWۄjZ/R)ؚ_`MsIֻ"EL9"jsdDZ@tĻ7 6 >­P2ʧ.OLq?y*~E<G:D4Ѽ^=Xqf~#@CAu?Nm? VGNCߞ{Cy}'֥e2/[ VuUw8ֲYKT=GپJP_Y `\rvPHqs\75ZS{, Ç|(˘TpuyeHb񻃭:EK[gqaDѹ~=q2fq=TQU\Q:}F1k;Ѭu^0~O$\Y >>1  + ݢ TF&CjH>`:egYaž> EƵ:~v:m ")0琎-s+yIvxt7D|R/ueقV##G^R~LiJj?[stf{-©*9lE Z%Rl(n>+r.ȊyzTxHrHr]1tRdd(e@\(KF'We >R|]? y>@ oSdQmf$2f(b{<Qӫ^']U"Uλ6ɘ^d(>Ӌ5ىgHp$͗lg6*P߫IyF3~^:ˍ-$-(C:f찰xOX>EM[‚#?yOƉ~g44X6hb.>mXsQlz!T> u{CeN=ah6NS{)@D*GœMQ:т᥮޽ҎGa6gV/1qu=E}LceNA EFdõJbO2h>oX\^"]!1 T~B^%D7˩=Q+rhOBcP7Sʐ3gOcqڌc((OdݣIBYjm)aQc.L=Ś[ދ-HX7 {~48z@W?#ht,k#@κ/欩Ǚ%ǑL̫l-I_ҦLn?V *;m{RjgUqkn\٠{]y;mc<`\iL@>tvp0*,h5-s(p $lcǹRʧʪ>@V6sD0Úb7ɣFScf}#o,?+;ZpM*qgYwڗURNGU FL~bW$Z Ul#cjSp )Z'%?Pdv \<"h́[6BcOYA'Vwc֯IxiobIzP\@ݽuW4io#%Mb׺/HƦNM]fLƚgvߴ^4NÀÌ')}0:,=;Mq'){Se54!bSýF4p./DUK]T8^㠽y?cF(xBlqQ E\놿#vMWK`k20DHz?R0P:D? f!p%|A3VE{N:Χsswe\Q0DbG9>X腓l9I*L{EMyjHkqSPk鋣Dj`swAl^%˜WXݦhj[Hi~Qpvj]DW{&ya0y_{ <QQu"/? ;gNauX{Nȧ3 y>T^DnUMÙ>¨i|>8 loϼ 'yBk}{Aj(XB*|7i96JtxfWħ 1vBefׄB Gl5 +] S+&CX!;Wu+^37 Y)#Ӕ['-Xh9A/{W8"Txmvޞ,^Z) J.Ds^0*~f!te@ߝJ<%+,WҲvL/FTax6Z꒰w5ZJ-OgWѺb yX4LѪ\ꑺՄ~g[//5 3Nk.eBQ]47޾I U׀v 37fOmQB2.hok֮+Om,&SRQ^%HDUj͏|1IK8M{F0Ƭf!2oSM}Hz?a f[2`q" ?.|lfLuR1-t$Jo܆ԱmGЇPtYO;4:1*&يWF@F2,/ϾBKH#q7YTjF[m;D(|kt$†UMY3/9ѳ&(pܹkԳg(Iy*р}7 Bī}69}j C'q]/zt 6< y)݇,=<5I΂*E˟t'i:'Ӻ!%֎8]dVK{5OTm+*og\WpN@\zz?*|?U`=G;$EYoGs-ZiweR-G"ӑC"F$*a(4|qY&tbdF]oqG!kA=AEs39OV?BI|@ xz; _O. L?xe`(ivO)!S<>_ƁI5 6_@ft59oppC@hyT 3F 0IxU/RH4YQ !uepz E_!u?SUC3hd 9T5Ud!j� Ʒ|p=qyc'iZȧIe$rj0Du23 //>^bBRvf 2a`1qV|_Cr[bqW<*i2kHeWmrr5vޣHn^ːǐl"P6 zYfsP祐0j}?8'1A ќ~E`zc#-ͳSkm%Yq5(jcb8A/Jd -/Mb4ܵ\".g@bQY=gvf7r]Qsi7}1 @GC5I\k+ˊAAaz_ƒ+հEbɒcxZW鵐'Z3RVvy kQqH,T8ĴSX#ZɃ8IU%];4w#(q~"?KdlÊ6WɯoNQ4^3.)ni'XYݦ:tRKBK"#j;Ecg}&AAJ߫3n^p5M{CĞ𾌆[Կ0 @   t}P]ݟMoS>2!{!q>$f۳VZa̟E.baQİlxMuAӶMse-(RbB졦 vnW%p9 8fj;093? e(Rg 痢#7U{mSö6 7^joB٪lذ/iA2+_ ټ.g67uR]$Ak,FA,p plu.@{/^<3FӀX= BliX4_ɱXE&IOTaK÷,n@@+XyGh"WX<\- sodJ?%@+Q >b*OAH!.Aj;[{JWQPj$_'h`9W\ C%F^J_L޺?ZT[ҋk:T$E~0c,2Sj;^Ǜ7&=FDIזC(T41̈\dGGđ'^W[9Uܪ(A4VCwMJ CVc;>b_mGw)kZ,xJdVu6uw2b|ueaԅ̑iX\gQ9&Rʬa-֜".,45<FЪ:9kBCi}e8K\*0XLƆ[ї:4UW+?]FjC?LJr=ZMzqEq?n{ RrKN-S'q/mlK"{hzk+hʠΐH*'s_PilGWsH"m?a*1},F&mA{$DʦŠ_8͑%< "`Wޢ| >}`[=>EW) yBi҃s!BYլ/YG43y^T{*9jfTagS4fl]a:^^"\ w4U# Gcɜ}ʁyZUɎz>86!ia~.*x,0쁅>qTs3~3's u|YP20|\+Vn1k5u0<")$uP`NiiH uR;qL .3 72qonCYv{2=t\gJ)޿cWpj.tW6^p!98<$TWAI*Kټb`wKt<_VwqJ\襶vxg?!8ܧ<=FB; SK(pi.L2-aNQ+}7X#G~6צ9W{ Zp5.S;7V/hj#r$:^Nĝ1F;(帿=WpمG?g $WxQ̜G?^@aaߙ-0a7xxkMψ=99uZk綀aNyuާe3A2 jMmW"ٖ L(q5]m+H6ovlAAbeg"`_)f}N @ ex$$޽0)SM,覬kr@'q$DŽ8Ls*=.`Ogm^U=R^lG8I`XfiV4D|쒯̣pq*ng%7.Ҵ Vȏ7e=z;$2ةlr\-OR8;bPNsbGE;pOKgpe 2=Ex\C|"9`y'řQc*Lb s>GY]ti[o[ΌBlY)H!?܄鮄s87{kOtʪ@NQ𼘢.JddGq M j[\}nXV{_"%SPJ;!(dƼ\lSdں;G77t+pQ9g^!(o_\ =ӽDB VHŁ,ؘܧ?+?X7y<#L(=[r8: n #ݳe%yUuHuՙA,Y)Gl :vfmf$S}cz@-?*.dLgNcl4'k&0Tse'xl'QAhq81<4.=eCd : O Oĉrz% ܰHE;s]kJRNo:C0>3v `  lc@wmC-!{CPTZx}Zb/{pD/n+Dn]K˟xG,@ͪyA^&!EL!PBxYMr$o+~=5xKj!Ok}< UC`=0IUjJi(y%OO9~ҥuAq)Y? ?6% XXwW޻8}I1r^rIƾ2HE~o;x|ؓ\lj:eStM[׋ i5S{ĬbԖ\w_ż*xpL\lMÁiȥzzfῙpE x!Bh'ug9gXHi>RyX.V&M!Ryd~n7?˗^~!򋮊$AΪoa-,ɗo-aXO1d aOKwp/<}/6l@o޲g/G G.C:s.ѡW\-%+Sb+u ]PodR@iU{!223 mh5[ |U3?:šf|CpG)ťP1p03NbY&k1BQ;TÉpI.$ q18ǵ'W8^T}BV_+rǂ*73׍:WUpGgWZ'Pr>D]=V-FKRY@>묽Y@ghuĸ^4LaꊈM/lVĈ2.!2f:W9;N/C|:]:~c3D!4KKTETwR*#gO8HK)OL9] ϰf? |<;ic^{nؔL:m{@)a"W!lw|]a(ܶQ$D3В`_x JUB6vP9覫^]w Ye!o0R!tv!l]VW!TM g'Ss[ V}߮T0lB"GFrJTvQV*`mQ[rK鵑?3'"A .s׷}p,aIcbĒ_3*FYN~-UFk+ej+΅By6ǼcP7e},TW \5SNqGw<dr*rSnĝpGN$Uo| )Zm׹h_zs8%<<$Q+6ƆV^`xM6rI)R ]Vm1z+;@ ~`?Cl9 c"iΩOyXh$ 2x$ޟVaLU@rdԊ $s:Հ옝 wKBi||7`]@TAƒ#:C.d_&pXA$Gq["r%:5bʓvνdvm!aNحO%1 _?Vs6jy|K#/rKRE(R)Q =t%K*$Za_t G M"rL)V?%Nbq5ХY~w@%.H{;u"5VHzPSO,j1R0cw#i.sQW8 QP*ty{"uOj²F W}yh <`dh(b-'n|[9bW77=ԯ0QzufsE~Ńf[7Ȏ[ bҨaly>5KA,D_4R %rPК< 'wz'!u9T9i/gǂ؞Ҿgy# <ߞEzi.!7gE%R!K]3L|2Id*1;RQwPl U~X3lp(/4)U'j>7HUR-7uméDy^Ou8#8Ha~Hd@6[l%~Qm CJ=oaB9_L҄TKY|wP]ljHS D_!+ u|KfYß`e*oYzG:Ɏ";ӾpyJ61j!W9S5Aa}N3ceK٭`E80mS-x,1 K/"60˶aq j!{Qx[ c$1Tμ.OՀ$3ڼ3u)n 3&,\Vtge0 C&1Ί6rnZu$P0P10\ъ^`!)>߁VXl'$)ƴ@a {S^e^~h62yL_3g_Tq78,:]m!]z~/y54y4񿂘leiڋG~o»#KD_4Atօb/p>{')ۑ 5lddZ(|nj endstream endobj 8 0 obj <>stream h2P0P0T0U06P0W0650U0Q0200= endstream endobj 9 0 obj <>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Type/Page>> endobj 10 0 obj <>stream q 0.145 0.145 0.145 rg 595.1999969 0 0 841.1999969 0 0 cm /Im0 Do Q BT /Suspect <>BDC 0.141 g /T1_0 1 Tf 0.0228 Tc 3 Tr 7.7 0 0 7.7 165.8 749.17 Tm (LYMPHOID )Tj EMC /Suspect <>BDC 0.0229 Tc 6.079 0 Td (PHENOTYPES )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 7.6396 0 0 7.7 268.27 749.17 Tm (IN )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0294 Tc 7.7 0 0 7.7 281.03 749.17 Tm (ASBESTOS-RELATED )Tj EMC /Suspect <>BDC 0.0237 Tc 10.936 0 Td (LESIONS )Tj EMC ET BT /T1_0 1 Tf -0.0065 Tc 8.7 0 0 8.7 510.62 749.65 Tm (941 )Tj -0.0122 Tc 10 0 0 10 42.37 725.41 Tm (factors )Tj -0.035 Tc 9.82 0 0 10.3 76.08 725.41 Tm ([2, )Tj 0.0018 Tc 10.3 0 0 10.3 92.34 725.41 Tm (25-27] )Tj -0.0034 Tc 10 0 0 10 126.88 725.41 Tm (indicate )Tj -0.0022 Tc 3.774 0 Td (that )Tj -0.0144 Tc 2.112 0 Td (these )Tj -0.0082 Tc 2.632 0 Td (cells )Tj -0.0062 Tc 2.456 0 Td (must )Tj 0.0026 Tc 2.523 0 Td (be )Tj -0.003 Tc -21.986 -1.081 Td (hyperactive. )Tj -0.0105 Tc 5.632 0 Td (This )Tj -0.0028 Tc 2.528 0 Td (hyperactivity )Tj 0.0064 Tc 5.975 0 Td (might )Tj 0.0026 Tc 3.027 0 Td (be )Tj 0.003 Tc 1.67 0 Td (due )Tj -0.035 Tc 9.7344 0 0 10 252.22 714.6 Tm (to )Tj 0 Tc 10 0 0 10 266.78 714.6 Tm (a )Tj 0.0032 Tc -22.487 -1.104 Td (direct )Tj 0.0008 Tc 2.902 0 Td (effect )Tj 0.05 Tc 10.0163 0 0 10 99.5 703.56 Tm (of )Tj -0.0044 Tc 10 0 0 10 113.66 703.56 Tm (asbestos )Tj -0.0196 Tc 3.936 0 Td (on )Tj -0.0037 Tc 1.614 0 Td (B-cells )Tj 0.0052 Tc 3.402 0 Td (and/or )Tj -0.0003 Tc 3.145 0 Td (defective )Tj 0.0024 Tc -19.277 -1.079 Td (suppressor )Tj 0 Tc 4.877 0 Td (T )Tj -0.0052 Tc 0.645 0 Td (-cell )Tj -0.0089 Tc 2.377 0 Td (function. )Tj /T1_1 1 Tf 0.0394 Tc 9.1 0 0 9.1 163.19 692.77 Tm (In )Tj /T1_0 1 Tf -0.0088 Tc 10 0 0 10 177.82 692.77 Tm (the )Tj 0.0047 Tc 1.828 0 Td (present )Tj -0.0072 Tc 3.512 0 Td (study )Tj -0.0208 Tc 2.796 0 Td (the )Tj 0.0003 Tc -21.746 -1.104 Td (B-cells )Tj -0.0055 Tc 3.291 0 Td (were )Tj 0.0006 Tc 2.363 0 Td (slightly )Tj -0.0014 Tc 3.462 0 Td (increased )Tj -0.035 Tc 9.9195 0 0 10 174.88 681.73 Tm (in )Tj -0.0003 Tc 10 0 0 10 187.19 681.73 Tm (number )Tj -0.035 Tc 9.9195 0 0 10 222.16 681.73 Tm (in )Tj -0.0088 Tc 10 0 0 10 234.22 681.73 Tm (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0136 Tc 10 0 0 10 250.46 681.73 Tm (com\255)Tj EMC ET BT /T1_0 1 Tf 0.0114 Tc 10 0 0 10 41.53 670.92 Tm (bined )Tj -0.0044 Tc 2.629 0 Td (asbestos )Tj -0.0145 Tc 3.722 0 Td (group. )Tj 0.0099 Tc -5.468 -1.056 Td (More )Tj -0.0024 Tc 2.708 0 Td (interesting )Tj -0.0126 Tc 4.734 0 Td (than )Tj -0.0328 Tc 2.256 0 Td (the )Tj -0.001 Tc 1.696 0 Td (changes )Tj -0.035 Tc 9.9195 0 0 10 201.52 660.36 Tm (in )Tj -0.0328 Tc 10 0 0 10 214.78 660.36 Tm (the )Tj -0.0011 Tc 1.672 0 Td (combined )Tj -0.0036 Tc -19.006 -1.103 Td (group )Tj 0.05 Tc 10.5727 0 0 10 69.02 649.33 Tm (of )Tj 0.0022 Tc 10 0 0 10 81.5 649.33 Tm (asbestos-exposed )Tj 0.0005 Tc 7.38 0 Td (persons )Tj -0.0259 Tc 3.494 0 Td (is )Tj -0.0088 Tc 1.11 0 Td (the )Tj -0.0091 Tc 1.623 0 Td (fact )Tj -0.0022 Tc 1.953 0 Td (that )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0192 Tc 10 0 0 10 255.94 649.33 Tm (sig\255)Tj EMC ET BT /T1_0 1 Tf 0.0036 Tc 10 0 0 10 41.51 638.53 Tm (nificant )Tj -0.0036 Tc 3.712 0 Td (differences )Tj -0.0169 Tc 5.089 0 Td (in )Tj -0.0088 Tc 1.446 0 Td (the )Tj 0.0029 Tc 1.842 0 Td (lymphocyte )Tj -0.005 Tc 5.394 0 Td (subsets )Tj -0.0055 Tc 3.517 0 Td (were )Tj 0.0018 Tc -21.009 -1.105 Td (observed )Tj 0.0029 Tc 3.995 0 Td (between )Tj -0.0039 Tc 3.735 0 Td (groups )Tj -0.0145 Tc 3.151 0 Td (with )Tj -0.0024 Tc 2.175 0 Td (clinically )Tj -0.008 Tc 4.104 0 Td (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0057 Tc 10 0 0 10 231.35 627.48 Tm (radiologi\255)Tj EMC ET BT /T1_0 1 Tf -0.018 Tc 10 0 0 10 41.42 616.68 Tm (cally )Tj -0.0118 Tc 2.257 0 Td (different )Tj -0.0117 Tc 3.719 0 Td (asbestos-related )Tj -0.016 Tc 6.6 0 Td (changes. )Tj /T1_1 1 Tf 0.0394 Tc 9.1 0 0 9.1 204.47 616.68 Tm (In )Tj /T1_0 1 Tf -0.0107 Tc 10 0 0 10 216.02 616.68 Tm (particular, )Tj -0.0328 Tc 4.388 0 Td (the )Tj 0.0313 Tc -21.89 -1.103 Td (PP )Tj -0.0036 Tc 1.58 0 Td (group )Tj 0.0056 Tc 2.759 0 Td (differed )Tj -0.035 Tc 9.9195 0 0 10 120.88 605.65 Tm (in )Tj -0.0185 Tc 10 0 0 10 133.18 605.65 Tm (many )Tj -0.0028 Tc 2.656 0 Td (aspects )Tj -0.035 Tc 9.7344 0 0 10 193.42 605.65 Tm (to )Tj 0 Tc 10 0 0 10 205.1 605.65 Tm (a )Tj 0.0045 Tc 0.89 0 Td (greater )Tj 0.0008 Tc 3.237 0 Td (extent )Tj -0.0221 Tc -20.52 -1.08 Td (from )Tj -0.0328 Tc 2.457 0 Td (the )Tj 0.0018 Tc 1.606 0 Td (BAPE/DPF )Tj -0.0096 Tc 5.132 0 Td (group )Tj -0.0206 Tc 2.814 0 Td (than )Tj -0.0221 Tc 2.127 0 Td (from )Tj -0.0088 Tc 2.409 0 Td (the )Tj 0.0143 Tc 1.657 0 Td (nonnals, )Tj -0.0289 Tc 3.903 0 Td (as )Tj -0.0152 Tc -22.108 -1.081 Td (seen )Tj -0.035 Tc 9.9195 0 0 10 62.32 584.04 Tm (in )Tj -0.0104 Tc 10 0 0 10 73.42 584.04 Tm (table )Tj /T1_1 1 Tf -0.035 Tc 8.1087 0 0 9.7 96.94 584.04 Tm (1. )Tj /T1_0 1 Tf -0.0105 Tc 10 0 0 10 106.95 584.04 Tm (This )Tj -0.0308 Tc 2.144 0 Td (was )Tj -0.0094 Tc 1.862 0 Td (especially )Tj -0.0209 Tc 4.329 0 Td (true )Tj -0.0166 Tc 1.839 0 Td (for )Tj -0.035 Tc 9.8288 0 0 10 224.38 584.04 Tm (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0003 Tc 10 0 0 10 239.33 584.04 Tm ("helper/ )Tj EMC /Suspect <>BDC 0.0063 Tc -19.837 -1.103 Td (inducer" )Tj EMC ET BT /T1_0 1 Tf -0.0111 Tc 10 0 0 10 79.35 573.01 Tm (T-cells. )Tj -0.0041 Tc 3.384 0 Td (These )Tj -0.0079 Tc 2.758 0 Td (findings )Tj 0.008 Tc 3.625 0 Td (are )Tj -0.035 Tc 9.5888 0 0 10 193.36 573.01 Tm (in )Tj -0.0018 Tc 10 0 0 10 204.62 573.01 Tm (accordance )Tj -0.0225 Tc 4.881 0 Td (with )Tj -0.0088 Tc -21.241 -1.08 Td (the )Tj -0.0018 Tc 1.648 0 Td (clinical )Tj -0.0113 Tc 3.407 0 Td (findings )Tj 0.05 Tc 10.2945 0 0 10 128.3 562.21 Tm (of )Tj 0.0228 Tc 7.2 0 0 7.2 141.15 562.21 Tm (NAVRATIL )Tj -0.008 Tc 10 0 0 10 183.5 562.21 Tm (and )Tj -0.035 Tc 9.0123 0 0 10 202.28 562.21 Tm (DoBIAs, )Tj 9.5041 0 0 10 237.61 562.21 Tm ([6] )Tj -0.0188 Tc 10 0 0 10 253.19 562.21 Tm (who )Tj -0.002 Tc -21.224 -1.104 Td (divided )Tj 0.0032 Tc 3.511 0 Td (the )Tj 0.0033 Tc 1.708 0 Td (pleural )Tj -0.001 Tc 3.3 0 Td (changes )Tj -0.0086 Tc 3.746 0 Td (into )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0067 Tc 10 0 0 10 184.13 551.17 Tm ("hyalinosis )Tj EMC /Suspect <>BDC -0.0025 Tc 5.045 0 Td (simplex" )Tj EMC ET BT /T1_0 1 Tf -0.02 Tc 10 0 0 10 40.94 540.36 Tm (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0074 Tc 10 0 0 10 58.85 540.36 Tm ("complicata". )Tj EMC ET BT /T1_0 1 Tf 0 Tc 10 0 0 10 49.66 529.56 Tm (A )Tj -0.0026 Tc 1.273 0 Td (hypothesis )Tj -0.0034 Tc 4.8 0 Td (which )Tj -0.0237 Tc 3.014 0 Td (fits )Tj -0.0065 Tc 1.81 0 Td (with )Tj -0.0024 Tc 2.327 0 Td (these )Tj 0.0007 Tc 2.585 0 Td (data )Tj -0.0259 Tc 2.233 0 Td (is )Tj -0.0022 Tc 1.206 0 Td (that )Tj -0.035 Tc 9.5888 0 0 10 262.48 529.56 Tm (in )Tj -0.0066 Tc 10 0 0 10 40.66 518.53 Tm (some )Tj -0.0032 Tc 2.598 0 Td (individuals )Tj 0.0015 Tc 4.941 0 Td (exposed )Tj -0.035 Tc 9.4099 0 0 10 154.3 518.53 Tm (to )Tj -0.001 Tc 10 0 0 10 166.46 518.53 Tm (asbestos )Tj -0.0095 Tc 3.84 0 Td (only )Tj -0.0016 Tc 2.288 0 Td (minor )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 9.9628 0 0 10 256.48 518.53 Tm (im\255)Tj EMC ET BT /T1_0 1 Tf -0.0022 Tc 10 0 0 10 40.54 507.73 Tm (munological )Tj -0.001 Tc 5.512 0 Td (changes )Tj -0.0122 Tc 3.753 0 Td (will )Tj -0.0067 Tc 2.056 0 Td (develop; )Tj -0.0024 Tc 3.967 0 Td (these )Tj 0.0005 Tc 2.548 0 Td (persons )Tj -0.0122 Tc 3.573 0 Td (will )Tj -0.0072 Tc -21.421 -1.105 Td (show )Tj -0.0007 Tc 2.464 0 Td (pleural )Tj -0.0032 Tc 3.144 0 Td (plaques )Tj -0.0217 Tc 3.444 0 Td (only. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0068 Tc 10 0 0 10 154.7 496.68 Tm (Other )Tj EMC ET BT /T1_0 1 Tf -0.001 Tc 10 0 0 10 181.22 496.68 Tm (persons, )Tj -0.009 Tc 3.693 0 Td (however, )Tj -0.016 Tc 4.023 0 Td (are )Tj 0.0033 Tc -21.828 -1.08 Td (prone )Tj -0.0307 Tc 2.876 0 Td (to )Tj 0 Tc 1.288 0 Td (a )Tj -0.0109 Tc 1.04 0 Td (more )Tj 0.0037 Tc 2.604 0 Td (severe )Tj 0.0013 Tc 3.102 0 Td (immunological )Tj -0.0068 Tc 6.647 0 Td (derangement; )Tj -0.0084 Tc -17.537 -1.104 Td (these )Tj -0.004 Tc 2.56 0 Td (are )Tj -0.0039 Tc 1.728 0 Td (ones )Tj -0.0188 Tc 2.361 0 Td (who )Tj -0.0017 Tc 2.224 0 Td (develop )Tj -0.0041 Tc 3.677 0 Td (BAPE )Tj 0.0052 Tc 3.09 0 Td (and/or )Tj -0.0171 Tc 3.077 0 Td (DPF. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0054 Tc 10 0 0 10 253.34 474.84 Tm (One )Tj EMC ET BT /T1_0 1 Tf -0.0026 Tc 10 0 0 10 40.3 464.05 Tm (manifestation )Tj 0.05 Tc 10.0163 0 0 10 99.98 464.05 Tm (of )Tj 0.0033 Tc 10 0 0 10 113.71 464.05 Tm (DPF )Tj -0.0019 Tc 2.349 0 Td (is )Tj -0.0088 Tc 1.206 0 Td (the )Tj 0.0033 Tc 1.721 0 Td (development )Tj 0.05 Tc 10.2945 0 0 10 223.58 464.05 Tm (of )Tj -0.0099 Tc 10 0 0 10 237.35 464.05 Tm (rounded )Tj 0.0014 Tc -19.737 -1.104 Td (atelectasis )Tj -0.035 Tc 9.9718 0 0 10 86.64 453.01 Tm ([5]. )Tj 0.0065 Tc 10 0 0 10 105.08 453.01 Tm (Patients )Tj -0.0225 Tc 3.699 0 Td (with )Tj -0.0022 Tc 2.243 0 Td (such )Tj -0.004 Tc 2.358 0 Td (lesions )Tj -0.0194 Tc 3.295 0 Td (have )Tj -0.0015 Tc 2.342 0 Td (earlier )Tj -0.0095 Tc -20.46 -1.08 Td (been )Tj -0.0044 Tc 2.673 0 Td (shown )Tj -0.035 Tc 9.7344 0 0 10 101.02 442.21 Tm (to )Tj 0.0046 Tc 10 0 0 10 116.15 442.21 Tm (have )Tj 0.0053 Tc 2.657 0 Td (immunological )Tj 0.0095 Tc 6.91 0 Td (abnonnalities, )Tj -0.0094 Tc -17.175 -1.104 Td (which )Tj 0.0029 Tc 2.798 0 Td (fit )Tj -0.0035 Tc 1.282 0 Td (well )Tj -0.0065 Tc 2.112 0 Td (with )Tj 0.0157 Tc 2.151 0 Td (our )Tj -0.0045 Tc 1.703 0 Td (findings )Tj -0.0202 Tc 3.731 0 Td ([28]. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0001 Tc 10 0 0 10 48.78 420.37 Tm (Since )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 9.9003 0 0 10 74.78 420.37 Tm (an )Tj 0.0062 Tc 10 0 0 10 88 420.37 Tm (intact )Tj 0.0013 Tc 2.616 0 Td (immunoregulatory )Tj -0.0013 Tc 7.855 0 Td (network )Tj -0.0019 Tc 3.641 0 Td (is )Tj -0.0126 Tc 1.11 0 Td (thought )Tj -0.035 Tc 9.7344 0 0 10 40.06 409.56 Tm (to )Tj 0.0266 Tc 10 0 0 10 51.13 409.56 Tm (be )Tj 0.05 Tc 10.2945 0 0 10 64.7 409.56 Tm (of )Tj -0.0014 Tc 10 0 0 10 76.96 409.56 Tm (importance )Tj -0.0046 Tc 4.893 0 Td (for )Tj -0.001 Tc 1.549 0 Td (protection )Tj 0.0063 Tc 4.452 0 Td (against )Tj -0.0062 Tc 3.248 0 Td (tumours, )Tj -0.0088 Tc 3.912 0 Td (the )Tj 0.0018 Tc -21.776 -1.079 Td (observed )Tj -0.0007 Tc 4.137 0 Td (numerical )Tj 0.0021 Tc 4.505 0 Td (imbalance )Tj -0.0011 Tc 4.641 0 Td (between )Tj 0.0032 Tc 3.854 0 Td (different )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0239 Tc 10 0 0 10 250.96 398.77 Tm (lym\255)Tj EMC ET BT /T1_0 1 Tf -0.0017 Tc 10 0 0 10 39.62 387.96 Tm (phocyte )Tj -0.001 Tc 3.56 0 Td (subsets )Tj 0.0064 Tc 3.3 0 Td (might )Tj 0.0046 Tc 2.737 0 Td (have )Tj -0.0044 Tc 2.294 0 Td (further )Tj -0.0029 Tc 3.121 0 Td (consequences. )Tj -0.0087 Tc 6.173 0 Td (DPF )Tj -0.032 Tc -21.173 -1.079 Td (and )Tj -0.0041 Tc 1.926 0 Td (BAPE )Tj -0.0196 Tc 3.11 0 Td (seem )Tj -0.0307 Tc 2.556 0 Td (to )Tj 0.0026 Tc 1.275 0 Td (be )Tj -0.0092 Tc 1.452 0 Td (fairly )Tj 0.0006 Tc 2.665 0 Td (common )Tj -0.0169 Tc 4.034 0 Td (in )Tj 0.0002 Tc 1.282 0 Td (populations )Tj -0.0305 Tc -18.315 -1.08 Td (with )Tj 0 Tc 2.127 0 Td (a )Tj -0.023 Tc 0.849 0 Td (high )Tj -0.0116 Tc 2.16 0 Td (risk )Tj 0.05 Tc 10.2945 0 0 10 109.58 366.37 Tm (of )Tj 0.0023 Tc 10 0 0 10 121.9 366.37 Tm (malignant )Tj 0.0038 Tc 4.392 0 Td (mesothelioma )Tj -0.0097 Tc 6.027 0 Td (but )Tj 0.0028 Tc 1.63 0 Td (rare )Tj -0.035 Tc 9.5888 0 0 10 262 366.37 Tm (in )Tj 0.0078 Tc 10 0 0 10 39.26 355.33 Tm (other )Tj 0.0022 Tc 2.592 0 Td (asbestos-exposed )Tj 0.0026 Tc 7.5 0 Td (populations )Tj -0.0031 Tc 5.253 0 Td (where )Tj -0.0162 Tc 2.999 0 Td (this )Tj -0.0036 Tc 1.969 0 Td (risk )Tj -0.0259 Tc 2.033 0 Td (is )Tj -0.0219 Tc -22.344 -1.08 Td (low )Tj -0.0118 Tc 1.952 0 Td ([29,30]. )Tj -0.0003 Tc 3.543 0 Td (The )Tj -0.0057 Tc 1.968 0 Td (question )Tj 0.05 Tc 10.0163 0 0 10 151.82 344.53 Tm (of )Tj 0.0044 Tc 10 0 0 10 164.39 344.53 Tm (whether )Tj -0.0088 Tc 3.647 0 Td (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0066 Tc 10 0 0 10 217.36 344.53 Tm (immunologi\255)Tj EMC ET BT /T1_0 1 Tf -0.0075 Tc 10 0 0 10 39.26 333.49 Tm (cal )Tj -0.0009 Tc 1.85 0 Td (imbalance )Tj -0.0017 Tc 4.798 0 Td (observed )Tj 0.0043 Tc 4.305 0 Td (here )Tj -0.0259 Tc 2.417 0 Td (is )Tj 0.05 Tc 10.5727 0 0 10 186.14 333.49 Tm (of )Tj 0.004 Tc 10 0 0 10 201.26 333.49 Tm (any )Tj -0.0013 Tc 2.136 0 Td (aetiological )Tj -0.0014 Tc -18.334 -1.056 Td (importance )Tj -0.0166 Tc 4.965 0 Td (for )Tj -0.0088 Tc 1.641 0 Td (the )Tj 0.0057 Tc 1.649 0 Td (development )Tj 0.05 Tc 10.5727 0 0 10 178.46 322.93 Tm (of )Tj -0.0007 Tc 10 0 0 10 191.98 322.93 Tm (malignant )Tj -0.0136 Tc 4.488 0 Td (tumours )Tj -0.0206 Tc -19.784 -1.081 Td (or )Tj -0.0046 Tc 1.161 0 Td (represent )Tj -0.0095 Tc 3.951 0 Td (only )Tj 0 Tc 2.112 0 Td (a )Tj -0.0112 Tc 0.812 0 Td (secondary )Tj -0.0086 Tc 4.347 0 Td (epiphenomena )Tj -0.0136 Tc 6.106 0 Td (necessitates )Tj -0.0084 Tc -18.49 -1.079 Td (further )Tj -0.0034 Tc 3.093 0 Td (studies. )Tj /T1_2 1 Tf 0.0287 Tc 7.9001 0 0 7.9001 98.28 285.96 Tm (Acknowledgements)Tj 0.294 g 0 Tc 8.17 0 Td (: )Tj 0.141 g /T1_0 1 Tf 0.05 Tc 7.7239 0 0 7.7 168.21 285.96 Tm (We )Tj -0.0045 Tc 7.7 0 0 7.7 183.83 285.96 Tm (wish )Tj 0.0046 Tc 2.461 0 Td (to )Tj 0.0144 Tc 1.309 0 Td (thank )Tj 0.0146 Tc 2.805 0 Td (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0247 Tc 7.7 0 0 7.7 248.0172 285.96 Tm (Swed\255)Tj EMC ET BT /T1_0 1 Tf -0.0139 Tc 7.7 0 0 7.7 89.4588 278.5295 Tm (ish )Tj 0.227 g 0.0119 Tc 1.945 0 Td (National )Tj 0.141 g 0.0063 Tc 4.357 0 Td (Assoc)Tj 0.294 g -0.0181 Tc 2.518 0 Td (ia)Tj 0.141 g 0.0023 Tc 0.784 0 Td (tion )Tj 0.0342 Tc 2.236 0 Td (against )Tj 0.0249 Tc 3.809 0 Td (Heart )Tj 0.0165 Tc 3.017 0 Td (and )Tj 0.0289 Tc 2.244 0 Td (Chest )Tj 0.0068 Tc -20.908 -0.999 Td (Diseas)Tj 0.294 g -0.033 Tc 2.768 0 Td (es )Tj 0.227 g 0.0009 Tc 1.34 0 Td (and )Tj -0.001 Tc 1.971 0 Td (the )Tj 0.141 g 0.0231 Tc 1.699 0 Td (Swedish )Tj 0.0279 Tc 4.004 0 Td (Medical )Tj 0.0162 Tc 3.896 0 Td (Research )Tj 0.0271 Tc 4.295 0 Td (Council )Tj 0.0464 Tc -20.042 -0.966 Td (for )Tj 0.0262 Tc 1.691 0 Td (their )Tj 0.007 Tc 2.388 0 Td (support. )Tj 0.0117 Tc 9.2 0 0 9.2 132.68 239.41 Tm (References )Tj -0.035 Tc 8.5768 0 0 8.8 38.82 221.17 Tm (1. )Tj 0.028 Tc 8.7 0 0 8.7 56.12 221.17 Tm (Becklake )Tj 0.0302 Tc 4.276 0 Td (M. )Tj 0 Tc 1.593 0 Td (-)Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.02 Tc 8.7 0 0 8.7 115.5236 221.17 Tm (State )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.9033 0 0 8.7 136.96 221.17 Tm (of )Tj -0.0019 Tc 8.7 0 0 8.7 148.3 221.17 Tm (the )Tj 0.05 Tc 8.1966 0 0 8.1 162.64 221.17 Tm (art )Tj 0.0148 Tc 8.7 0 0 8.7 175.94 221.17 Tm (:asbestos-related )Tj 0.0106 Tc 7.271 0 Td (diseases )Tj 0.05 Tc 9.1816 0 0 8.7 38.31 212.05 Tm (of )Tj -0.0157 Tc 8.7 0 0 8.7 50.38 212.05 Tm (the )Tj 0.0196 Tc 1.649 0 Td (lung )Tj 0.0151 Tc 2.343 0 Td (and )Tj 0.0298 Tc 1.96 0 Td (other )Tj 0.0096 Tc 2.593 0 Td (organs: )Tj 0.0189 Tc 3.538 0 Td (their )Tj 0.0215 Tc 2.364 0 Td (epidemiology )Tj 0.0151 Tc 6.207 0 Td (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0061 Tc 8.7 0 0 8.7 247.1305 212.05 Tm (impli\255)Tj EMC ET BT /T1_0 1 Tf 0.0146 Tc 8.7 0 0 8.7 38.0782 202.4539 Tm (cations )Tj 0.0005 Tc 3.418 0 Td (for )Tj 0.0168 Tc 1.685 0 Td (clinical )Tj 0.0164 Tc 3.514 0 Td (practice. )Tj /T1_2 1 Tf 0.05 Tc 9.0617 0 0 9 147.98 202.45 Tm (Am )Tj 0.0135 Tc 9 0 0 9 164.23 202.45 Tm (Rev )Tj 0.0123 Tc 1.973 0 Td (Respir )Tj -0.0228 Tc 3.096 0 Td (Dis, )Tj /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 229.14 202.45 Tm (1976, )Tj -0.0078 Tc 2.814 0 Td (114, )Tj 0.0304 Tc -24.717 -1.076 Td (187-227. )Tj -0.0139 Tc -0.054 -1.076 Td (2. )Tj 0.0207 Tc 2.015 0 Td (Morris )Tj 0.0035 Tc 3.283 0 Td (DL, )Tj 0.0127 Tc 2.063 0 Td (Greenberg )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0019 Tc 8.7 0 0 8.7 143.8452 183.7276 Tm (SD, )Tj EMC ET BT /T1_0 1 Tf 0.0186 Tc 8.7 0 0 8.7 160.9929 183.7276 Tm (Lawrence )Tj 0.002 Tc 4.497 0 Td (EC. )Tj 0 Tc 1.953 0 Td (-)Tj 0.0376 Tc 0.887 0 Td (Immune )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.025 Tc 8.7 0 0 8.7 258.4764 183.7276 Tm (re\255)Tj EMC ET BT /T1_0 1 Tf 0.01 Tc 8.7 0 0 8.7 38.0445 174.1315 Tm (sponses )Tj 0.0391 Tc 3.978 0 Td (in )Tj 0.0145 Tc 1.625 0 Td (asbestos-exposed )Tj 0.0115 Tc 7.975 0 Td [(individuals. )-563(Editorial. )]TJ /T1_2 1 Tf -0.0071 Tc 9 0 0 9 245.82 174.13 Tm (Chest, )Tj /T1_0 1 Tf -0.0067 Tc 8.7 0 0 8.7 38.34 165.01 Tm (1986, )Tj 0.0132 Tc 2.638 0 Td (87, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0426 Tc 8.7 0 0 8.7 76.0284 165.01 Tm (278-280. )Tj EMC ET BT /T1_0 1 Tf 0.0041 Tc 8.7 0 0 8.7 37.5744 155.4139 Tm (3. )Tj 0.0164 Tc 2.076 0 Td (Hillerdal )Tj -0.019 Tc 4.187 0 Td (G. )Tj 0 Tc 1.433 0 Td (-)Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0138 Tc 8.7 0 0 8.7 113.7081 155.4139 Tm (Pleural )Tj EMC ET BT /T1_0 1 Tf 0.017 Tc 8.7 0 0 8.7 143.0358 155.4139 Tm (plaques )Tj 0.0116 Tc 3.66 0 Td (in )Tj 0 Tc 1.267 0 Td (a )Tj 0.0204 Tc 0.892 0 Td (health )Tj 0.0127 Tc 3.049 0 Td (survey )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0122 Tc 8.7 0 0 8.7 248.1231 155.4139 Tm (mate\255)Tj EMC ET BT /T1_0 1 Tf 0.0051 Tc 8.7 0 0 8.7 37.4091 146.2876 Tm (rial. )Tj 0.0143 Tc 2.038 0 Td (Frequency, )Tj 0.0228 Tc 5.016 0 Td (development )Tj 0.0013 Tc 5.792 0 Td (and )Tj 0.0194 Tc 1.848 0 Td (exposure )Tj -0.0298 Tc 4.174 0 Td (to )Tj 0.0056 Tc 1.178 0 Td (asbestos. )Tj /T1_2 1 Tf 0.0066 Tc 9 0 0 9 247.19 146.28 Tm (Scand )Tj /T1_3 1 Tf 0 Tc 8.6 0 0 8.6 37.12 136.69 Tm (J )Tj /T1_2 1 Tf 0.0017 Tc 9 0 0 9 44.95 136.69 Tm (Respir )Tj -0.005 Tc 2.989 0 Td (Dis, )Tj /T1_0 1 Tf 0.0071 Tc 8.7 0 0 8.7 90.66 136.69 Tm (1978, )Tj -0.001 Tc 2.724 0 Td (59, )Tj 0.0386 Tc 1.691 0 Td (257-263. )Tj 0.0101 Tc -10.537 -1.105 Td (4. )Tj 0.0164 Tc 2.097 0 Td (Hillerdal )Tj 0.0086 Tc 4.132 0 Td (G, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.01 Tc 8.7 0 0 8.7 104.3103 127.0765 Tm (Ozesrni )Tj EMC ET BT /T1_0 1 Tf -0.025 Tc 8.7 0 0 8.7 135.8043 127.0765 Tm (M. )Tj 0 Tc 1.593 0 Td (-)Tj 0.0285 Tc 0.945 0 Td (Benign )Tj 0.0145 Tc 3.498 0 Td (asbestos )Tj 0.0129 Tc 3.874 0 Td (pleural )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.016 Tc 8.7 0 0 8.7 250.9575 127.0765 Tm (effu\255)Tj EMC ET BT /T1_0 1 Tf -0.0105 Tc 8.7 0 0 8.7 37.5639 117.9589 Tm (sion: )Tj -0.0099 Tc 2.376 0 Td (73 )Tj 0.0237 Tc 1.434 0 Td (exudates )Tj 0.0391 Tc 4.085 0 Td (in )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0177 Tc 8.7 0 0 8.7 117.0123 117.9589 Tm (60 )Tj EMC ET BT /T1_0 1 Tf 0.0092 Tc 8.7 0 0 8.7 129.1314 117.9589 Tm (patients. )Tj /T1_2 1 Tf -0.0093 Tc 9 0 0 9 163.27 117.96 Tm (Eur )Tj /T1_3 1 Tf 0 Tc 8.3 0 0 8.3 179.92 117.96 Tm (J )Tj /T1_2 1 Tf 0.0123 Tc 9 0 0 9 187.51 117.96 Tm (Respir )Tj -0.0139 Tc 3.042 0 Td (Dis, )Tj /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 233.94 117.96 Tm (1987, )Tj -0.0058 Tc 2.672 0 Td (71, )Tj 0.0304 Tc -25.21 -1.131 Td (113-121. )Tj 0.0014 Tc -0.062 -1.047 Td (5. )Tj 0.0164 Tc 2.051 0 Td (Hillerdal )Tj 0 Tc 4.27 0 Td (G)Tj 0.294 g 0.817 0 Td (. )Tj 0.141 g 0.726 0 Td (-)Tj 0.0223 Tc 1.092 0 Td (Non-malignant )Tj 0.0067 Tc 6.909 0 Td (asbestos )Tj 0.0129 Tc 3.984 0 Td (pleural )Tj 0.0107 Tc 3.438 0 Td (disease. )Tj /T1_2 1 Tf -0.013 Tc 9 0 0 9 37.02 89.4 Tm (Thorax, )Tj /T1_0 1 Tf 0.0071 Tc 8.7 0 0 8.7 69.3 89.4 Tm (1981, )Tj 0.0141 Tc 2.699 0 Td (36, )Tj 0.0394 Tc 1.711 0 Td (745-751. )Tj -0.035 Tc 8.6907 0 0 8.7 37.33 80.05 Tm (6. )Tj 0.0212 Tc 8.7 0 0 8.7 54.76 80.05 Tm (Navratil )Tj 0.0302 Tc 3.908 0 Td (M, )Tj 0.0109 Tc 1.766 0 Td (Dobias )Tj /T1_3 1 Tf 0.0286 Tc 8.8 0 0 8.8 133.77 80.05 Tm (I. )Tj /T1_1 1 Tf 0 Tc 1.099 0 Td (-)Tj /T1_0 1 Tf 0.0262 Tc 8.7 0 0 8.7 152.6 80.05 Tm (Development )Tj 0.05 Tc 9.738 0 0 8.7 205.59 80.05 Tm (of )Tj 0.0175 Tc 8.7 0 0 8.7 217.69 80.05 Tm (pleural )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0093 Tc 8.7 0 0 8.7 247.1917 80.05 Tm (hyali\255)Tj EMC ET BT /T1_0 1 Tf -0.0095 Tc 8.7 0 0 8.7 36.9475 70.4365 Tm (nosis )Tj 0.0116 Tc 2.448 0 Td (in )Tj 0.0105 Tc 1.159 0 Td (long )Tj -0.0023 Tc 2.268 0 Td (term )Tj 0.0015 Tc 2.223 0 Td (studies )Tj 0.05 Tc 9.1816 0 0 8.7 135.03 70.44 Tm (of )Tj 0.0074 Tc 8.7 0 0 8.7 145.69 70.44 Tm (persons )Tj 0.0138 Tc 3.492 0 Td (exposed )Tj -0.0298 Tc 3.76 0 Td (to )Tj -0.0052 Tc 1.178 0 Td (asbestos )Tj -0.0078 Tc 3.725 0 Td (dust. )Tj /T1_2 1 Tf -0.0053 Tc 9 0 0 9 292.63 726.85 Tm (Environ )Tj -0.0006 Tc 3.547 0 Td (Resp, )Tj /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 348.42 726.85 Tm (1978, )Tj -0.0238 Tc 2.731 0 Td (15, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0304 Tc 8.7 0 0 8.7 386.8218 726.85 Tm (108-118. )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 8.6907 0 0 8.7 292.71 717.24 Tm (7. )Tj 0.0164 Tc 8.7 0 0 8.7 310.52 717.24 Tm (Hillerdal )Tj -0.019 Tc 4.105 0 Td (G. )Tj 0 Tc 1.433 0 Td (-)Tj 0.0145 Tc 0.975 0 Td (Asbestos-related )Tj 0.0213 Tc 7.314 0 Td (pleuropulmonary )Tj 0.0136 Tc 7.66 0 Td (lesions )Tj -0.0125 Tc -23.506 -1.076 Td (and )Tj -0.0019 Tc 2.105 0 Td (the )Tj 0.016 Tc 1.868 0 Td (erythrocyte )Tj 0.0179 Tc 5.321 0 Td (sedimentation )Tj 0.0119 Tc 6.413 0 Td (rate. )Tj /T1_2 1 Tf 0.0003 Tc 9 0 0 9 450.78 707.88 Tm (Thorax, )Tj /T1_0 1 Tf 0.0071 Tc 8.7 0 0 8.7 485.7 707.88 Tm (1984, )Tj 0.0141 Tc 2.92 0 Td (39, )Tj 0.0316 Tc -25.102 -1.075 Td (752-758. )Tj -0.0252 Tc -0.007 -1.076 Td (8. )Tj 0.0165 Tc 2.026 0 Td (Karlsson-Parra )Tj -0.035 Tc 8.5053 0 0 8.7 368.87 689.17 Tm (A, )Tj 0.0159 Tc 8.7 0 0 8.7 382.04 689.17 Tm (Forsum )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 8.4993 0 0 8.7 413.99 689.17 Tm (U, )Tj EMC ET BT /T1_0 1 Tf 0.0145 Tc 8.7 0 0 8.7 427.16 689.17 Tm (Klareskog )Tj -0.0202 Tc 4.771 0 Td (L, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0163 Tc 8.7 0 0 8.7 481.0391 689.17 Tm (Sjoberg )Tj EMC /Suspect <>BDC 0.05 Tc 10.4831 0 0 8.8 513.49 689.17 Tm (0. )Tj EMC ET BT /T1_0 1 Tf 0 Tc 8.7 0 0 8.7 292.22 679.8 Tm [(-)-780(A )]TJ 0.0187 Tc 2.425 0 Td (simple )Tj 0.0182 Tc 3.344 0 Td (immunoenzyme )Tj 0.0272 Tc 7.209 0 Td (batch )Tj 0.0128 Tc 2.826 0 Td (staining )Tj 0.0305 Tc 3.874 0 Td (method )Tj 0.0005 Tc 3.715 0 Td (for )Tj 0.0119 Tc 1.802 0 Td (the )Tj 0.0158 Tc -25.167 -1.075 Td (enumeration )Tj 0.05 Tc 8.9033 0 0 8.7 342.4 670.45 Tm (of )Tj 0.0201 Tc 8.7 0 0 8.7 354.73 670.45 Tm (peripheral )Tj 0.0382 Tc 4.77 0 Td (human )Tj 0 Tc 3.386 0 Td (T )Tj 0.0232 Tc 1.269 0 Td (lymphocyte )Tj 0.0126 Tc 5.511 0 Td (subsets. )Tj /T1_3 1 Tf 0 Tc 8.6 0 0 8.6 517.84 670.45 Tm (J )Tj /T1_2 1 Tf 0.0024 Tc 9 0 0 9 292.17 660.85 Tm (Immunol )Tj -0.0073 Tc 3.893 0 Td (Methods, )Tj /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 364.5 660.85 Tm (1983, )Tj -0.0196 Tc 2.698 0 Td (64, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0421 Tc 8.7 0 0 8.7 402.5712 660.85 Tm (85-90. )Tj EMC ET BT /T1_0 1 Tf -0.0079 Tc 8.7 0 0 8.7 292.2204 651.7324 Tm (9. )Tj 0.0164 Tc 2.075 0 Td (Ledbetter )Tj -0.0144 Tc 4.69 0 Td (JA, )Tj 0.0065 Tc 2.179 0 Td (Evans )Tj -0.017 Tc 3.312 0 Td (RL, )Tj 0.0186 Tc 2.289 0 Td (Lipinski )Tj -0.025 Tc 4.194 0 Td (M, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0208 Tc 8.7 0 0 8.7 472.2408 651.7324 Tm (Cunningham\255)Tj EMC ET BT /T1_0 1 Tf 0.0063 Tc 8.7 0 0 8.7 292.29 642.1189 Tm (Rundles )Tj -0.0116 Tc 3.829 0 Td (C, )Tj 0.0276 Tc 1.434 0 Td (Good )Tj -0.0179 Tc 2.792 0 Td (RA, )Tj 0.0107 Tc 2.179 0 Td (Herzenberg )Tj 0.0013 Tc 5.295 0 Td (LA. )Tj 0 Tc 2.063 0 Td (-)Tj 0.0159 Tc 1.054 0 Td (Evolutionary )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0124 Tc 8.7 0 0 8.7 505.8402 642.1189 Tm (con\255)Tj EMC ET BT /T1_0 1 Tf 0.0178 Tc 8.7 0 0 8.7 292.203 632.7664 Tm (servation )Tj 0.05 Tc 9.4598 0 0 8.7 337.59 632.77 Tm (of )Tj 0.0155 Tc 8.7 0 0 8.7 349.56 632.77 Tm (surface )Tj 0.0117 Tc 3.956 0 Td (molecules )Tj 0.0167 Tc 5.214 0 Td (that )Tj 0.0175 Tc 2.503 0 Td (distinguish )Tj 0 Tc 5.049 0 Td (T )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0198 Tc 8.7 0 0 8.7 504.8811 632.77 Tm (lym\255)Tj EMC ET BT /T1_0 1 Tf 0.0169 Tc 8.7 0 0 8.7 292.0791 623.4088 Tm (phocyte )Tj 0.017 Tc 3.777 0 Td (helper/inducer )Tj 0.0151 Tc 6.501 0 Td (and )Tj 0 Tc 1.961 0 Td (T )Tj 0.0188 Tc 1.213 0 Td (cytotoxic/suppressor )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0157 Tc 8.7 0 0 8.7 488.5077 623.4088 Tm (subpopu\255)Tj EMC ET BT /T1_0 1 Tf 0.0047 Tc 8.7 0 0 8.7 292.2357 614.2912 Tm (lations )Tj 0.0391 Tc 3.117 0 Td (in )Tj 0.0316 Tc 1.164 0 Td (mouse )Tj 0.0151 Tc 3.137 0 Td (and )Tj -0.0115 Tc 1.884 0 Td (man. )Tj /T1_3 1 Tf 0 Tc 8.6 0 0 8.6 393.76 614.29 Tm (J )Tj /T1_2 1 Tf -0.023 Tc 9 0 0 9 401.83 614.29 Tm (Exp )Tj -0.0217 Tc 1.869 0 Td (Med, )Tj /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 441.06 614.29 Tm (1981, )Tj -0.0078 Tc 2.731 0 Td (153, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0412 Tc 8.7 0 0 8.7 483.4986 614.29 Tm (310-323. )Tj EMC /Suspect <>BDC -0.01 Tc -21.954 -1.105 Td (10. )Tj EMC ET BT /T1_0 1 Tf 0.0183 Tc 8.7 0 0 8.7 310.0293 604.6765 Tm (Engleman )Tj 0.0016 Tc 4.772 0 Td (EG, )Tj 0.0233 Tc 2.18 0 Td (Benike )Tj -0.0072 Tc 3.525 0 Td (CJ, )Tj 0.0227 Tc 1.931 0 Td (Glickman )Tj -0.0196 Tc 4.667 0 Td (E, )Tj 0.0134 Tc 1.49 0 Td (Evans )Tj -0.017 Tc 3.118 0 Td (RL. )Tj 0 Tc 2.117 0 Td (-)Tj 0.01 Tc -25.867 -1.102 Td (Antibodies )Tj -0.035 Tc 8.112 0 0 8.7 336.22 595.09 Tm (to )Tj 0.025 Tc 8.7 0 0 8.7 347.02 595.09 Tm (membrane )Tj 0.0126 Tc 4.899 0 Td (structures )Tj 0.0259 Tc 4.536 0 Td (that )Tj 0.0202 Tc 2.034 0 Td (distinguish )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0124 Tc 8.7 0 0 8.7 491.3965 595.09 Tm (suppres\255)Tj EMC ET BT /T1_0 1 Tf 0.0085 Tc 8.7 0 0 8.7 292.1926 585.9724 Tm (sor )Tj 0.0137 Tc 1.687 0 Td (cytotoxic )Tj 0.0151 Tc 4.302 0 Td (and )Tj 0.0257 Tc 1.885 0 Td (helper )Tj 0 Tc 3.028 0 Td (T )Tj 0.017 Tc 1.103 0 Td (lymphocyte )Tj 0.016 Tc 5.346 0 Td (subpopulations )Tj 0.0129 Tc 6.746 0 Td (block )Tj -0.0019 Tc -24.086 -1.105 Td (the )Tj 0.0182 Tc 1.6 0 Td (mixed )Tj 0.0202 Tc 3.001 0 Td (leucocyte )Tj 0.0175 Tc 4.366 0 Td (reaction )Tj -0.016 Tc 3.772 0 Td (in )Tj -0.0023 Tc 1.22 0 Td (man. )Tj /T1_3 1 Tf 0 Tc 8.6 0 0 8.6 434.32 576.36 Tm (J )Tj /T1_2 1 Tf -0.0097 Tc 9 0 0 9 442.39 576.36 Tm (Exp )Tj -0.0128 Tc 1.922 0 Td (Med, )Tj /T1_0 1 Tf 0.0071 Tc 8.7 0 0 8.7 482.34 576.36 Tm (1981, )Tj -0.0078 Tc 2.759 0 Td (153, )Tj 0.0304 Tc -24.607 -1.075 Td (193-198. )Tj -0.01 Tc 0 -1.076 TD (11. )Tj 0.0247 Tc 1.99 0 Td (Wood )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0021 Tc 8.7 0 0 8.7 336.1539 557.6463 Tm (GS, )Tj EMC ET BT /T1_0 1 Tf 0.0258 Tc 8.7 0 0 8.7 353.9715 557.6463 Tm (Warner )Tj 0.009 Tc 3.622 0 Td (NL, )Tj 0.0255 Tc 2.144 0 Td (Wranke )Tj -0.0041 Tc 3.833 0 Td (RA. )Tj 0.05 Tc 10.9235 0 0 8.7 456.35 557.65 Tm (-Anti )Tj 0.0158 Tc 8.7 0 0 8.7 486.19 557.65 Tm (Leu )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.7269 0 0 8.7 504.38 557.65 Tm (3{fu )Tj EMC ET BT /T1_0 1 Tf 0.0078 Tc 8.7 0 0 8.7 291.99 548.29 Tm (antibodies )Tj 0.0257 Tc 4.975 0 Td (react )Tj 0.0072 Tc 2.786 0 Td (with )Tj 0.0098 Tc 2.613 0 Td (cells )Tj 0.05 Tc 9.1816 0 0 8.7 405.27 548.29 Tm (of )Tj 0.022 Tc 8.7 0 0 8.7 419.26 548.29 Tm (monocyte/macrophage )Tj 0.0151 Tc 10.282 0 Td (and )Tj 0.0076 Tc -24.906 -1.077 Td (Langerhans )Tj 0.0078 Tc 5.184 0 Td (lineage. )Tj /T1_3 1 Tf 0 Tc 8.3 0 0 8.3 368.32 538.92 Tm (J )Tj /T1_2 1 Tf -0.007 Tc 9 0 0 9 375.93 538.92 Tm (Immunol, )Tj /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 414.18 538.92 Tm (1983, )Tj 0.0014 Tc 2.731 0 Td (131, )Tj 0.0386 Tc 2.18 0 Td (212-216. )Tj -0.0238 Tc -18.925 -1.076 Td (12. )Tj 0.0264 Tc 1.989 0 Td (Meeker )Tj 0.0176 Tc 3.941 0 Td (TC, )Tj 0.0215 Tc 2.431 0 Td (Miller )Tj -0.035 Tc 8.4671 0 0 8.7 394.76 529.56 Tm (R, )Tj 0.0188 Tc 8.7 0 0 8.7 406.51 529.56 Tm (Link )Tj 0.0026 Tc 2.732 0 Td (M, )Tj 0.0226 Tc 1.6 0 Td (Bind! )Tj -0.035 Tc 8.4585 0 0 8.7 471.79 529.56 Tm (J, )Tj 0.02 Tc 8.7 0 0 8.7 480.93 529.56 Tm (Warnke )Tj -0.0034 Tc 3.695 0 Td (R, )Tj 0.0094 Tc -25.463 -1.075 Td (Levy )Tj -0.0309 Tc 2.539 0 Td (R. )Tj 0 Tc 1.317 0 Td [(-)-642(A )]TJ 0.0182 Tc 2.107 0 Td (novel )Tj 0.0313 Tc 2.703 0 Td (human )Tj 0 Tc 3.279 0 Td (B )Tj 0.0201 Tc 1.1 0 Td (lymphocyte )Tj 0.013 Tc 5.349 0 Td (antigen )Tj 0.0171 Tc 3.449 0 Td (defined )Tj 0.0027 Tc 3.514 0 Td (by )Tj 0 Tc -25.336 -1.103 Td (a )Tj 0.0158 Tc 1.056 0 Td (monoclonal )Tj 0.0054 Tc 5.564 0 Td (antibody. )Tj 0.0196 Tc 4.475 0 Td (Manuscript )Tj 0.0116 Tc 5.403 0 Td (in )Tj 0.016 Tc 1.416 0 Td (preparation, )Tj 0.0288 Tc 5.622 0 Td (Berton )Tj 0.0127 Tc -23.559 -1.077 Td (Dickinson )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0202 Tc 8.7 0 0 8.7 331.9686 501.2415 Tm (Source )Tj EMC ET BT /T1_0 1 Tf 0.03 Tc 8.7 0 0 8.7 359.9304 501.2415 Tm (Book )Tj 0.0155 Tc 2.667 0 Td (section )Tj 0.0142 Tc 3.292 0 Td (4.32. )Tj -0.0238 Tc -13.768 -1.076 Td (13. )Tj 0.0136 Tc 1.989 0 Td (Brodsky )Tj -0.0251 Tc 3.862 0 Td (FM. )Tj 0 Tc 2.034 0 Td [(-)-614(A )]TJ -0.0019 Tc 2.078 0 Td (matrix )Tj -0.0014 Tc 3.054 0 Td (approach )Tj -0.035 Tc 8.4365 0 0 8.7 441.34 491.88 Tm (to )Tj 0.0106 Tc 8.7 0 0 8.7 450.95 491.88 Tm (human )Tj 0.0025 Tc 3.192 0 Td (class )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 6.7167 0 0 8.7 499.15 491.88 Tm (IT )Tj EMC /Suspect <>BDC /T1_1 1 Tf -0.0261 Tc 8.1 0 0 8.1 508.4 491.88 Tm (his)Tj 0.294 g 0 Tc 1.315 0 Td (\255)Tj EMC ET BT 0.141 g /T1_0 1 Tf 0.0017 Tc 8.7 0 0 8.7 291.58 482.53 Tm (tocompatibility )Tj -0.005 Tc 6.53 0 Td (antigens)Tj 0.294 g 0 Tc 3.378 0 Td (: )Tj 0.141 g 0.603 0 Td (r)Tj 0.294 g 0.0441 Tc 0.322 0 Td (ea)Tj 0.141 g -0.0042 Tc 0.939 0 Td (ctions )Tj 0.05 Tc 8.9033 0 0 8.7 417.99 482.53 Tm (of )Tj 0.227 g -0.0008 Tc 8.7 0 0 8.7 429.02 482.53 Tm (four )Tj 0.141 g 0.0036 Tc 2.051 0 Td (monoclonal )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0012 Tc 8.7 0 0 8.7 491.9123 482.53 Tm (antibod\255)Tj EMC ET BT /T1_0 1 Tf 0.0053 Tc 8.7 0 0 8.7 291.2903 473.1688 Tm (ies )Tj 0.0164 Tc 1.745 0 Td (with )Tj -0.0019 Tc 2.426 0 Td (the )Tj 0.0179 Tc 1.824 0 Td (products )Tj 0.05 Tc 8.9033 0 0 8.7 379.6 473.17 Tm (of )Tj 0.0163 Tc 8.7 0 0 8.7 392.39 473.17 Tm (nine )Tj 0.0129 Tc 2.4 0 Td (haplotypes)Tj 0.294 g 0 Tc 4.505 0 Td (. )Tj 0.141 g /T1_2 1 Tf -0.006 Tc 9 0 0 9 459.93 473.17 Tm (Immunogenetics, )Tj /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 291.78 463.33 Tm (1984, )Tj -0.0238 Tc 2.703 0 Td (19, )Tj 0.0343 Tc 1.683 0 Td (179-194. )Tj -0.0183 Tc -4.386 -1.048 Td (14)Tj 0.294 g 0 Tc 1.007 0 Td (. )Tj 0.141 g 0.0029 Tc 1.008 0 Td (Lampson )Tj -0.0109 Tc 4.138 0 Td (La, )Tj 0.0002 Tc 1.683 0 Td (Levy )Tj -0.0309 Tc 2.456 0 Td (R. )Tj 0 Tc 1.262 0 Td (-)Tj 0.0164 Tc 0.886 0 Td (Two )Tj 0.0036 Tc 2.271 0 Td (populations )Tj 0.05 Tc 8.9033 0 0 8.7 464.32 454.21 Tm (of )Tj 0.0143 Tc 8.7 0 0 8.7 474.65 454.21 Tm (la-like )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0048 Tc 8.7 0 0 8.7 500.6195 454.21 Tm (mole\255)Tj EMC ET BT /T1_0 1 Tf 0.0024 Tc 8.7 0 0 8.7 291.0365 444.6139 Tm (cules )Tj 0.0135 Tc 2.455 0 Td (on )Tj 0 Tc 1.406 0 Td (a )Tj 0.0106 Tc 0.809 0 Td (human )Tj 0.036 Tc 3.141 0 Td (B-cellline. )Tj /T1_3 1 Tf 0 Tc 8.6 0 0 8.6 401.92 444.61 Tm (J )Tj /T1_2 1 Tf -0.0156 Tc 9 0 0 9 409.54 444.61 Tm (/mmunol, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0067 Tc 8.7 0 0 8.7 446.82 444.61 Tm (1980, )Tj EMC ET BT /T1_0 1 Tf -0.017 Tc 8.7 0 0 8.7 470.1012 444.61 Tm (125, )Tj 0.0268 Tc 2.07 0 Td (293-299. )Tj -0.01 Tc -22.594 -1.077 Td (15. )Tj -0.0029 Tc 2.046 0 Td (Abo )Tj 0.0116 Tc 2.505 0 Td (T, )Tj 0.03 Tc 1.686 0 Td (Balch )Tj 0.0186 Tc 3.194 0 Td (CM. )Tj 0 Tc 2.62 0 Td [(-)-1028(A )]TJ 0.0162 Tc 2.871 0 Td (differentiation )Tj 0.0176 Tc 6.757 0 Td (antigen )Tj 0.05 Tc 9.1816 0 0 8.7 513.27 435.24 Tm (of )Tj 0.0175 Tc 8.7 0 0 8.7 291.11 426.12 Tm (human )Tj 0.0456 Tc 3.233 0 Td (NK )Tj 0.0013 Tc 1.971 0 Td (and )Tj 0 Tc 1.937 0 Td (K )Tj 0.0098 Tc 1.154 0 Td (cells )Tj 0.0149 Tc 2.374 0 Td (identified )Tj 0.0027 Tc 4.395 0 Td (by )Tj 0 Tc 1.506 0 Td (a )Tj 0.0189 Tc 0.863 0 Td (monoclonal )Tj 0.0104 Tc 5.399 0 Td (antibody )Tj 0.007 Tc -22.815 -1.102 Td (\(HNK-1\). )Tj /T1_3 1 Tf 0 Tc 8.6 0 0 8.6 329.2 416.53 Tm (J )Tj /T1_2 1 Tf 0.05 Tc 9.0866 0 0 9 337.1 416.53 Tm (lmmunol, )Tj /T1_0 1 Tf 0.0071 Tc 8.7 0 0 8.7 378.66 416.53 Tm (1981, )Tj -0.0078 Tc 2.731 0 Td (127, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 421.6206 416.53 Tm (1024. )Tj EMC ET BT /T1_0 1 Tf -0.0238 Tc 8.7 0 0 8.7 291.5382 407.4037 Tm (16. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0035 Tc 8.7 0 0 8.7 309.321 407.4037 Tm (Phillips )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 9.1671 0 0 9.6 341.23 407.4 Tm (JH, )Tj 0.0075 Tc 8.7 0 0 8.7 358.51 407.4 Tm (Le )Tj 8.6 0 0 8.6 372.7 407.4 Tm (Am, )Tj 0.0164 Tc 8.7 0 0 8.7 393.31 407.4 Tm (Lanier )Tj -0.0116 Tc 3.228 0 Td (LL. )Tj 0 Tc 2.036 0 Td (-)Tj 0.0158 Tc 1.092 0 Td (Natural )Tj 0.0091 Tc 3.69 0 Td (killer )Tj 0.0167 Tc 2.697 0 Td (cells )Tj -0.0007 Tc -24.47 -1.102 Td (activated )Tj 0.0116 Tc 3.975 0 Td (in )Tj 0 Tc 1.211 0 Td (a )Tj 0.0175 Tc 0.754 0 Td (human )Tj 0.0113 Tc 3.171 0 Td (mixed )Tj 0.0079 Tc 2.918 0 Td (lymphocyte )Tj 0.0128 Tc 5.138 0 Td (response )Tj 0.0055 Tc 3.964 0 Td (culture )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf -0.0058 Tc 8.7 0 0 8.7 502.9735 397.8126 Tm (iden\255)Tj EMC ET BT 0.141 g /T1_0 1 Tf 0.0039 Tc 8.7 0 0 8.7 291.1024 388.4514 Tm (tified )Tj 0.0303 Tc 2.541 0 Td (by )Tj 0.0208 Tc 1.423 0 Td (expression )Tj 0.05 Tc 8.9033 0 0 8.7 367.84 388.45 Tm (of )Tj 0.0156 Tc 8.7 0 0 8.7 378.91 388.45 Tm (Leu-12 )Tj -0.0125 Tc 3.416 0 Td (and )Tj 0.0163 Tc 1.822 0 Td (class )Tj 0.05 Tc 8.8979 0 0 8.7 445.38 388.45 Tm (II )Tj 0.0173 Tc 8.7 0 0 8.7 455.03 388.45 Tm (histocompatibility )Tj -0.0009 Tc -18.823 -1.076 Td (antigen. )Tj /T1_3 1 Tf 0 Tc 8.6 0 0 8.6 322.72 379.09 Tm (J )Tj /T1_2 1 Tf -0.023 Tc 9 0 0 9 330.55 379.09 Tm (Exp )Tj -0.0217 Tc 1.922 0 Td (Med, )Tj /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 370.02 379.09 Tm (1984, )Tj 0.0014 Tc 2.731 0 Td (159, )Tj 0.0043 Tc 2.175 0 Td (993. )Tj -0.01 Tc -13.926 -1.076 Td (17. )Tj 0.0238 Tc 1.988 0 Td (Bozelka )Tj 0.0202 Tc 3.807 0 Td (BE, )Tj 0.0123 Tc 2.013 0 Td (Jones )Tj -0.0179 Tc 2.76 0 Td (RN, )Tj 0.05 Tc 8.7805 0 0 8.7 401.68 369.73 Tm (de )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0119 Tc 8.7 0 0 8.7 414.08 369.73 Tm (Shazo )Tj EMC ET BT /T1_0 1 Tf 0.0488 Tc 8.7 0 0 8.7 439.6406 369.73 Tm (RD)Tj 0.294 g 0 Tc 1.474 0 Td (.)Tj 0.141 g 0.616 0 Td (-)Tj 0.0375 Tc 0.97 0 Td (Is )Tj -0.0019 Tc 1.246 0 Td (the )Tj 0.0215 Tc 1.649 0 Td (immune )Tj 0.0128 Tc -23.04 -1.048 Td (system )Tj 0 Tc 3.369 0 Td (a )Tj 0.0168 Tc 0.884 0 Td (contributing )Tj 0.0048 Tc 5.625 0 Td (factor )Tj -0.035 Tc 8.4365 0 0 8.7 402.22 360.61 Tm (to )Tj -0.0019 Tc 8.7 0 0 8.7 413.5 360.61 Tm (the )Tj 0.0182 Tc 1.686 0 Td (pathogenesis )Tj 0.05 Tc 9.1816 0 0 8.7 479.19 360.61 Tm (of )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0068 Tc 8.7 0 0 8.7 491.43 360.61 Tm (asbesto\255)Tj EMC ET BT /T1_0 1 Tf 0.0056 Tc 8.7 0 0 8.7 290.9994 351.0139 Tm (sis? )Tj -0.0024 Tc 1.943 0 Td (An )Tj 0.0106 Tc 1.62 0 Td (evaluation. )Tj /T1_2 1 Tf 0.0022 Tc 9 0 0 9 365.03 351.01 Tm (Sem )Tj -0.0152 Tc 2.116 0 Td (Resp )Tj -0.0306 Tc 2.296 0 Td (Med, )Tj /T1_0 1 Tf 0.0071 Tc 8.7 0 0 8.7 426.66 351.01 Tm (1984, )Tj 0.0014 Tc 2.697 0 Td (5, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0386 Tc 8.7 0 0 8.7 460.2768 351.01 Tm (289-299. )Tj EMC ET BT /T1_0 1 Tf -0.01 Tc 8.7 0 0 8.7 291.3054 341.8837 Tm (18. )Tj 0.0315 Tc 2.012 0 Td (de )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0119 Tc 8.7 0 0 8.7 320.7288 341.8837 Tm (Shazo )Tj EMC ET BT /T1_0 1 Tf -0.0179 Tc 8.7 0 0 8.7 346.2894 341.8837 Tm (RD. )Tj 0.0163 Tc 2.078 0 Td (Nordberg )Tj 0.0194 Tc 4.349 0 Td (BA, )Tj 0.0369 Tc 2.069 0 Td (Baser )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0267 Tc 8.7 0 0 8.7 444.7038 341.8837 Tm (Y, )Tj EMC ET BT /T1_0 1 Tf 0.033 Tc 8.7 0 0 8.7 456.4401 341.8837 Tm (Bozelka )Tj 0.0159 Tc 3.807 0 Td (B, )Tj 0.0198 Tc 1.325 0 Td (Weill )Tj -0.0229 Tc -24.167 -1.075 Td (H, )Tj 0.0117 Tc 1.421 0 Td (Salvaggio )Tj 0 Tc 9.3 0 0 9.3 342.67 332.53 Tm (J)Tj 0.294 g 0.372 0 Td (. )Tj 0.141 g 0.551 0 Td (-)Tj 0.0136 Tc 8.7 0 0 8.7 359.5 332.53 Tm (Analysis )Tj 0.05 Tc 9.1816 0 0 8.7 394.47 332.53 Tm (of )Tj 0.0155 Tc 8.7 0 0 8.7 405.28 332.53 Tm (depressed )Tj 0.0156 Tc 4.497 0 Td (cell-mediated )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0139 Tc 8.7 0 0 8.7 496.978 332.53 Tm (immu\255)Tj EMC ET BT /T1_0 1 Tf 0.0164 Tc 8.7 0 0 8.7 290.6401 323.1688 Tm (nity )Tj -0.016 Tc 2.09 0 Td (in )Tj 0.0106 Tc 1.239 0 Td (asbestos )Tj 0.0054 Tc 3.926 0 Td (workers. )Tj /T1_3 1 Tf 0 Tc 8.3 0 0 8.3 388.24 323.17 Tm (J )Tj /T1_2 1 Tf 0.0087 Tc 9 0 0 9 396.38 323.17 Tm (Allergy )Tj 0.0075 Tc 3.431 0 Td (Clin )Tj -0.007 Tc 2.163 0 Td (Immunol, )Tj /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 485.7 323.17 Tm (1983, )Tj -0.0058 Tc 2.7 0 Td (75, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 8.4974 0 0 8.7 290.61 313.56 Tm (41&--424. )Tj EMC ET BT /T1_0 1 Tf -0.01 Tc 8.7 0 0 8.7 291.06 304.21 Tm (19. )Tj 0.0244 Tc 2.016 0 Td (Kagan )Tj 0.008 Tc 3.309 0 Td (E, )Tj 0.0304 Tc 1.52 0 Td (Webster )Tj 0.011 Tc 4.079 0 Td (I, )Tj 0.0198 Tc 1.266 0 Td (Cochrane )Tj -0.0002 Tc 4.612 0 Td (JC, )Tj 0.027 Tc 1.96 0 Td (Miller )Tj -0.0043 Tc 3.228 0 Td (K. )Tj 0 Tc 1.593 0 Td (-)Tj 0.0317 Tc 1.162 0 Td (The )Tj 0.0166 Tc -24.772 -1.048 Td (immunology )Tj 0.05 Tc 9.1816 0 0 8.7 340.47 295.09 Tm (of )Tj 0.0096 Tc 8.7 0 0 8.7 351.99 295.09 Tm (asbestosis. )Tj /T1_2 1 Tf -0.035 Tc 8.5143 0 0 9 393.68 295.09 Tm (In: )Tj /T1_0 1 Tf 0.0273 Tc 8.7 0 0 8.7 407.46 295.09 Tm (Inhaled )Tj 0.0174 Tc 3.539 0 Td (particles. )Tj 0.05 Tc 8.7103 0 0 8.7 475.17 295.09 Tm (WH )Tj 0.0202 Tc 8.7 0 0 8.7 493.89 295.09 Tm (Walton )Tj 0.0147 Tc -23.372 -1.103 Td (ed)Tj 0.294 g 0 Tc 1.01 0 Td (. )Tj ET BT /Suspect <>BDC 0.141 g /T1_0 1 Tf 0.0145 Tc 8.7 0 0 8.7 305.0043 285.4939 Tm (Pergamon )Tj EMC /Suspect <>BDC 0.0005 Tc 4.607 0 Td (Press)Tj 0.294 g 0 Tc 2.168 0 Td (, )Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 370.0281 285.4939 Tm (1977, )Tj 0.141 g 2.656 0 Td (pp. )Tj 0.0402 Tc 1.677 0 Td (429-433)Tj 0.294 g 0 Tc 3.68 0 Td (. )Tj ET BT /Suspect <>BDC 0.141 g /T1_0 1 Tf -0.0087 Tc 8.7 0 0 8.7 290.5884 276.124 Tm (20. )Tj EMC ET BT /T1_0 1 Tf -0.0037 Tc 8.7 0 0 8.7 308.841 276.124 Tm (Kang )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0183 Tc 8.7 0 0 8.7 332.6007 276.124 Tm (KY, )Tj EMC /Suspect <>BDC 0.0267 Tc 2.221 0 Td (Sera )Tj EMC /Suspect <>BDC -0.0267 Tc 2.333 0 Td (Y, )Tj EMC /Suspect <>BDC 0.0174 Tc 1.482 0 Td (Okochi )Tj EMC ET BT /T1_0 1 Tf 0.0392 Tc 8.7 0 0 8.7 415.3725 276.124 Tm (T, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0252 Tc 8.7 0 0 8.7 427.9005 276.124 Tm (Yamamura )Tj EMC /Suspect <>BDC 0 Tc 5.159 0 Td (Y)Tj 0.376 g 0.726 0 Td (. )Tj EMC ET BT 0.141 g /T1_0 1 Tf 8.7 0 0 8.7 484.9377 276.124 Tm [(-)-664(T )]TJ ET BT /Suspect <>BDC /T1_0 1 Tf 0.0106 Tc 8.7 0 0 8.7 503.4513 276.124 Tm (lym\255)Tj EMC ET BT /T1_0 1 Tf 0.0101 Tc 8.7 0 0 8.7 290.4144 267.0151 Tm (phocytes )Tj 0.0116 Tc 4.046 0 Td (in )Tj 0.227 g 0.0069 Tc 1.211 0 Td (asbestosis. )Tj 0.141 g /T1_2 1 Tf -0.0258 Tc 9 0 0 9 377.6 267.01 Tm (New )Tj -0.0111 Tc 2.186 0 Td (Engl )Tj 0 Tc 9.6 0 0 9.6 417.22 267.01 Tm (J )Tj -0.0306 Tc 9 0 0 9 424.65 267.01 Tm (Med, )Tj /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 446.82 267.01 Tm (1974, )Tj 0.227 g -0.0069 Tc 2.677 0 Td (291, )Tj 0.141 g 0.0079 Tc 2.147 0 Td (735-736. )Tj 0.0051 Tc -22.782 -1.105 Td (21. )Tj 0.0215 Tc 2.064 0 Td (Gaumer )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0251 Tc 8.7 0 0 8.7 344.1165 257.3965 Tm (HR)Tj 0.294 g 0 Tc 1.451 0 Td (, )Tj EMC ET BT 0.141 g /T1_0 1 Tf 8.7 0 0 8.7 365.2401 257.3965 Tm (D)Tj 0.294 g 0.713 0 Td (o)Tj 0.141 g -0.035 Tc 8.5757 0 0 8.7 376.01 257.4 Tm (ll )Tj -0.0047 Tc 8.7 0 0 8.7 387.4 257.4 Tm (NJ, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.012 Tc 8.7 0 0 8.7 406.1572 257.4 Tm (Scuyler )Tj EMC ET BT /T1_0 1 Tf 0.0026 Tc 8.7 0 0 8.7 439.3999 257.4 Tm (M, )Tj 0.0117 Tc 1.972 0 Td (Salvaggio )Tj 0.0177 Tc 4.839 0 Td (IE. )Tj 0 Tc 1.982 0 Td (-)Tj 0.0172 Tc -25.897 -1.075 Td (Diminished )Tj 0.0212 Tc 5.343 0 Td (suppressor )Tj 0.014 Tc 4.998 0 Td (cell )Tj 0.0102 Tc 2.039 0 Td (function )Tj 0.0116 Tc 4.003 0 Td (in )Tj 0.0147 Tc 1.333 0 Td (patients )Tj 0.0072 Tc 3.805 0 Td (with )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0049 Tc 8.7 0 0 8.7 498.3859 248.0475 Tm (asbes\255)Tj EMC ET BT /T1_0 1 Tf -0.0021 Tc 8.7 0 0 8.7 290.6125 238.4514 Tm (tosis. )Tj /T1_2 1 Tf -0.0013 Tc 9 0 0 9 312.3 238.45 Tm (Clin )Tj -0.035 Tc 8.9842 0 0 9 331.51 238.45 Tm (Exp )Tj -0.007 Tc 9 0 0 9 348.81 238.45 Tm (Immunol, )Tj /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 387.3 238.45 Tm (1981, )Tj 0.0033 Tc 2.651 0 Td (44, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0343 Tc 8.7 0 0 8.7 425.7018 238.45 Tm (108-116. )Tj EMC ET BT /T1_0 1 Tf -0.0087 Tc 8.7 0 0 8.7 290.5908 229.3324 Tm (22. )Tj 0.0215 Tc 2.043 0 Td (Miller )Tj 0.0013 Tc 3.061 0 Td (LG, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.016 Tc 8.7 0 0 8.7 353.1264 229.3324 Tm (Sparrow )Tj EMC ET BT /T1_0 1 Tf -0.0175 Tc 8.7 0 0 8.7 387.5697 229.3324 Tm (D, )Tj 0.0137 Tc 1.429 0 Td (Ginns )Tj -0.012 Tc 2.956 0 Td (LC. )Tj 0 Tc 1.98 0 Td (-)Tj 0.0133 Tc 0.975 0 Td (Asbestos )Tj 0.0115 Tc 4.213 0 Td (exposure )Tj 0.0124 Tc -22.702 -1.103 Td (correlates )Tj 0.0164 Tc 4.56 0 Td (with )Tj 0.01 Tc 2.418 0 Td (alterations )Tj 0.0391 Tc 4.857 0 Td (in )Tj -0.0019 Tc 1.385 0 Td (the )Tj 0.0136 Tc 1.786 0 Td (circulating )Tj 0 Tc 4.939 0 Td (T )Tj 0.0232 Tc 1.213 0 Td (cell )Tj 0.0008 Tc 2.064 0 Td (subsets. )Tj /T1_2 1 Tf -0.0013 Tc 9 0 0 9 290.46 210.37 Tm (Clin )Tj -0.023 Tc 2.108 0 Td (Exp )Tj -0.0004 Tc 1.897 0 Td (/mmunol, )Tj /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 364.98 210.37 Tm (1983, )Tj -0.001 Tc 2.697 0 Td (51, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0304 Tc 8.7 0 0 8.7 403.6254 210.37 Tm (110-116. )Tj EMC ET BT /T1_0 1 Tf 0.0051 Tc 8.7 0 0 8.7 290.3514 201.2524 Tm (23. )Tj 0.0315 Tc 2.066 0 Td (de )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0119 Tc 8.7 0 0 8.7 322.4022 201.2524 Tm (Shazo )Tj EMC ET BT /T1_0 1 Tf -0.0036 Tc 8.7 0 0 8.7 349.8855 201.2524 Tm (RB, )Tj 0.0182 Tc 2.262 0 Td (Hendrich )Tj 0.0263 Tc 4.471 0 Td (AI, )Tj 0.0291 Tc 2.039 0 Td (Diem )Tj 0.0315 Tc 2.922 0 Td (IE, )Tj 0.0163 Tc 1.915 0 Td (Nordberg )Tj -0.0144 Tc 4.569 0 Td (JA, )Tj 0.0369 Tc -25.047 -1.077 Td (Baser )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0267 Tc 8.7 0 0 8.7 314.868 191.8825 Tm (Y, )Tj EMC ET BT /T1_0 1 Tf 0.0347 Tc 8.7 0 0 8.7 327.0915 191.8825 Tm (Bevier )Tj 0.0101 Tc 3.255 0 Td (D, )Tj 0.0123 Tc 1.461 0 Td (Jones )Tj -0.0179 Tc 2.815 0 Td (RN, )Tj 0.0323 Tc 2.069 0 Td (Barkman )Tj 0.0136 Tc 4.303 0 Td (HW, )Tj 0.0117 Tc 2.441 0 Td (Salvaggio )Tj 0.0315 Tc 4.563 0 Td (IE, )Tj 0.006 Tc -25.155 -1.075 Td (Weill )Tj 0.05 Tc 11.8808 0 0 8.7 313.38 182.53 Tm (H.-)Tj 0.0176 Tc 8.7 0 0 8.7 332.82 182.53 Tm (Immunologic )Tj 0.007 Tc 5.955 0 Td (aberrations )Tj 0.0116 Tc 4.94 0 Td (in )Tj 0.0067 Tc 1.184 0 Td (asbestos )Tj 0.0233 Tc 3.753 0 Td (cement )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0097 Tc 8.7 0 0 8.7 499.9122 182.53 Tm (work\255)Tj EMC ET BT /T1_0 1 Tf -0.0051 Tc 8.7 0 0 8.7 290.3118 172.9165 Tm (ers: )Tj 0.0159 Tc 2.098 0 Td (dissociation )Tj -0.0012 Tc 5.598 0 Td (from )Tj 0.0096 Tc 2.649 0 Td (asbestosis. )Tj /T1_3 1 Tf 0 Tc 8.6 0 0 8.6 423.28 172.92 Tm (J )Tj /T1_2 1 Tf 0.0132 Tc 9 0 0 9 432.86 172.92 Tm (Allergy )Tj 0.0075 Tc 3.564 0 Td (Clin )Tj -0.007 Tc 2.323 0 Td (Immunol, )Tj /T1_0 1 Tf -0.0067 Tc 8.7 0 0 8.7 290.82 163.09 Tm (1983, )Tj 0.0218 Tc 2.617 0 Td (72, )Tj 0.046 Tc 1.661 0 Td (454-461. )Tj 0.0051 Tc -4.36 -1.021 Td (24. )Tj 0.227 g 0.0066 Tc 2.124 0 Td (Lange )Tj 0.141 g -0.035 Tc 8.5053 0 0 8.7 336.47 154.21 Tm (A. )Tj 0 Tc 8.7 0 0 8.7 350.54 154.21 Tm (-)Tj -0.0024 Tc 1.251 0 Td (An )Tj 0.227 g 0.0167 Tc 1.895 0 Td (epidemiological )Tj 0.0183 Tc 7.362 0 Td (survey )Tj 0.141 g 0.05 Tc 8.9033 0 0 8.7 471.76 154.21 Tm (of )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0147 Tc 8.7 0 0 8.7 484.73 154.21 Tm (immunol\255)Tj EMC ET BT /T1_0 1 Tf 0.0071 Tc 8.7 0 0 8.7 290.0762 144.8488 Tm (ogical )Tj 0.227 g 0.0077 Tc 3.006 0 Td (abnormalities )Tj 0.141 g -0.035 Tc 8.5969 0 0 8.7 369.05 144.85 Tm (in )Tj 0.227 g 0.0106 Tc 8.7 0 0 8.7 379.59 144.85 Tm (asbestos )Tj 0.141 g 0.0112 Tc 3.871 0 Td (workers)Tj 0.294 g 0 Tc 3.401 0 Td (. )Tj 0.227 g 0.0045 Tc 0.593 0 Td (II. )Tj ET BT /Suspect <>BDC 0.141 g /T1_0 1 Tf 0.0185 Tc 8.7 0 0 8.7 460.152 144.85 Tm (Serum )Tj EMC /Suspect <>BDC 0.0127 Tc 3.128 0 Td (immuno\255)Tj EMC ET BT /T1_0 1 Tf 0.0149 Tc 8.7 0 0 8.7 290.0844 135.4888 Tm (globulin )Tj 0.0117 Tc 3.834 0 Td (levels)Tj 0.376 g 0 Tc 2.47 0 Td (. )Tj 0.227 g /T1_2 1 Tf -0.0009 Tc 9 0 0 9 350.47 135.49 Tm (Environ )Tj 0.141 g -0.0101 Tc 3.6 0 Td (Re)Tj 0.294 g 0 Tc 1.062 0 Td (s)Tj 0.141 g 0.453 0 Td (, )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf 0.0071 Tc 8.7 0 0 8.7 401.94 135.49 Tm (1980, )Tj EMC ET BT 0.141 g /T1_0 1 Tf -0.0224 Tc 8.7 0 0 8.7 425.4735 135.49 Tm (22, )Tj 0.0264 Tc 1.764 0 Td (176-183. )Tj 0.0051 Tc -17.323 -1.077 Td (25. )Tj -0.0164 Tc 2.125 0 Td (Doll )Tj -0.035 Tc 8.0557 0 0 8.9 327.8 126.12 Tm (J, )Tj -0.0077 Tc 8.7 0 0 8.7 337.64 126.12 Tm (Diem )Tj 0.0315 Tc 2.674 0 Td (IE, )Tj 0.0123 Tc 1.739 0 Td (Jones )Tj -0.0316 Tc 2.76 0 Td (RN, )Tj 0.0111 Tc 2.124 0 Td (Rodriguez )Tj -0.035 Tc 8.5601 0 0 8.7 459.56 126.12 Tm (M, )Tj 0.0192 Tc 8.7 0 0 8.7 473.24 126.12 Tm (Bozelka )Tj 0.0064 Tc 3.807 0 Td (BE, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0116 Tc 8.7 0 0 8.7 290.0006 116.7588 Tm (Stankus )Tj EMC /Suspect <>BDC -0.0176 Tc 3.683 0 Td (RP, )Tj EMC ET BT /T1_0 1 Tf 0.0198 Tc 8.7 0 0 8.7 338.6162 116.7588 Tm (Weill )Tj -0.0229 Tc 2.757 0 Td (H, )Tj 0.0186 Tc 1.393 0 Td (Salvaggio )Tj 0.0177 Tc 4.591 0 Td (IE. )Tj 0.05 Tc 9.575 0 0 8.7 429.01 116.76 Tm (-Humoral )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0095 Tc 8.7 0 0 8.7 473.45 116.76 Tm (immunologi\255)Tj EMC ET BT /T1_0 1 Tf 0.0078 Tc 8.7 0 0 8.7 289.8365 107.1639 Tm (cal )Tj 0.0077 Tc 1.599 0 Td (abnormalities )Tj 0.0391 Tc 5.961 0 Td (in )Tj 0.0066 Tc 1.221 0 Td (workers )Tj 0.0184 Tc 3.66 0 Td (exposed )Tj -0.035 Tc 8.4365 0 0 8.7 431.26 107.16 Tm (to )Tj 0.0027 Tc 8.7 0 0 8.7 441.27 107.16 Tm (asbestos )Tj 0.0122 Tc 3.78 0 Td (cement )Tj -0.0078 Tc 3.31 0 Td (dust. )Tj /T1_3 1 Tf 0 Tc 8.6 0 0 8.6 289.36 97.56 Tm (J )Tj /T1_2 1 Tf -0.0002 Tc 9 0 0 9 297.02 97.56 Tm (Allergy )Tj 0.0075 Tc 3.324 0 Td (Clin )Tj -0.007 Tc 2.137 0 Td (Immunol, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0071 Tc 8.7 0 0 8.7 384.42 97.56 Tm (1980, )Tj EMC ET BT /T1_0 1 Tf 0.0003 Tc 8.7 0 0 8.7 407.9013 97.56 Tm (39, )Tj 0.0343 Tc 1.743 0 Td (176-182. )Tj 0.0051 Tc -15.309 -1.076 Td (26. )Tj 0.0184 Tc 2.098 0 Td (Huuskonen )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0129 Tc 8.7 0 0 8.7 354.4485 88.1988 Tm (MS, )Tj EMC /Suspect <>BDC -0.0299 Tc 2.372 0 Td (Rasii.nen )Tj EMC ET BT /T1_0 1 Tf -0.0144 Tc 8.7 0 0 8.7 411.0768 88.1988 Tm (JA, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0262 Tc 8.7 0 0 8.7 428.6073 88.1988 Tm (Hii.rkonen )Tj EMC ET BT /T1_0 1 Tf -0.0229 Tc 8.7 0 0 8.7 469.4103 88.1988 Tm (H, )Tj 0.0112 Tc 1.63 0 Td (Asp )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0266 Tc 8.7 0 0 8.7 503.1315 88.1988 Tm (S. )Tj EMC ET BT /T1_0 1 Tf 0 Tc 8.7 0 0 8.7 514.9548 88.1988 Tm (-)Tj 0.0133 Tc -25.867 -1.076 Td (Asbestos )Tj 0.0234 Tc 4.157 0 Td (exposure )Tj -0.0209 Tc 4.276 0 Td (as )Tj 0 Tc 1.324 0 Td (a )Tj 0.0298 Tc 0.884 0 Td (cause )Tj 0.05 Tc 9.4598 0 0 8.7 406.71 78.84 Tm (of )Tj 0.0192 Tc 8.7 0 0 8.7 418.49 78.84 Tm (immunological )Tj 0.0074 Tc 6.753 0 Td (stimulation. )Tj /T1_2 1 Tf 0.0066 Tc 9 0 0 9 289.43 69.24 Tm (Scand )Tj 0 Tc 9.6 0 0 9.6 314.74 69.24 Tm (J )Tj 0.0123 Tc 9 0 0 9 322.15 69.24 Tm (Respir )Tj -0.005 Tc 3.016 0 Td (Dis, )Tj /T1_0 1 Tf 0.0002 Tc 8.7 0 0 8.7 368.1 69.24 Tm (1978, )Tj -0.001 Tc 2.697 0 Td (59, )Tj 0.0412 Tc 1.685 0 Td (326-332. )Tj ET endstream endobj 11 0 obj <>/Filter/JBIG2Decode/Height 3505/ImageMask true/Length 38603/Name/X/Subtype/Image/Type/XObject/Width 2480>>stream ae T.!kHu 9+ըuekU;12;|sVkiAf!=DvE*Bya 淬O?W[63#gDq%"U^@":&imv&}#RF/oQ]-{9[,ԏNXO3M.LLvd#DҴò"`wHJ{C" 1)n2u==1[J5]\֮Ұ7KK۽Ap0_d#}WG8_0fo0&αwQL9嬞Uy\2ͺww]3݄Zl<[U_̯g9SRH3UnxR߲+m~å0[,ʒD3Gɘ/wWKڎP$fCqe]*?tֺЮ> *xrz-7nQ[B+i\dR|&YwJ@E٥Rq?;jRmCnń.8U6,-hf'|9h ſh)%4Fq7݈VP糬c{5*NK@@h䥗0#XcX|/N9(p9=Dk9P2R#Q Nc/r9=w7|2:0NҮ {6)M͗~nw98D)HğbU nZPvu yڂ;HDD C2rmQܨ3燡ֵB[m#[Ȣe:䅻jཝ~.ﲌ/sTx~XT> ⏶JQ;&1ra C;-JnrhbBڊN="rܣ{^ƺ&,-1 ?R[gj\tG_q_1;^1.4_@BY2P[Q';'xpCImG~YtNO0ن2} H,}[֮sK.5*3ԓ'Ml+K6@ |T܋uF~tcg_W]q$Yx N$xZl; V =YR|h]X[sATB"Ec]UV'w7qhb T^1C/D`7pNb HVt1jlhr8+nR}ܒ+JF`"b9U7"y~V@_5E{.YJO r/ea|K 8R }."+|o+ec7҇ j?e CO8ۑ҂~rXx˙S g zJ&UH|h9ܱ@t_t.򢈹`I(tR1] PsWh}\lG~ /QiMISxbAU -.l mrejA ƲYȒ*dÇv׆VS6MgfYVhLh&HZt:^M*M_Ho+$Ǯ/sWn-o@Ph6l*]1ó^t ]D}Aߩ**/u:Oϰ*m*^Kc8M?3! !L`Sɶ+WXmџQf(͙&RP>ʸo櫹Zp\(~2?VBؔ35#!֝:e^ʿQ`R[Y}h]5;vuR:KsPkuFehUP%wuᦸ{#z( f5U-ıxo4>YY<;8)L5 כ ٦:l%=qGD/Q?c2>uwzU,5ڶw:ޚ.h6ʢ~yfYxLlrl2nmQe= TiG`i+^57?'n)^*]-NjC0#-Fi9N-H}Cot&yC>9{ Q?mΗ12MM3D,d8:o+>,[Fe H2F)䬆ՕU4"xfjK1&\ $"%jj!2|ml{nMpm jWo ra̦>ĮhŎF[}s8T-ϜPAbkwMM~E[[bFi8^`No Q fI k|n/0T% % g=PʁOf3s<'Ey,PFy١瓤[ KHvq[prk_P}{ͳA5K ==%ZtHO3QVk_}CD|\&}J&óEv.YdGghRGsE9WMX"~ 4݃INUe Fkx,3@ulҝξ@š#qvK)KjM Lƀ$RDtv] Kb OSHlP]yAQո$ѐdΑ|ZdPZ ?>COv\EV7S?Jr?A/JrO﵉fk [i>7W63FUWpB\}~1Ǹ+LkU§Neޯm2G⿋2 ca>$uΕ`T]od6GXVݸ^0*҆T+.)ǹon1w ⽏%NdJRȲ/[ ATet[Qnb,UHȸTH,tŨL) dN/wz'!k/ùTmRXHvL8AǗt1̃$F@<ߕ(}8Q$̖ O?ݑN.Kb劵AATa l9f?r2WE 86 <N ' E]6,zєHq P)?o~?@ne9WV}_mM"\Z[j/aЖ:65U?K^mjCL)͛JObn- D'E/|miqVwPuЬJ@*7z?p7i`nqA`70w-Mn|(jXTkͪ_I)]Пռ!}&b^l<L3hN֢"$h]t5VldL߆G;36x*-"0}u{v"-b.ѻ8Z{gh:us,;Sz][Ĭ fK }NU7+t3&]=*o4UuB_eI)D_In# 1^{Y,KR[hpn1kOe_]fCAJ0k@zM + ZhYJ@RE }<)9{KETv?6Zm'Z7>%.5(ATY{PGzn `R-ᰲai9! M,I5"Fk^x3덡6*C23a[E* V5PEO9_y@[66~2 ܫ'pm+ewLF֍] 7Ei: F写%dž5IN4y,C4Rc-\t 2ުTR/g/ԕ^tq,mkkfQ#pO`<ho,"}׿NlXruP*V&M&F*M1!tjQ:!e"jZ>"oaԓo=<\~ipֿzf+7[^DIb_to?rZwH^}D}W"GV]vO. ',ZFLH $+0 =!ڟ\[9vJE@ݤ;DDyRGYy:͑l8b: rc7|؛Ǎ+U#:韼U '?|<7 cG2CJ"͸Uìbm-iA:- {ހ+㟼I>vMXQ{D``tT-`5'CIcDsw%o>e];'E&)m0C IVP>\JYq %Q~o'qe&=npB9= +(0g;P¡.$b`r-Mͥ-U($ TwHg>O*6`hj3wWO5SL tA;\R3K9I tr..:ۀ&I=?^A oqn1@rkez<794&C]7uo{|MhzyxLm Ga|}\Pv?bwkQـ1 }[lb&C1mcN0Xl Ѡ"1fOiqΎ 0]:}`}1ojRsmZ0N$$?>h̞0u&`-S.wlC(;"tNX<+j%($=?<(;s!6(srve$97ʄ^ 0<ݟh "J"UiaY^(Zu/q UnY\PkP*{>.ZKŋn+ن!6ڷE}zqYU 8Eo.,> y2)66*ܻdGQ0D?,yj1 DR@*As 2R$>fxtŋJ4/ޥ΋!v NA 5Ճg}6"s_C{28P H;η`xssX y񁣌UoF $@m` G zP#3$҄u8Jb&[W#vڪoqU>݊k+n\"ej:FkGUt-}w/G0KW* "nע'R ]pvC=Oh ^=N+EA\Jj,DoMYUiTI28`ɧv[\Hus rr ~%+ܭe8}t0x#Pgֹ1ƱcBvhxbT&@4C_9Z8_(bO9*"1~ôQPr⇋ƓSL\ Ûo>ɶ;a2+89ۓЛESbuk SپPg'/.IAk-ƨeCbu:r vEŠIF8udÆoC Qp*Gg+ĵ\Y[W~s{ͨ׎.I־2LĪ̸"nm8ڀ:ɻYHӈP8Xsw̶T5}_<ô֡7.mBlAuSLGul98v+4R]csQmuЁ0Zi-۞OC4ezv TcJhJLNv$Bf{|GlalꎿD,`ٛR-*jYqwYq's[/^d>ώπ\t-M)8mzqvΦ%3 4Wub}Obh4'~B]EȮ vCԠ ϩQ}v]ymRKi@E`{W6}CϞ8ψ FRSi}řj*8#Y.Q ,N,&΃Sa4yWT*D\c#|\E ŐpnaVa\PN[TpPp}#-f.3DBԟ,p:l86;h䦾_ǣ|X)Pz*EsS;pqfW9ݝhGnwJS@jZ{۱A0FP!!nt4-(( ٿy:UKWަe=I!p | E`i"4З/; QӣRtyFXїfK'rֺad $j۲g+(&gE:Ùa Æ˪tU3΄,mS"ݻ'+e?'pޣ\˟HIm2>~m'=|p9el71&AY@Io] *T@0P4-[Px0tRi:g75lz%|IQ]#KyKLA2jP͈S<riYp7L>k]}k<O-x 8:*Ȝj[%gKAqH3}ȉq3+Rۙ!q?sF L5*0!|a-%)c*QQls cv`o#wXq,z{5ѮAx[`:]9[G×^Q&ZWmޏ .jszy,]Z@f.0/8s&e1Ͳ?6bӗ7E"*<7mP AQboګ64;iKŋ3`D1i7; 9B&a>6Ek UB.{p?nC5n@C|NY'.%3CK2e`m>8kϏ_#bϙ v>zL1+,v %6(5qdȼ$wBTLbfMUi2&l^5|\ڰҭnUA(3wzqPJ g0i*vD7}F ~0")thٌJDlϱb!Mgm>W- r-Zymbn7l*w9#$c35"7]A͵+W2|@VN;{~Pp g![HekOtBD(ś6_u^ .pfIxSϫƆճM;dUSwl\cr#t+_FBA ྑ˄ `Ͳr\k#)Y{IAiR.ޤ?*hI_K[/94$j?*RZˏW`E^%<0o5J,ڣc_ْcvZ;"|_<[ppȫS/TC" ;lm铹d; 7Kde!4'za3}oK,q)v?S\ciXB0 ri"47DPEIRzϖ~Hlϕ/h+K׈56$?'HAr^:2|2#"\G ,Jmd'ke@QO5S31&o.|vj!7=c;1dEA㾋4a=[TPy~7Ec.#vhZs\y Gu‡QXQfpH ͢jG@{:2w=ol&ڑ\E) 2h5aox`(տ\3p>#b`v_!UvzlmH~n60 ʆ!Jsgtz< |ޙƚ|m=C4cB:5ΣdZfȚ,u*cDžaw6 :ɀyL'Ś#oX k/h2VPK=Gª8^7IHO<*XU&p:/mW 2GH#E,^rbUFBί76ᆃw,4o8˱ɑV4R 'rp,A#ĩ/m$ޣIXo4fe2{gfh_%I+ ңX]qdGm+!+oBIÉ1Pg6`DJ w'&i#HdGC5k* ZSIc4NeaF1M[1l}Wr{I{tV#€d 6?օ`IyŦUIf@ӉQɸo.U,"ƗQW'=8ݪƍVdr9u:nRNcֈ6˙4QӸmY2d1ud&pۢG/Ajt}jųҴCj-(;B[`|3FWO1cj.x| (nϿ?@KeE>j529Xt5d jWO)QJ+rƤGץ0\gY8ch?SiA#>Q @]Xp0]o)B'sM V!V+|K鄡$dZvߖ-y0n-^ߐxS?L1)H}ͣWiUFq#[u`3 7v{W: O v㺣UכRˁS$9OhA0<(!:^4+Ʈ*}+QFk}/ $ Kn1m^#%WS+t8Erv `ֱ,CKiM!o^h5zB޷ԱNψh.{'Q0Z̵Ɩ}Z%~Ah{Fx! }j#2b _)m wݿ"wxј3߹`d HoQGd~?.1@r}#}i{$hgʞOV~)BrbYg;~f[ R}}}ǕA:$ -D0D|gF6־ǥ 9aks f+ўЅeʉf52 <Ӌ5\):՜ H=8I*J($نVW3)tveZZWVsMF7[$]8 0$s?±AD?8}\줳2I[!Z#8iG }<˜K Hmx-NVXpA2ѱ uj`:jbԤ t%0dZ1YpQF"ˀi%SZL׎qP{Tfvږ=NnJ0\}KU8WlEw9( 섗H1x::~fص ocnʹ nl% 2AA@"B8k;-FOLBTdFCdU* rFd^fzŒ7QH߷]}8 !̓?/cT@)P-A;?FM(~?sVct9."b&(6j]B.p /qkhGBo۰݁.l.sWL\%D@`LNZ'c]"4onD]_v~Q3Lm:W.z3L1X03n]()v~MOnD1CdNiQ&( +g`nkV yvf(_N^^ꀲBR2Mv ^O߃\uMk73ǵB/}%e{ \P4۹Fx0\mHsL$з~bd(XRlOdV`؅ӶJp#S\e2JzSV c!;sf9 i,Ozywk#[/]`8b\O Y+XEb  @~dd#sp򃔒aj611LUhL i ۟ S!;ӵKD|/;^'<xo'm31H9)G wcO'S-fm}DbpS(}KG"۹^p ڻ-$brl:CbZhd?QaF*a]ͳG_Sw0I;}+Fx Q.p+_>@|O8RЬDqnrf`TewljPT!1aQ(dcJXs%Qտ%FD:2"qvX8P]@0s/y)hY=~Tz"10dE\-L;![ 2 p yZL7¯^<v{j_Jӝ$Anth#Ams@n4trӔR`}@m|BR6>{iO8D $|@("X@}@rI?OJ' BL`Wq,|z!c:ף4h {7+%: ӮgjK([eTk8-RӒ6RU,  )j yhG77:35ӝ>Rc^e rR<%%)9 mx.NSƄUַV.^bt+1Dy vs≸Ҝ-@MӺ"rFjrQ힏@Q4swu/%wICM.̫92"V7@[m' 8-zg%@K fCi1|k(g?{ z-A(! X6 RrC&EMjʺPO+>aZZF݄ZhD~Pjz2tz190IcRP<>x|:RAV4}>kA 49gOW:TPJ 5ѧM"<ĨB>^ mNzj%pG9ЧbQ.6ʆm)>J2fϋ{ۉJ?T&HV%Ȇ~jF䇎ތ8z֖hQ'uWWrXzժzJ@nxi ~ʒ#"k1{/ѻ}N4Tk:uT1TD[buSeiiEͶQѽZzz~v?b%_(5i ^T~sPBb)Hgo앾l48VWD9' P|JЛ[$c*[eRBRCUIeDGڭӴ/AV}ᬍ3P Sn\Ъ-ŐFn틇Ѕ[;>}u;{@9 =M_NK1y@G:%BW<j'̝yG}y|X98(ܸYR@JhEW\ UW/FxX'= ~d2'@rR6Xo46[x{!1&f-Y]L,2f2ՃCi#q-}/.R*)ԛa5yf}tٶɨy}pB|źZÀUd|Iט,\%Cb|DT ŗ?6n;={}G,gdU :'*w.l0-T@*ξ|I0L9ijZxi4~*V飯RA~] QapV8nQqؑw^~j'}ޡ2/~mmLaP D 8k5֢TAkkYJ|6z*QUVrM3_U@?!5B:BZ|nUȃ*sU(15c+(k)$dL^TS"5͒T32U磆ͻ0~Y?x)zDX}3ؤN{%W}*=闸;+Pas3jsFdFFdἝ )hfm+C0k}³f콈. GIbkCUxdC!j8[+ -u_1}0a OΰiL;6DվW/`Vۅjt}m\Ǻ,v R;-lt?Ԯ,RȮ-\Dq迮Sw")f$Fnc"ZA9+4% mOVB]]^GtF.YA2k;~Pt&!ڲjR>X[F0:&ٗoۭOE閾+ҢHq'I@-;4 nKplki'k8=Y \9z۪Z-vf <W>UMbf!rFxk6/OO?YG\ hڇK=鄷"3l!xJni]hx͚ jKl ]9QOi$'#'QW81O_x8!ZvK$<8Kze eK4?0 }jd8"du; CtTtDˡMDۋ1pD}wc՛p6Jw=4uG(2}.VC)#p42HOyOwX:AD@/ heTwr$Z <{-BO u|U jV Tb>8cPة 'Gp00Ɋ q?S}警۴$^򱬳ӼŅJEW7 Z\kxI+^@؏+Jx'4 [jL 4BT8ҕY<ؿ)/78E <`=H,LI, NAO6͋&R+,o#Tx7) Կڞ 1^ˣg{/` /m0,;zzW9P̗FEbMmvJ{T#1=`39b@ץn ӍpnvMqΛ1(Ħg5!Jzoq>^b9+n+qYKB%<(]Xci.vYHBVpM[.a^[|4..v&j$αB~B(#_jUL.6v7/ !hڀ%Q$%v]"{[D1u! u[x5V(ImiIVCt%$hTF+KlߴxN] >4 U`TL&v%(X+%\bݰ\>SWoiTFvt_$'&٤P|*Q&NjxQ勽vC%܋O((Zo} i7c/34Qvy, 9~.+dj*Z㙶ձ4|bҤwS_mM3'ȣZ1̄H& @>[n45BX9t92j U̓}EF(ѩ{ķN=}Y I㹈^4=OHҐ4ZQ3X) P:/a.IpCy#ͻèVf%NǚFuU|aɦQKXr_h'VM)0]Kow/X,v˻72֕]duP⠀Q}5xyye}|ZΈ+B v*]ߥ+M{8³XZjXQ?9(AKgH;eH xGS>L8 rkr Ӛ3Q>ƧUۥ??hstū3p\H}:Ý%e:c z|HC.Ȥ pN +13_4E'Sf"eŒם|X*!`kܙ}mni$@KL28^ndlT;iŦ^KC9:k6D1QT tcӃe-MCΦ y1kQWY|;ގGP?iI/L`',]vE7_ jݧjiѼ6 Bו1b a2ƹ1{1Q'EYHC01PE6'^aJb)<agC^ەyz'" YdvɦZߺ}M\d\@J0NN.. g%.9]2ȶLT1#kIu-U۲w*VJJtW;ǙX7^|[Jp0ӿO-CW"LѨgmcC5=#%E-sL%iݧ] .;vRG "^d{~'86&U]N+N'֥EMԚvrZO̦vT?4E968s8xTQ.h֩9g ==N` NcIz u#nb{NR M.* = gl놷%sn@_?v0gnN LZ ,vV9$ }n? A?QxvW?hn錴Y2/ʜGX?YU ϫ+||r*zn2mJc u}"5} _FG*6sS ^.BL-+!ԫ8a %Y_[y1#ܻ G,^ҩyH$/yieJ0|#Af"nTlޯL,2Q+&.藚*Z^=Z ed?GFh}ܲt!<ى̤xՄKd` Ϝ>!kfڷh/ yQ#/ *|.懶 85nn8W0:+$eq`]/>?v@Z M+U(-jқI}_3x͝i}ؙ۽a6F[]OQ)u_8L޲F]'qTD' atFbN3Id'\TK@Aʉ&_ECkIfȼr>U#jvVDӴ3㬛x& =J|a^]4q1^jj~8N,g>F z#~Q]G5Qs-"&wYB?9W@-fіp -j)qor{+P^duaS:pJ9 S%}AjUhr'|efӚK($_m%xK/{X? `{gH$0P΃ߘao$ޓWAQHE{=/d6y<$10mD V$8\: &cO<-]-Ȕ^/r~̾`o"C < wL؈R=ǪfrKDiJzIa=FwJÌ@V vڥFK'Xe=-ShxSV 2y;iv+RZ"maމ^J11ז8KT^DY.=x}4UX7KK0 9dž,r䢏$7v'A l jqQ6- j./qˁ@Ðb0"2͝ uH zbs[f VA.Z@4\t x@prH!_- QE~5 |AaeMXf**՘5{w~y ~)?&VL^>11 TaB-BX+Kr{FJR7La0;r8R %NU?P^v?] dΕG=LkB[h0)702}M´(PsmC![gЖfY+;1FbӘ4-Τ!GIAML%V}$R*-"{l8UŲ:Dm3(OkqwST ÷f λy6<6nfUՂJ`rUIv?[ג`^IGiv){ @!%RAe@ ^Acd  Ia-)T0b&2qT_i(ŜPk8JtqTF7@zX#dZJ=/ WϺxD׆ 2 sBPcr6Pgjʐ[-|X]ϑUAlk6α73|# g@@]]-; yҢ8):Ha>pC_Q Q0Ni-zWO:ctDyAK:_ N^v* ,!/Mm÷]RNf_`\U6R9[.`*ewEO:36Si\,ZQ1y2z*'a*+  ). v/*Za1[13Lʮ)TS^0KN];* n-u.TJMpNAI^Pc8ogAKvG4}\{FIН^DsYbcw+G/(BY]!t. &,"u&ۓ.:%|nmv&!3(ÙHߎ )#Z{@hm).gJA lh.-TGG!:c]^e|kJJt'3,;XE'VV?cp < R1w&2_aF'9xEc3})IOS3@y>s9co_(qяLhSQA3K7z6oS69QfɲρVi\C_ZFwF?qS#JYMuno֞{睙\_;{i/rJ~Am{#d,%%1*Yǵ.tI%֊M,(2_~~dqD0g#cv7˾Ez(i뼵אyK ]J88=^\᝽-v3OCoK]V&8' aZ?+C5ΓmoAC5XAvJj.~, ʾEpV-Z_LHB=bk&1GR'/Tm!I?g}і/UP<3BӚqQ.&)dPMnzR*jdz|3ׯ[VLRs.8p羒胧E<| ks)" ,畮90h@p6" GгG_7F=KAb(7S#֫FH/@&o,|lq<̺RLwI٫ÏkN`]s EKsyQ+ڞ$Tvי#?KOw7iv@_`KX}>z̿ₕ$)tiFuKі_~:~ϑKS߅rR@  qe_:'d:į=g4]ѯa0I6a(t4c>" -nPsT&=_ $'p\,@nA in7@?1-!@̣WӖi&Fc" Փ7፳GMMGϖhG pojHkSZS}(IVF>"Hm*"/,U=kGM*BQkePi|,#J%m߽3ta. YӜ`HZEe6Bc,ߣ6e@gJ>klU˙1ә\dž]'ͶeB˵^\)XD@_YfOcQrBHi.dls.ا#f] 'c ]t;6)窰QEhUbf )A{6/a( a}PTω4M}% N~ðTyOΨI9{d,5zbIBnɌY#7m ,y1eVRy?H"@]fƖ>ʿ?Q{z g߽eCؼ['˔7aV/>c[b)~զ6 y۟EPNmZr cաFpb[nh:*!Ȣo[gH6|<59\~+|[}y*rI(·kb3"ɾHmV؄VJLfM(;ɂꞮBB|u0D_"&ن`O4TuAL| j4ȴ,$φ[n,/09|5'>!ʼWS3[#$PV2"s f 3 (b (AQE fbxJUi}N+2t%Z(aG V7?*-[M=@UrS&؃twf훓ѤA`hnwtY7sITIkQM0^~9oJ@YM{ul\FxEsv> ^O}x0ŅFv@J2:o!`n/$?GP~ٞ'FNK6z-UpɄ0x`C咝QE>NT^DJ&Wan 75Ƨ3028AoJeۥ׬92-JyavVFw áxƥWNI?pK>)Ź'5N,6/r](~HޙlWwl@x0( JoS۶QI#P0lRGE n w)*N"M}jA( kly[u cUQ7ILvbv8s<crh%oqei@2DOaukE!Ӟ"VI׿PRO`YرtN2I7W=~(w<̞ 4)BهN"HA8չ0}5gЭQ]-ݕ[VOSR/d;CUC086P2{Zkh7$Ҁg*z<1tgX ؖQK/qױ.vߨMHtI:R:đLU"iV!Z*CӂN{ݠQuPh޻{\' NwNTl짦`̽F{n;4Me#dQ+jXGDU{9sQc;Fe7!JsK2ә)rU)fvz~}ꍜJ"NhF*N(\WK4)3;m iy|)UoSG qxqL8)LjGZ?b w=%Hr:`rYu+)'L4 ;-t֬;A_`%utܐP'V@nRUfX@1L>-RƸ.A5c§Qc'4,nQ=<'6IZ $ nlŝr+]ש[m~l]l;ovkaAޕ@|:\PM~(#QS#Èi ^sZٚsE<2>#$s҈|#BbLaG:t8 ~v cZ[E N^fӈuʘ kG5G&N,=c.GG/F QwFV]Ly}F%&p+t&F VUTf!}uLQ!l/ΈM3%!ϻ%CTs:MWvO)IaB-W5$C*8 PP1lW(y1$r9&b45I#'2]cTpbpbVhcVd'꓂Hښר,x 0N0s7c@!(E[xvXb=WWbQJ\OLbrޕpbqm(.br0@Z| (xCAke~X52H06!灹WuT%v YϛgX-p'O @8q3+Y(۾g\;m·+:!kJkK}ɫ 3᭦6䯳"?JAZ\;Ψ'Gs WB|ܣ&~ɸ(?A?.QZN;B1^'5)+wDLvY+ni?yhObѣVXTΈp d 1x(jEQL+'Л~3&9Bc2 dPmO(X (13SY_<-\n.߶r97hk*u LT-HwL;fBw7LD+̩V h8l h@dh gl9_5*{Ka;}CvLE 'f%dE.:JfSN Eщ(dt:$7+|gs*@X%2~y>=m~}f f+̬ϨǍ+{|@m5]2kڇWW3 b`U~#8W|u'v r2BOC6tG\p:ZdQiFȷZ}kʊOc\+FFXഴ{FU]/BV+2Q&ұ[2J5Z,bFlU 鮥x,iQ͝c*4> {,$ݵ'RXf*΁5e92v5ᑸfpɟDoF,ٻ= f?#|hjhKy3}@mD5H5tlВw)QoȊ/|"&ͪ.K =9iaՆ2t˚daFP$l䪳ɲ{v;1w7F5zQ}Pm]C&5<}MԒDDpc`iLnqHڍA'j 뺞\ 3:ڛt40`0GI_]=/8R<(7oIC s+"2V4( h*QSkH1`.C0X 7 'lA$cBtJɡucuo`'"BD, If06,"[9TBvYh>alðsG$)}׊ٸZ̢,S;|G$ABSPL^tYP'CR4u* w* s1k7[ 2|!RVIW'&N*=#9mNÇ:]v4ψ9•\W" QqJ^|A|DR2~wۃ?E" R#cQb@߇N'U@>Ỉ݂x>s9SpeK'}Db{2eoة’#L3yWTppNr*9n8@Fa Ujobމׇc"}6xwt$AYNSX"7TXd.0e$n/WQ;IjpB| ]Dp[+,[0+@K]FFQOpl5^iW=dα{IΉ|7G P{Q6 i{Bʯ2p3ζlDz;pi*a*}1Nbl!cjˍ767xtQ/:eo8\ U12fO䕹ҧ:**rUvJ=Ga5 Arw%~_Yh[؈ߗ@XlӋNq2nm}O3 qDi`I'fC6/|‘sLS>%Xg9M'6b(h5#Z @7LA*C 3_7O :n&CE! F`$ qP @Dĭ R@L&!17 %(I= ar2+mh%;p1'{ubIIg\VN3J1mVc'Ys ]#~ ;BS`C35 8!7Wm7PAb#*7tHM[c'>L9ӀpɩsZ+ )(mh\ީ8(dτN~ᯭJ.ir]vIM->rO RDʧ{3M ]vo_㸱IvEgAި 9U^UsS_ךZ 1 ӯ+Q^iNP*7!y M}DIZnzI4uN`{|LQSv.T)aoP5dsâWf&VN c B!0c9&F7' Z"$L`0-8=v:R|4d맥HPY27"dfOpϢn[^{ BcB(O$Թ|%A&w*C,YtpPָ4Hif ?{m LMZdTb3a?Kp@na0: v $:ּW< b1N!RYN8 $(.ٯT 4VbXxr*;#bǴ{!`dx}QzҼϊf}/7쐨ʤ4dglR~ߩ/_lRB7WP 4l'ZC ˑDdV򿢳bt|ön AΘ27y)a @$$&ĉnBMFqEe.Cv~R{^$>Et/5ݾQqOg(^ Gc} Ifuk4_qT ,i|vB.cT%ƥ2 OD%\fUZZAAXqpw_KpZZd^a^6snpڢ_7O.xмiF;sm SI(Qy~ݪ`TZPl 5и8p{_ &U0YS܉6*XoǠ^KTAM`y[N( ͎N4F n17jT)wy;NL;vQG/ȉd\\X nfrɋ6sB6Q4.!1몟\Xt/6<$jb.0{X#{eWh~ @)=-޶^7컱rGYvy!PoM{|KdO@&~+flNs9g7P !?7Z%爎> 9p( c&'f01H3SQs\dטTW4jx6A{e_STE%V.qU_9BV9" DDeE$CBF;3ϗjۻ霌.Դ 7 ߜ-M/PY픓 "Gɼ¤W r3騲=I?k2̿}|?&yqs r*XF* Z%rJyR#Pq[ɏ_. {JU#JIjG+ z3Tj gu1OeYI ȇĠ<~J ɟA=@:H | NV8_,UTw͎.a^Ց%PgLe A,W]BXM[*+8._0: 3>Rd-ZiqltƟjb"P`GzΊEX)˜ )p>OYL7 DKz.ӮdF *5?7֕L!!f{-+IBSͲ7BPB=`n͕nwRB*an,[U|sgrB@oء7)aڑS<4R0Nqv=o{[b[ 3M9PsdѻSqh_XO6_IAt)-F^pT~ʪ0c7_Cenjt[,h>Q;εjdk[F`M܋$vo*Z\\Վ"qe۸zR.FMh9%2̈́]Y- $ ?4n)_|yTvjB#ݟdfwlePyb-yk &ڞM>g(Z*zuއ-,88>7DP-z+}(TK.4;ox:1ỳmz:\lжY=1(g " 8OUj_FQwa U~]pSND3#Zk'A_OK CytRS #CM/mI+|Px}&Mti}_ J.e:fO)}W:l3g\*~zn1U4%[){()dg|{DiƁ*=upF:P<l8 J2^6ihTr)BGcO/(wxh;^=@ˇ臶3α QP$}~鳥#l'%*b[)QTԺ1xʯh0jkRD1 a;df'] fHb7SEQ^w^!CַHD0cjD dž-\ˮ/fm͚?:Lec=9 q& pszB\{2k^|",Fqe^t{/۲B:aKW)~CѶds"T#-\E'+(N~1?{Q3e2E.K`RG5 M `4JMP|&<JC]Yj3Vu%JBc]P}3d-zc؇C|*pƋ~<0wEud|\l.WqZv2ıR=MAJh갠'",U 1nJvW,OuU8/ui]; L`%8 (<׹p'*pp8lT@Zէ1&yZġ**8Y#?.[gw7뢹/'tk[^Z|IZY*-Y τtޘP%,.I:ƒrQ"%礷Ujh.i潑n26B5Cgn l=IUj$vj?v8weP ==bq+P|u8'( yn;[?1~Oݸ trVͪh6!l@VXT):[ j4oAC$;.q%<2~ӛ@pX4vyxp)W3+ @U ~td9Ȫ0!a&r [wQȡff%G$B/PKQm$A3LtsHDԐ?9^va^jYe-tDg@0ONDD6 wK1BPF-(uM,dg=scSf+ɆOWEXB₽&;?*K/֛W2w?D1I狵WC_7l;k 8"YsQ(飧ve=W\*7bE6I |X:ZǢU^z:@lnn{tcx4'sѥU?u=˴i|;$i Iq%E9ۀFV aq8keY(ЀK섽,Dm!s(9Ed2cD«hc1DՅG=OõB&MvSG^k8?sw l%o6 ϻXY$cL/?`fRA\5خ@`dEv{c(sQ{eӒ0ls E'Z [Dy%Z"gDldeVJN0ې콢g5H.J e \ͱOod Cݼ_ul(0%mcNsHWEetGzOUޱޗ1-l.TpO:,keqT~ շnimN7B.$r=8IZYw@c܋- m:jz+!*C[$xd"?υBڒ.c6+e YW^XnRS5И1lwҬ% ^7Qͽ#LH &ӷPhL1ZSCy*?!)7tb|8DWиmW :yQB%0(mU7mD7ߏXfvyZ掝Tn4W}!oTF> (Z7V>zV8j[D=zYmdd]DZS:FމOE9*EiUF9QE'4vGm5Є?~ cfw7_ul{)6=&59&na U$)J-b]Fj`ϥQ(w=kO/WZ]Y}i@ \l.a:O5$rm ƚc;Qk!6!by'07 u1IQjR;O/S-cYv( z{[כҊl`<odcKMvsJcJ>CT@9%^!@ُlnk=Nހִ+>5'r*r[MnI:/B>+Јvȥ m/7<7^Ѯ;ʼD ajE7̠4(o tPKV*)fz!ՠKMԸ(iWa eG,ӰYfn8JAyPFf7dǬ&.Se @uߌHL]N%bJD(U>7\|J;5𒐱;h,*]Rd MXS%U(#Ŋ84RB-:⥝N5[XePTD `J8=Gq*,KԈ~= {w6YVK˿fcś]?<.~0-xz1MOQxºke–Fx!6%LW?t8(ʙ1|RZϽN_u0n7Q̲,%Jij\HX 5n.rz43((V^t5>l/ +|8ScNFOGb+zK︽sW)д)\˔NO>ct eur" +O¹zS%)e.?@o!N|l2jn9 y_!1Ac*lf*P1u].T[;Y I# [x8$VDmu!Jn~J#dzSJ҈C5AA.|+.zRLĶ4V;|2ǜYT<]*+W%\Ru @<%2 / N :oR77Z[F֧?T @ەr{̽'\Z؟f(>yS Y&ˏLT?f7mUZdDEl 4v2DU˶^ "j"yFPYm'El4Qƽ5#VBHBUfР\Y?ի5oԹѧ6vUSg&ϠSIc#ƜƳl7`,lOrwE#93#02žH`tMZMobn/^ ^ͱ^ZY ܗN؁5!?Y8x endstream endobj 12 0 obj <>stream h26T0P06R0U06V0W0650U0Q0200= endstream endobj 13 0 obj <>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Type/Page>> endobj 14 0 obj <>stream q 0.071 0.071 0.071 rg 597.1906281 0 0 844.013382 0 0 cm /Im0 Do Q BT 0.11 g /T1_0 1 Tf -0.0047 Tc 3 Tr 9.2 0 0 9.2 64.67 753.1196 Tm (942 )Tj 0.05 Tc 7.9693 0 0 7.7 269.66 753.3596 Tm (M. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 8.0195 0 0 7.7 283.81 753.3596 Tm (6ZESMI )Tj EMC ET BT /T1_0 1 Tf 8.2365 0 0 7.7 317.57 753.3596 Tm (ET )Tj 0.0406 Tc 7.7 0 0 7.7 332.29 753.3596 Tm (AL. )Tj -0.0266 Tc 9.2 0 0 9.2 66.17 729.5196 Tm (27. )Tj 0.0331 Tc 8.9 0 0 8.9 83.72 729.5196 Tm (Turner )Tj 0.0178 Tc 3.198 0 Td (Warwick )Tj 0.0079 Tc 4.139 0 Td (M, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0081 Tc 8.9 0 0 8.9 163.2237 729.5196 Tm (Parkers )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 10.7238 0 0 9.2 193.81 729.5196 Tm (WR.-)Tj 0.0101 Tc 8.9 0 0 8.9 222.17 729.5196 Tm (Circulating )Tj 0.0123 Tc 4.961 0 Td (rheuma)Tj 0.243 g 0 Tc 3.047 0 Td (\255)Tj 0.11 g -0.0031 Tc -25.506 -1.055 Td (toid )Tj 0.0146 Tc 2.021 0 Td (and )Tj 0.0148 Tc 1.948 0 Td (antinuclear )Tj 0.0038 Tc 5.004 0 Td (factors )Tj -0.0033 Tc 3.276 0 Td (in )Tj 0.0013 Tc 1.27 0 Td (asbestos )Tj -0.0042 Tc 3.879 0 Td (workers. )Tj /T1_1 1 Tf 0.05 Tc 9.4063 0 0 9.2 256.04 720.1296 Tm (Br )Tj -0.0045 Tc 9.2 0 0 9.2 269.55 720.1296 Tm (Med )Tj /T1_2 1 Tf -0.0219 Tc 8.6 0 0 8.6 289.36 720.1296 Tm (J, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0277 Tc 9.2 0 0 9.2 66.62 710.7296 Tm (1970, )Tj EMC ET BT /T1_0 1 Tf -0.0064 Tc 9.2 0 0 9.2 89.4728 710.7296 Tm (3, )Tj 0.0176 Tc 1.133 0 Td (492-495. )Tj -0.0266 Tc -3.691 -1.021 Td (28. )Tj 0.0328 Tc 8.9 0 0 8.9 83.76 701.3396 Tm (Demevik )Tj 0.0181 Tc 4.572 0 Td (L, )Tj 0.017 Tc 1.597 0 Td (Bjorkander )Tj 0.0058 Tc 8.7 0 0 8.7 186.33 701.3396 Tm (J, )Tj 0.0083 Tc 8.9 0 0 8.9 198.86 701.3396 Tm (Hanson )Tj -0.0002 Tc 3.815 0 Td (LA, )Tj 0.0113 Tc 2.381 0 Td (Larsson )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0139 Tc 8.9 0 0 8.9 288.8034 701.3396 Tm (S, )Tj EMC /Suspect <>BDC -0.0248 Tc -25.027 -1.028 Td (SOderslrom )Tj EMC ET BT /T1_0 1 Tf 0.0493 Tc 8.9 0 0 8.9 109.7354 692.1904 Tm (T, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.005 Tc 8.9 0 0 8.9 120.8515 692.1904 Tm (William-Olsson )Tj EMC ET BT /T1_3 1 Tf 0.05 Tc 11.607 0 0 8.2 180.9 692.1896 Tm (G.-)Tj /T1_0 1 Tf 0.0021 Tc 8.9 0 0 8.9 200.53 692.1896 Tm (Immunological )Tj -0.0078 Tc 6.49 0 Td (abnormali\255)Tj -0.0103 Tc -21.61 -1.028 Td (ties )Tj 0.05 Tc 9.2063 0 0 8.9 82.04 683.0396 Tm (in )Tj 0.0114 Tc 8.9 0 0 8.9 93.31 683.0396 Tm (shrinking )Tj 0.008 Tc 4.29 0 Td (pleuritis )Tj 0.0228 Tc 3.785 0 Td (with )Tj 0.0015 Tc 2.264 0 Td (atelectasis. )Tj /T1_1 1 Tf 0.0031 Tc 9.2 0 0 9.2 228.35 683.0396 Tm (Eur )Tj /T1_2 1 Tf 0 Tc 8.6 0 0 8.6 245.54 683.0396 Tm (J )Tj /T1_1 1 Tf 0.0025 Tc 9.2 0 0 9.2 253.63 683.0396 Tm (Respir )Tj -0.0237 Tc 3.012 0 Td (Dis, )Tj /T1_0 1 Tf -0.0212 Tc -23.391 -1.021 Td (1985, )Tj -0.0238 Tc 2.536 0 Td (66, )Tj 0.0181 Tc 1.626 0 Td (128-134. )Tj -0.0266 Tc -4.212 -1.047 Td (29. )Tj 0.0143 Tc 8.9 0 0 8.9 83.52 664.0196 Tm (Hillerdal )Tj 0.0171 Tc 4.188 0 Td (G, )Tj 0.0128 Tc 1.494 0 Td (Baris )Tj -0.013 Tc 2.708 0 Td (YI. )Tj 0 Tc 1.803 0 Td (-)Tj 0.0061 Tc 1.089 0 Td (Radiological )Tj 0.0059 Tc 5.7 0 Td (study )Tj 0.05 Tc 9.4914 0 0 8.9 258.77 664.0196 Tm (of )Tj 0.0083 Tc 8.9 0 0 8.9 270.92 664.0196 Tm (pleural )Tj -0.0009 Tc -23.064 -1.055 Td (changes )Tj 0.0238 Tc 3.627 0 Td (in )Tj 0.0166 Tc 1.117 0 Td (relation )Tj -0.035 Tc 8.4647 0 0 8.9 139.65 654.6296 Tm (to )Tj 0.0125 Tc 8.9 0 0 8.9 149.28 654.6296 Tm (mesothelioma )Tj 0.05 Tc 8.9093 0 0 8.9 203.16 654.6296 Tm (in )Tj -0.0013 Tc 8.9 0 0 8.9 213.28 654.6296 Tm (Turkey. )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0021 Tc 9 0 0 9 244.23 654.6296 Tm (Thorax, )Tj EMC ET BT /T1_0 1 Tf -0.0277 Tc 9.2 0 0 9.2 276.6 654.6296 Tm (1983, )Tj -0.024 Tc 9.3 0 0 9.3 65.63 645.2396 Tm (38, )Tj 0.021 Tc 1.535 0 Td (443-448)Tj 0.243 g 0 Tc 3.453 0 Td (. )Tj ET BT /Suspect <>BDC 0.11 g /T1_0 1 Tf -0.0045 Tc 9.2 0 0 9.2 65.39 635.8396 Tm (30. )Tj EMC ET BT /T1_0 1 Tf 0.0076 Tc 8.9 0 0 8.9 83.52 635.8396 Tm (Hillerdal )Tj 0.0441 Tc 3.945 0 Td (G, )Tj 0 Tc 1.387 0 Td (Zitting )Tj -0.0192 Tc 3.139 0 Td (A, )Tj 0.0253 Tc 1.326 0 Td (van )Tj 0.0069 Tc 1.867 0 Td (Assendelft )Tj 0.0068 Tc 4.654 0 Td (AHW, )Tj 0.0093 Tc 3.054 0 Td (Kuusela )Tj 0.0223 Tc 3.594 0 Td (T. )Tj 0 Tc -25.03 -1.055 Td (-)Tj 0.0153 Tc 0.927 0 Td (Rarity )Tj 0.05 Tc 9.4914 0 0 8.9 99.84 626.4496 Tm (of )Tj 0.0155 Tc 8.9 0 0 8.9 110.99 626.4496 Tm (mineral )Tj -0.0028 Tc 3.563 0 Td (fibre )Tj 0.0169 Tc 2.285 0 Td (pleurisy )Tj -0.0076 Tc 3.776 0 Td (among )Tj 0.0066 Tc 3.096 0 Td (persons )Tj 0.0166 Tc 3.506 0 Td (exposed )Tj -0.035 Tc 8.7902 0 0 8.9 288.94 626.4496 Tm (to )Tj 0.0081 Tc 8.9 0 0 8.9 65.46 617.2996 Tm (Finnish )Tj 0.0013 Tc 3.376 0 Td (anthophyllite )Tj 0.0146 Tc 5.628 0 Td (and )Tj 0.0047 Tc 1.821 0 Td (with )Tj 0.0022 Tc 2.13 0 Td (low )Tj 0.0145 Tc 1.847 0 Td (risk )Tj 0.05 Tc 9.2123 0 0 8.9 213.74 617.2996 Tm (of )Tj -0.0026 Tc 8.9 0 0 8.9 224.41 617.2996 Tm (mesothelioma. )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0254 Tc 9 0 0 9 279.15 617.2996 Tm (Tho\255)Tj EMC ET BT /T1_1 1 Tf -0.0186 Tc 9 0 0 9 65.454 607.6696 Tm (rax, )Tj /T1_0 1 Tf -0.0146 Tc 9.2 0 0 9.2 83.24 607.6696 Tm (1984, )Tj -0.0045 Tc 2.562 0 Td (39, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0077 Tc 9.2 0 0 9.2 121.972 607.6696 Tm (608-611. )Tj EMC ET BT /T1_1 1 Tf 0.0259 Tc 9.2 0 0 9.2 64.6284 588.8924 Tm (Les )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0179 Tc 9.2 0 0 9.2 83.8656 588.8924 Tm (Phinotypiques )Tj EMC ET BT /T1_1 1 Tf 0.0063 Tc 9.2 0 0 9.2 144.4292 588.8924 Tm (des )Tj 0.0038 Tc 2.039 0 Td (cellules )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0079 Tc 9.2 0 0 9.2 198.0744 588.8924 Tm (lympholdes )Tj EMC /Suspect <>BDC 0.0117 Tc 5.123 0 Td (periphiriques )Tj EMC ET BT /T1_1 1 Tf -0.035 Tc 9.1168 0 0 9.2 65.21 579.2596 Tm (de )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 3.7325 0 0 6.5017 76.1 579.2596 Tm <0070007E007400690065006E007400730020>Tj EMC ET BT /T1_1 1 Tf 0.0038 Tc 9.2 0 0 9.2 109.51 579.2596 Tm (atteints )Tj -0.035 Tc 9.1168 0 0 9.2 140.1 579.2596 Tm (de )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0053 Tc 9.2 0 0 9.2 152.33 579.2596 Tm (lesion )Tj EMC ET BT /T1_1 1 Tf 0.0107 Tc 9.2 0 0 9.2 176.8204 579.2596 Tm (pleurale )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.007 Tc 9.2 0 0 9.2 211.1364 579.2596 Tm (d'origine )Tj EMC ET BT /T1_1 1 Tf -0.0116 Tc 9.2 0 0 9.2 247.2372 579.2596 Tm (asbestosique. )Tj -0.035 Tc 8.861 0 0 9.2 64.87 569.8596 Tm (M. )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0034 Tc 9.2 0 0 9.2 80.27 569.8596 Tm (Ozesmi* )Tj EMC /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 9.3172 0 0 9.8 118.04 569.8596 Tm (***, )Tj EMC ET BT /T1_1 1 Tf 0 Tc 9.2 0 0 9.2 139 569.8596 Tm (G)Tj 0.243 g 0.77 0 Td (. )Tj ET BT /Suspect <>BDC 0.11 g /T1_1 1 Tf -0.0075 Tc 9.2 0 0 9.2 153.2324 569.8596 Tm (Hillerdal*, )Tj EMC ET BT /T1_1 1 Tf 0.0085 Tc 9.2 0 0 9.2 199.0392 569.8596 Tm (A. )Tj -0.0109 Tc 1.486 0 Td (Karlsson-Parra**, )Tj 0 Tc 8.1 0 Td (U)Tj 0.243 g 0.702 0 Td (. )Tj 0.11 g -0.0148 Tc -24.874 -1.021 Td (Forsum**. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0002 Tc 8.9 0 0 8.9 64.98 551.3196 Tm (RESUME: )Tj EMC ET BT /T1_0 1 Tf 0.0324 Tc 8.7 0 0 8.7 107.59 551.3196 Tm (Les )Tj 0.0114 Tc 8.9 0 0 8.9 124.03 551.3196 Tm (plaques )Tj 0.0138 Tc 3.49 0 Td (pleurales )Tj 0.0059 Tc 4.085 0 Td (parietales )Tj 0.0325 Tc 4.264 0 Td (d'origine )Tj -0.0062 Tc 4.166 0 Td (asbesto\255)Tj 0.0134 Tc -22.651 -1.055 Td (sique )Tj 0.032 Tc 2.679 0 Td (se )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0159 Tc 8.9 0 0 8.9 101.2816 541.9301 Tm (developpent )Tj EMC ET BT /T1_0 1 Tf 0.0205 Tc 8.9 0 0 8.9 150.4185 541.9301 Tm (lentement )Tj 0.05 Tc 8.9871 0 0 8.9 191.34 541.9296 Tm (et )Tj 0.0346 Tc 8.9 0 0 8.9 202.67 541.9296 Tm (ont )Tj 0.0271 Tc 1.824 0 Td (peu )Tj 0.04 Tc 2.019 0 Td (de )Tj 0.0077 Tc 1.51 0 Td (signification )Tj 0.0088 Tc 7.58 21.051 Td (clinique. )Tj 0.0198 Tc 4.037 0 Td (D'aulres )Tj 0.0128 Tc 3.926 0 Td (reactions )Tj 0.0071 Tc 4.17 0 Td (pleurales )Tj 0.0426 Tc 4.156 0 Td (d'origine )Tj 0.0034 Tc 4.328 0 Td (asbestosique, )Tj 0.0276 Tc -20.617 -1.056 Td (comme )Tj 0.0159 Tc 3.475 0 Td (par )Tj 0.0076 Tc 1.746 0 Td (exemple )Tj 0.0213 Tc 3.871 0 Td (les )Tj 0.0112 Tc 1.607 0 Td (pleuresies )Tj 0.0202 Tc 4.561 0 Td (exsudatives )Tj 0.0059 Tc 5.33 0 Td (aigues )Tj 0.05 Tc 9.629 0 0 8.9 527.98 719.8796 Tm (et )Tj -0.0057 Tc 8.9 0 0 8.9 538.84 719.8796 Tm (les )Tj 0.0052 Tc -24.84 -1.055 Td (fibroses )Tj 0.0071 Tc 3.665 0 Td (pleurales )Tj 0.0055 Tc 4.112 0 Td (progressives, )Tj 0.0346 Tc 5.807 0 Td (ont )Tj 0.0364 Tc 1.769 0 Td (une )Tj 0.0197 Tc 1.966 0 Td (importance )Tj 0.0054 Tc 5.112 0 Td (clinique. )Tj 0.0415 Tc -22.426 -1.055 Td (La )Tj 0.01 Tc 1.549 0 Td (pathogenie )Tj 0.013 Tc 4.967 0 Td (de )Tj 0.0084 Tc 1.461 0 Td (ces )Tj 0.0094 Tc 1.767 0 Td (reactions )Tj 0.0371 Tc 4.211 0 Td (est )Tj 0.0202 Tc 1.653 0 Td (inconnue, )Tj 0.0132 Tc 4.579 0 Td (mais )Tj 0.0364 Tc 2.41 0 Td (une )Tj 0.0014 Tc 1.993 0 Td (des )Tj 0.009 Tc -24.613 -1.028 Td (hypotheses )Tj 0.05 Tc 8.9093 0 0 8.9 361.59 691.9496 Tm (est )Tj 0.0141 Tc 8.9 0 0 8.9 375.81 691.9496 Tm (que )Tj 0.0014 Tc 1.894 0 Td (des )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0055 Tc 8.9 0 0 8.9 408.829 691.9496 Tm (!roubles )Tj EMC ET BT /T1_0 1 Tf 0.0194 Tc 8.9 0 0 8.9 442.0349 691.9496 Tm (immunologiques )Tj 0.0239 Tc 7.381 0 Td (seraient )Tj 0.0237 Tc 3.656 0 Td (en )Tj 0.0083 Tc -25.027 -1.028 Td (cause. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0158 Tc 8.9 0 0 8.9 343.3428 682.8004 Tm (Pour )Tj EMC ET BT /T1_0 1 Tf 0.0096 Tc 8.9 0 0 8.9 363.2966 682.8004 Tm (investiguer )Tj 0.0077 Tc 4.842 0 Td (ceci, )Tj 0.0118 Tc 2.254 0 Td (nous )Tj 0.0082 Tc 2.318 0 Td (avons )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0258 Tc 8.9 0 0 8.9 471.485 682.8004 Tm (realise )Tj EMC ET BT /T1_0 1 Tf 0.0093 Tc 8.9 0 0 8.9 499.1907 682.8004 Tm (une )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0044 Tc 8.9 0 0 8.9 515.4688 682.8004 Tm (caracteri\255)Tj EMC ET BT /T1_0 1 Tf 0.0149 Tc 8.9 0 0 8.9 317.4883 673.4109 Tm (sation )Tj 0.0056 Tc 2.857 0 Td (phenotypique )Tj 0.0149 Tc 5.887 0 Td (des )Tj 0.0079 Tc 1.758 0 Td (cellules )Tj 0.0187 Tc 3.519 0 Td (lymphoides )Tj 0.0146 Tc 5.248 0 Td (dans )Tj 0.05 Tc 9.2525 0 0 8.9 509.22 673.4096 Tm (le )Tj 0.011 Tc 8.9 0 0 8.9 519.77 673.4096 Tm (sang )Tj 0.013 Tc 2.278 0 Td (de )Tj -0.0163 Tc 9.2 0 0 9.2 317.34 663.7796 Tm (45 )Tj 0.0059 Tc 8.9 0 0 8.9 329.43 663.7796 Tm (patients )Tj -0.0044 Tc 3.506 0 Td (atteints )Tj 0.04 Tc 3.22 0 Td (de )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0045 Tc 8.9 0 0 8.9 401.1017 663.7796 Tm (lesions )Tj EMC ET BT /T1_0 1 Tf 0.0037 Tc 8.9 0 0 8.9 429.1189 663.7796 Tm (pleurales )Tj 0.0359 Tc 3.994 0 Td (d'origine )Tj -0.0056 Tc 4.165 0 Td (asbestosique: )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0135 Tc 9.2 0 0 9.2 317.32 654.3896 Tm (20 )Tj EMC ET BT /T1_0 1 Tf 0.0219 Tc 8.9 0 0 8.9 330.3 654.3896 Tm (cas )Tj 0.04 Tc 1.758 0 Td (de )Tj 0.0069 Tc 1.391 0 Td (plaques )Tj 0.0138 Tc 3.49 0 Td (pleurales )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0017 Tc 8.9 0 0 8.9 426.3577 654.3896 Tm (\(PP\), )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 9.1622 0 0 9.2 448.78 654.3896 Tm (15 )Tj 0.0219 Tc 8.9 0 0 8.9 461.53 654.3896 Tm (cas )Tj 0.05 Tc 9.0546 0 0 8.9 477.19 654.3896 Tm (de )Tj 0.0078 Tc 8.9 0 0 8.9 490.18 654.3896 Tm (fibrose )Tj 0.0173 Tc 3.231 0 Td (pleurale )Tj 0.0125 Tc -22.657 -1.055 Td (diffuse )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0051 Tc 8.9 0 0 8.9 348.3407 645.0001 Tm (\(DPF\), )Tj EMC ET BT /T1_0 1 Tf 0.0303 Tc 8.9 0 0 8.9 378.2091 645.0001 Tm (et )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0454 Tc 8.9 0 0 8.9 390.5089 645.0001 Tm (10 )Tj EMC ET BT /T1_0 1 Tf 0.0072 Tc 8.9 0 0 8.9 404.6955 645.0001 Tm (atteints )Tj 0.0326 Tc 3.518 0 Td (d'epanchement )Tj 0.0128 Tc 6.91 0 Td (pleural )Tj ET BT /Suspect <>BDC /T1_3 1 Tf -0.035 Tc 8.7886 0 0 9 528.15 644.9996 Tm (benin )Tj EMC ET BT /T1_0 1 Tf -0.003 Tc 8.9 0 0 8.9 317.53 635.5996 Tm (asbestosique )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.007 Tc 8.9 0 0 8.9 365.4298 635.5996 Tm (\(BAPE\). )Tj EMC ET BT /T1_0 1 Tf -0.0011 Tc 8.9 0 0 8.9 399.4723 635.5996 Tm (Vingt-quatre )Tj -0.0005 Tc 5.431 0 Td (donneurs )Tj 0.05 Tc 9.2993 0 0 8.9 483.93 635.5996 Tm (de )Tj -0.025 Tc 8.9 0 0 8.9 496.41 635.5996 Tm (sang )Tj 0.0071 Tc 2.153 0 Td (bien )Tj -0.0022 Tc 2.083 0 Td (por\255)Tj -0.0042 Tc -24.327 -1.028 Td (tants )Tj 0.0211 Tc 2.401 0 Td (ont )Tj 0.0078 Tc 1.754 0 Td (servi )Tj 0.04 Tc 2.412 0 Td (de )Tj 0.0065 Tc 1.434 0 Td (controles. )Tj 0.0156 Tc 4.465 0 Td (Tous )Tj 0.0078 Tc 2.517 0 Td (les )Tj 0.0206 Tc 1.651 0 Td (groupes )Tj 0.0031 Tc 3.785 0 Td (asbestosiques )Tj 0.0149 Tc -20.5 -1.055 Td (reunis )Tj -0.0007 Tc 2.913 0 Td (avaient )Tj 0.05 Tc 9.1787 0 0 8.9 371.08 617.0596 Tm (un )Tj 0.0105 Tc 8.9 0 0 8.9 383.37 617.0596 Tm (pourcentage )Tj 0.013 Tc 5.319 0 Td (de )Tj 0 Tc 1.304 0 Td (B )Tj 0.0158 Tc 1.051 0 Td (lymphocytes )Tj 0.0004 Tc 5.622 0 Td (significative\255)Tj 0.0212 Tc -20.74 -1.055 Td (ment )Tj 0.0159 Tc 2.411 0 Td (plus )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0128 Tc 8.9 0 0 8.9 357.0171 607.6701 Tm (eleve )Tj EMC ET BT /T1_0 1 Tf 0.0141 Tc 8.9 0 0 8.9 379.1781 607.6701 Tm (que )Tj 0.0078 Tc 1.84 0 Td (les )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0212 Tc 8.9 0 0 8.9 409.0376 607.6701 Tm (conlrOles. )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.8308 0 0 8.7 447.84 607.6696 Tm (Le )Tj 0.0214 Tc 8.9 0 0 8.9 460.43 607.6696 Tm (pourcentage )Tj 0.04 Tc 5.427 0 Td (de )Tj 0.0041 Tc 1.353 0 Td (cellules )Tj 0 Tc -22.916 -1.082 Td (T )Tj 0.0016 Tc 1.054 0 Td (adjuvantes )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0154 Tc 8.9 0 0 8.9 367.6119 598.0398 Tm (etait )Tj EMC ET BT /T1_0 1 Tf 0.0079 Tc 8.9 0 0 8.9 386.6045 598.0398 Tm (significativement )Tj 0.0249 Tc 7.348 0 Td (plus )Tj 0.0287 Tc 2.11 0 Td (bas )Tj 0.0237 Tc 1.748 0 Td (dans )Tj 0.0213 Tc 2.246 0 Td (les )Tj 0.0071 Tc 1.516 0 Td (groupes )Tj 0.0397 Tc -22.805 -1.028 Td (BAPE )Tj 0.05 Tc 9.308 0 0 8.9 345.21 588.8896 Tm (et )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0112 Tc 8.9 0 0 8.9 356.83 588.8896 Tm (DPF )Tj EMC ET BT /T1_0 1 Tf 0.0141 Tc 8.9 0 0 8.9 378.2167 588.8896 Tm (que )Tj 0.0146 Tc 2.002 0 Td (dans )Tj 0.0078 Tc 2.463 0 Td (les )Tj 0.0116 Tc 1.651 0 Td (groupes )Tj 0.0182 Tc 3.787 0 Td (controles )Tj 0.05 Tc 9.308 0 0 8.9 504.86 588.8896 Tm (et )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0397 Tc 8.9 0 0 8.9 516.72 588.8896 Tm (PP)Tj 0.243 g 0 Tc 1.174 0 Td (. )Tj EMC ET BT 0.11 g /T1_0 1 Tf 0.0024 Tc 8.9 0 0 8.9 534.0572 588.8896 Tm (Des )Tj 0.0059 Tc -24.356 -1.082 Td (anomalies )Tj 0.0086 Tc 4.784 0 Td (significatives )Tj 0.0284 Tc 6.12 0 Td (des )Tj 0.0118 Tc 2.056 0 Td (cellules )Tj 0.0157 Tc 3.843 0 Td (lymphoides )Tj 0.0371 Tc 5.519 0 Td (du )Tj 0.002 Tc 1.727 0 Td (sang )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0116 Tc 8.9 0 0 8.9 316.9061 570.1106 Tm (peripherique )Tj EMC ET BT /T1_0 1 Tf 0.0113 Tc 8.9 0 0 8.9 366.8885 570.1106 Tm (existent )Tj 0.0317 Tc 3.573 0 Td (done )Tj 0.0193 Tc 2.462 0 Td (chez )Tj 0.0078 Tc 2.328 0 Td (les )Tj 0.0214 Tc 1.579 0 Td (patients )Tj -0.0006 Tc 3.749 0 Td (atteints )Tj 0.05 Tc 9.0546 0 0 8.9 518.6 570.1096 Tm (de )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0112 Tc 8.9 0 0 8.9 531.41 570.1096 Tm (DPF )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.9871 0 0 8.9 317.04 560.4696 Tm (et )Tj 0.04 Tc 8.9 0 0 8.9 326.93 560.4696 Tm (de )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0079 Tc 8.9 0 0 8.9 338.5267 560.4696 Tm (BAPE, )Tj EMC ET BT /T1_0 1 Tf 0.0024 Tc 8.9 0 0 8.9 367.3805 560.4696 Tm (qui )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0109 Tc 8.9 0 0 8.9 381.8341 560.4696 Tm (different )Tj EMC ET BT /T1_0 1 Tf 0.0149 Tc 8.9 0 0 8.9 416.5085 560.4696 Tm (des )Tj 0.0098 Tc 1.689 0 Td (patients )Tj 0.184 g 0.011 Tc 3.56 0 Td (atteints )Tj 0.11 g 0.04 Tc 3.356 0 Td (de )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0104 Tc 8.9 0 0 8.9 504.93 560.4696 Tm (PP, )Tj EMC ET BT /T1_0 1 Tf 0.0295 Tc 8.9 0 0 8.9 520.3003 560.4696 Tm (qui )Tj 0.0054 Tc 1.703 0 Td (eux )Tj 0.0213 Tc -24.544 -1.028 Td (sont )Tj 0.001 Tc 2.083 0 Td (sirnilaires )Tj 0.0146 Tc 4.307 0 Td (aux )Tj 0.0099 Tc 1.821 0 Td (normaux. )Tj /T1_1 1 Tf -0.01 Tc 9.2 0 0 9.2 316.96 542.1696 Tm (Eur )Tj 0.0077 Tc 1.833 0 Td (Respir )Tj /T1_2 1 Tf -0.0219 Tc 8.6 0 0 8.6 360.16 542.1696 Tm (J.)Tj 0.243 g 0 Tc 0.843 0 Td (, )Tj 0.11 g /T1_1 1 Tf -0.0152 Tc 9.2 0 0 9.2 372.84 542.1696 Tm (1988, )Tj -0.0265 Tc 2.565 0 Td (1, )Tj 0.017 Tc 1.083 0 Td (938-942. )Tj ET endstream endobj 15 0 obj <>stream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endstr endstream endobj 16 0 obj <>stream Hd͊zy8 >sRhF^#y QG#Oç==o/ϧ;c_mӷKv|~_oo~y>}~W=|z>{O݇q~?>Ï?o+~ߒ~;%zΏx߽w;>lp?(O?{wٸ^ PZUuTGu^5P5FjFDMԤU PjVjUmFmک]uPuNNE]E5|| _#_k55|| _#_k55|| _#_k55|| _#_k5Z||-_+_kZ||-_+_kZ||-_+_kZ||-_+_ku:||_'_uu:||_'_uu:||_'_uu:||_'_uz||=_/_z||=_/_z||=_/_z||=_/_ || ߀o77 || ߀o77 || ߀o77 || ߀o77 KG#(~? ?G#(~? ?G#(~? ?G#(~? ?z $߄o77MM&|| $߄o77MM&|| $߄o77MM&|| $߄o77MM&||3,ߌo77f||3,ߌo77f||3,ߌo77f||3,ߌo77f|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|ۯ\t;]~~߅ww;]~~߅ww;]~~߅ww;]~~߅w߁w;;|C߁w;;|C߁w;;|C߁w;;|C߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S ߅w]..|K ߅w]..|K ߅w]..|K ߅w]..|?|x>/Filter/JBIG2Decode/Height 3505/ImageMask true/Length 12649/Name/X/Subtype/Image/Type/XObject/Width 2480>>stream "**{v _):hL9Ƀ24@Č= M ;'bv=#ќ41[+ \kn{#euhVໞ[\M(N"0nHW{~Zra c)3rVNӕ43K4E+=Co,߃;u%*-B, <-ƻFtTTLYy^XN/s#giJ$VpXy, wLFVG l|O}oVԖ|VZ&|s EjWՁW#G sh`&plmҵѓ;Zs4 w .Ͷjiա6,خZ>uDK;0aV~)Ъ!O32`o #.gk=Qk< \4t@a)gle (xྔO-1ړ\r z 1~Sɇ#q1=W0)Z%@a !|;t $Ja=̙3!N͙L$m_+[|*% B~!Ԡ1g 6> M`TU=3粻Vhj |]3 K)W puX^\4ǯa/=TESXښpm/pD0|tM@/c$ ~i?~իIU- jk(H d3 7o=!_XѾg탽2)d_z a»Ekq-b?cdЋOz[f2{P4̱YTߗ A<5./>\`Imi*G#[(gU͐\i( Nς 4 ;.Ww%jrߧc_~V#U V2a 62T1!;eoFH1UbPrpO֩6K5y~>X.hwCQewk,^\g"DJ~wWہaƳ]-Q\G'\$|5 Mrn;l53!ڭu:xo6P> Y DN>"Sѯϧgd|θ͋w~= ['OLN`:a9a(k:/1Du|HP =1u ,OI-厎fuo[E )ڌ`cV)!em9%B `Mt"iW[|-%; w.y c*) kƹ..@gzz±w[^є~e-&gdI8Qb)'QXUBY Յg %ehِ7t!rʽXfMlZB/ ].n]l8TDBW[D!4%i!^i!P8C 4ʽÁW>`4$RO,x4:P&CC]ߪx%ר-E!+%} !LMA4C=hU+k)N1\ t\"7DCmJwI 纁gđdk(wNeOuOUw5C_[JsMM`w=qڶNeSH_IMV3T&^]K(u.I<7f^a]ؖ/WDXɰ5U*3 Oy!wtWn/,,a̘"&i+JûLx:FkA588Y3zLSoLu϶fcTja٨X_ RW~T" ! JU2HQ3OV~oaY1u`JEJv9.RU4'F|}衷&&3k=$pIY^ Tڰ;cD7[FM>kצj 붎L%3+QY ,D=C]QU 3n Ò-%˗ey S(d.aQ: MsDnIH|x#́RӬ$`ݒQ`}%-{sARPtKaӄa_=,?%E^RD**Â`dkI$#;+QDBx߁#ϏcCCOu۩$'_ +]kO^[> * ģ']d<蹬;c}Μ\NرƜ`X2qW B X$İ-GjC0~?( Alidg-K\@#2?bИA#+sDz 7b\ #o/Ux U>lN= 9p{?v &xIyfI,|#|xm"]Uc$ŸKx2oq^pg>Uۼ(pӰT& /,N4xS `\rΰrÓSxФ؈a[f(r)D{>m% #OɒW綻ץfDB5vӓh )Iɼ?f!x7 EM+Mx̴keA-$%.5N5C/F]U &/dI=6m1B=#b-* `FӽRg[b-WL(s=b̗iC \EtOӬ_$ FsljȘ-Ƥp 3)Ցhxxy< Fǘq?Kemoֱь}9t4UԠdi>k 94އɏ~r[9y4(pan9@90m_n`qn&~;leMc_n==&78=<ޛ?*kؚ%J<e"!$_;\i>^a[DpQ'r.8[N|-3w<xy6`p5^5i1h]mgx?KBaQ̥7JFi2hʢKEN5wL]c@{ :{* \ Z'fP|E:;0+3J]rku1pdCR|&74aj!lg\ ;%oϴn8Nym&|T,Kܛ*ƙEƵS9ߦj(Y>=Zq氥39h\%̀=ONeC\\UL 3S\^IA\':+d.^kN,Y8, P ,楏BbC.ϞUfĚvx&B;:i9 k'iOLT"B&(mgƂe[! 6%[[ք8`΀)HG!UE Jz)QCi#iR䁪F'Ey ZkF=ޖ'd\P{~dtAÙ6aPa^"̷}n-Ĵ50-Y=#WSt טa9AtkSxeP)oR(J;* $ ngᷠ)0}YHBzGj 1ɐo>'g$wKxin,PB"~ؓ$<,>BT vze9[^9Kqjyaf ?zJƹFeq6+ZT@ȦQd.5 (7Y6 vc}֑+(Q\{iV$϶T(3%¸%F,Yɩ$x(jN u냒dϓv۩/E%VH}];wK>򈍗'g FQg{R@<K‡Go uQ0 BSY^KM)RHeK[do~J&WHQv %\VsQ ʢ̣'|ETl!%&\ʣI_^;CڋǪ&ܘ 1f\WOf5 p28 mu;KjcQRވJ Qg~3n5Ȟ6UJxu LQG-kS8E3yx/A DPJ3LCCK8=̨ӉV 0eu GMͤȩn/Z_R)> i9sVr;QVgo!Xre'i A/>zG0 ΀*Ws&Oڋ!Eo8GSI#24ˋ@ݢ9+]0k]Mؕ<]lznl5ƌHʿP"䱣i]E.H)24#“l(s;TDTYОҕB9+dՇUe2dgfG}qO^ Z?i6׿@I4+XHCo`%ȕm1OJ?^ fy@5l_Z;qvk 4*D I`)Lv"T@DV;zG@A3H6#k7LPLG/vaHm¬Kk;B%]ՒKP ꂪMBc 8]q"*L,8U!(pL$0R w4eisVgL~˽4 mr:v7F_9FB2Ox,KXX] 9RrCLa ݢ`5_ i[hv—ωVFp}7򑦌degʥ#U1qByTb@mQU>AZi{ʞKU}_ʑ `)b RwhZ3.ZFq<3ĨUGC;T4]4@_O^ ol,&>dpRFiVa3=ǟF<BASzzN+|U -(V 7D0f.Y_:4S,S/YqܔIY'EG;n*{ rcꡔq%0CGH|gD#_T.hه6=RkgփF'RAPւ =ߵzo]O_O]0C( ߄7$<;|9xcN=Iofn s?hJ y [v٬Lb%s 4~o,% @dr~?6׺.>, U -RєgD-B~R r-b949-LM"DĶdO`S2 NHWI4a!Uކ)Q[4lȯs`ц5G6I:[.T9R \B{޺Cv;CDn&5hI{3T5]L,)=.n2x`,4synuMx>mEVPѝ%B &}pMl:d88SmĢYBPyBVWdb ߌ%3A#VJ=ut墛*cH xhs/=Uӱ@B8 0Jտi@[JA3PYpE!TR[fow&.PxxZ>,Q8&> |&W.dyg`"ugQ% a[V qcY/?jep'n>-o >Py4Nhk`fsM<_K7u8[YW9Y[18`wlvW*IL2ȵkrw<^2ڏٶ /Is/gse`sAЃ2u3͉^2R p E0DҺbBakFoČFµjf/J2bk y(ogTċ`Je( {he@-|DuoՅ+^e`8ȬOB#_%n{ Bo >Nfe+ue%Q" ²~OřesDr9+6V7Rfej  $ɀ[i]ORX<$bU},^8bݏ@,* XQ<&V+]b"& \J?]b$E|/8 Xov'Cãk0->7J+SO r$@ʐo41b}L+vrWs$ D-KJDHr}6)nN/ζu5i8ũcrvđ>0 @   ? $5EeQuK4ؙQ&l sE!%S1d=;)bֻ@iph232G\H.MbΑ,)~5u"osW~"0Sr$h*Yč/MZߛL Rv= G'/ux5E!m@i- eU$)ת ~V(J"N'Z #3EPd(@!-dzl,qLe䪸Se2V%>?Ųy`~B"_"vzv St&|Ttg.֧il7{Afc)q$Qe&lʒۨ"i?9PĮ'ls݉lGd[W[TQ-k3qLYYG]W?)jc(| z y "h&5f#3?6b e{Ykg {g)f,6?eO_FSaZ}v*CO_87Mi2k|^.Yi~/LuᴉcyN_MUXa$>>y P>zg>?OF!RHQ6☋Ep`q9 5$%VZ*Ε*5x@Gm)\볌y^MR.FWmJ9r%M8it?90I~78JNc8YڃnI\4\|3,mȪl?d&(۞`j]ʸ3U AQ\rҮwztr'oˌ^/ocn.b^f&`LjN/"xY1a4WK#zOZ2? ~O9hBO6dtEgT<.\HlpF4*%Kyy?UC& لQz(J5Ǥ*vۻ~ l{rkŜri0R D¦N\:hҪպT !W-y#H()2_FSiFeq/mhv/ 2ڜ 7׆[#ĥ$;d4}w2^94hAIAgs2]DZhg{ґS.aYџ֢zUT/D]cO9YT wDQT EK|׻u6Um 5"jd"b6e(W77`h%hRFF3-iGL s4.@g} )ǁ_"GCPUܺv>jلKV)]o4@YӖaWϟu~Bip 9/I:Pd $>$dt.9vOweskxa7Xo؃C) ܾ} `)OI[JIGj6 M(:Qh/ѣpl(#<\vU,`L@gώilnQo0 BҎk81XH:ɣ7(6dE9rn], Ou8w/A&Iۤ?<+%8B @7ry]&D~X!IC66?cq,eYP܌9!}y7彈}T[2N5FCYc(6uJ$tl\L E YpϾHl iI\.f?̔$v)좛O+v(eDngwo6U߷g7OT'o ]7SW]4 pyo%Dq3~T6z<}<&twuߘJ೷dC[Ĭi|.Mq~ ;-Y rIu($}D"~;h>v&xĦœ2 <7 >Hr)xy}t}.%'$ _5'O""iHc  .~ʚs6TvR2N䋵f|<]|DF_- v/^ PA(H;(:@ _g6Ur|"{eИŴ}Z@fdAȫ@.Nf` '`B>R2T nRhwV@ɞ:3 1Z}r8@{I5ǫ:1^ڜU 1x\=Qc_^%]%Lv8iX|ic`}N.j2Gf*nRC.l8'"q<%H9áw2S{h! qVuH {<]~Jn{{.cbjeĠNm{˸Gٞ7UwBx*p0vSb䃝 ĩ֐׉$99vqF5 : hXT |,QMv5~ѧg$"%l#(Zb)"'W-MUIeJSe2^KhPoH\m n=$tnRs"a0uʅe{`vk(t"fAC\W0} ^ѬXaL'vlд^3'gJ9%qq˪$$0.o51;N< endstream endobj 18 0 obj <>stream h\j0_eɡH4`>4҃o-IO_I!Evo ,r`[vbưߓ\PZPJIN-p=D1%8)Yigx>ª2.툤]RImA\R< cO%8V^>stream hTj0lA/SuآB]E2+84G.Ρ%P-$f4tk h@p(^ !j. 1o>aױ}8Ogj 3tSmjQbW~l}욘&p|P~ǖ)SVb S:e0Е endstream endobj 20 0 obj <>stream h25U0P,H.)*M. )JM /0 endstream endobj 21 0 obj <>stream 2012-10-24T09:28:47+01:00 2012-09-17T13:44:02+01:00 2012-10-24T09:28:47+01:00 Canon iR-ADV C2020L PDF application/pdf uuid:8ca6c841-1d98-4833-99d9-c2ae8d4e3dce uuid:60c58c2b-57c6-416e-9b9c-8627ce058c8a Adobe Acrobat 10.14 Paper Capture Plug-in endstream endobj 22 0 obj <>stream h25S0Pw/+Q0L)63 )IS0i 1Q!vvr endstream endobj 23 0 obj <>stream hL @_J3ӆ". 7]BD;"ɅKwf$ƎZ:C*DK$X`]&_A;>Wxy, d5*ذM#T GoD.& endstream endobj 24 0 obj <>/Filter/FlateDecode/ID[]/Info 57 0 R/Length 134/Root 59 0 R/Size 58/Type/XRef/W[1 3 1]>>stream hbb&F L ߀$;D24?<% X"D] ~,&yA.4DMfo|u`6 s?, YaA&d".gd0|\ endstream endobj startxref 116 %%EOF